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Abstract
Kallmann’s syndrome (KS) is characterised by the association of anosmia (a loss 
of sense of smell) and hypogonadotrophic hypogonadism. Defects of anosmin-1, a 
protein encoded by KAL-1, underlie the X-linked inherited form of KS. Anosmin-1 
comprises an N-terminal cysteine rich domain and a whey acidic protein like (WAP) 
domain, followed by four consecutive fibronectin type HI (Fnlll) like repeats. In vivo 
and in vitro studies revealed that anosmin-1 functions as an adherent extracellular 
matrix protein involved in cell adhesion and neurite outgrowth, actions dependent on 
an interaction of Fnin domains with heparan sulphate (HS). However, the binding 
characteristics and kinetics between C-terminal Fnlll domains of anosmin-1 and HS 
have not hitherto been systematically investigated. Although anosmin-1’s N-terminal 
WAP domain shares homology with serine protease inhibitors, its putative protease 
ligand is still unknown. In this thesis:
1. A Drosophila S2 cell expression system was used to express full length and 
truncated domain specific versions of anosmin-1. The full-length (PIWF4), truncated 
(PIWF1, with single FnDI-1 domain) protein, and their C172R WAP domain mutants 
were purified using Ni-NTA affinity chromatography. The high yield of PIWF1 
protein enables the generation of an anti-anosmin-1 antibody.
2. A HS competitive assay showed that anosmin-1 was S2 cell surface associated 
through a Fnlll domain-HS interaction. A solid phase ELISA assay indicated purified 
anosmin-1 bound to HS in a dose-dependent manner. Surface plasmon resonance 
(SPR) revealed real-time kinetic interactions with K& = 2 nM.
3. Urokinase-type plasminogen activator (uPA) was identified as a putative anosmin- 
1 interactant. Anosmin-1 significantly enhanced uPA amidolytic activity in vitro; 
anosmin-1 /HS/uPA cooperation induced cell proliferation in a PC-3 prostate 
carcinoma cell line. Both the HS interaction and an intact WAP domain are required 
for anosmin-l’s mitogenic activity. These effects appear to be mediated by a direct 
protein interaction between anosmin-1 and uPA since anosmin-1/uPA complex can be 
co-immunoprecipitated from PC-3 cell lysates as well as their higher binding affinity 
(Kd = 6.91 nM) is demonstrated by SPR. I thus propose that anosmin-1 may modulate
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uPA’s catalytic activity and its signalling pathway, whereas HS determines cell 
surface localization of the anosmin-1/uP A complex.
4. The structure of anosmin-1 was investigated by analytical ultracentrifugation and
Y.rav criiifmina wnArimpntc fnllnw<v1 Kv hnmnlnm/ mnHptltno PTWF4 wac etimim tr»
uPA’s catalytic activity and its signalling pathway, whereas HS determines cell 
surface localization of the anosmin- 1/uPA complex.
4. The structure of anosmin-1 was investigated by analytical ultracentrifugation and 
X-ray scattering experiments, followed by homology modelling. PIWF4 was shown to 
exhibit an extended conformation, whereas PIWF1 was supposed to possess a relative 
compacted structure.
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Chapter 1
General Introduction
1.1 Introduction to Kallmann’s syndrome
Kallmann’s syndrome (KS) is the association of hypogonadotrophic 
hypogonadism (HH) and anosmia (a loss of sense of smell), first described in 1856 by 
the Spanish pathologist Maestre de San Juan (Maestre de San Juan, 1856). It was 
subsequently recognised as an inherited entity by the American medical geneticist, 
Kallmann (Kallmann, 1944). While most presentations are sporadic, a significant 
proportion of KS cases are inherited, with pedigrees demonstrating autosomal 
dominant, recessive or X-linked modes of inheritance (X-KS). Although HH and 
anosmia represent the sine qua non diagnostic features of KS, depending on the mode 
of inheritance, KS may occur together with a variety of apparently discordant 
abnormalities (Oliveira et al., 2001). Signs specifically associated with the X-linked 
form of the disease include upper body mirror movements, affecting about 80% of 
cases, and unilateral renal agenesis occurring in approximately 30% of cases. Until 
recently, the phenotypes associated with the autosomal forms of KS were thought to 
be less consistent, with a heterogeneous collection of associated defects present in a 
minority of cases including midline/craniofadal abnormalities (harelip and cleft plate), 
mental retardation, sensorineural deafness, colour blindness and spastic paraplegia, 
eye movement disorders and cerebellar signs (Wegenke et al., 1975; Conrad et al., 
1978; Oliveira et al., 2001; Quinton et al., 2001). About 1 in 10,000 males suffer from 
this disease, with a frequency five to seven times lower in females (Jones and 
Kemmann, 1976).
In KS, anosmia is caused by olfactory bulb dysgenesis; although first 
documented as a post mortem finding, it is now diagnosable in life using high 
resolution MRI scanning of the brain. This charateristically shows defective olfactory 
bulb and sulcus formation. Postnatal nasal biopsies also show abnormal morphological 
features in the olfactory epithelium, consequent upon lack of central connectivity 
(Quinton et al., 1996; MacColl et al., 2002a). The hypogonadotrophic hypogonadism
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is secondary to hypothalamic GnRH (gonadotrophin releasing hormone) neuronal 
deficiency leading to failed release of luteinising hormone (LH) and follicle 
stimulating hormone (FSH) from the pituitary gonadotrophs (Oliveira et al., 2001; 
Pitteloud et al., 2002; MacColl et al., 2002b). Although micropenis/cryptorchidism 
may represent die earliest clinical manifestation of the condition, most KS patients 
present in adolescence with failed or, more rarely, arrested puberty. The successful 
administration of exogenous pulsatile subcutaneous injection (sc) or intravenous 
injection (iv) GnRH in invariably producing phasic release of LH and FSH in KS 
patients (used therapeutically to induce puberty and fertility), has confirmed the 
hypothalamic origin, of the HH (ie hypothalamic GnRH neuronal deficiency), and has 
proved thin gonadotrophs retain their functional secretory capability (Oliveira et al., 
2001; Pitteloud et al., 2002).
Bimanual synkinesis, a defining feature of X-KS, has been attributed to 
misrouting of decending corticospinal tract axons. Cross correlation analysis of 
surface electromyograms and electromagnetic stimulation of the motor cortex hand 
areas have revealed fast bilateral conducting projections from each motor cortex in X- 
KS patients, implicating the presence of a novel ipsilateral corticospinal tract (Krams 
et al., 1997; Mayston et al., 1997; Krams et al., 1999). Statistical analysis of pooled 
white matter data from structure T1 weighed MR images has also demonstrated a 
hypertrophied corticospinal tract in the X-KS patients compared with autosomal KS 
and normal controls (Krams et al., 1999).
Non-neurological associations of X-KS include urogenital defects such as 
unilateral renal agenesis and possible renal dysplasia leading to premature renal failure 
(Duke et al., 1998). It has been proposed that defects in the initial branching of the 
mesonephros at the stage of uretic bud formation may be present in X-KS. However, 
defective condensation of the metanephrogenic blastema that forms the metanephros, 
possibly due to loss of growth signaling or abnormal reciprocal mesenchymal- 
epithelial cell interactions necessaiy for organogenesis (Duke et al., 1998; Hardelin et 
al., 1999; Woolf, 2001), could also be implicated.
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1.2 Pathophysiology of KSolfaetory system
The joint origin and migration pathway of olfactory and GnRHl neurons provide 
important clues as to the pathogenesis of the defining diagnostic features of anosmia 
and hypogonadotrophic hypogonadism in KS. To understand the effects of disrupted 
morphogenesis, the normal development of olfactory system is first described.
The olfactory, vomeronasal, terminal neurons (cranial nerve 1 complex) and 
GnRHl neurons derive from precursor neuron cells in the olfactory placode. In the 
human, axons of the cranial nerve 1 have begun to migrate towards the telencephalon, 
reaching die olfactory bulb (OB) anlage as early as embryonic week four, prior to the 
appearance of GnRH immunoreactivity in the medial olfactory placodes (about 6 
weeks). GnRHl neurons migrate along the medial portion of the olfactory nerve fibres 
and at 6.5 weeks enter the medial forebrain at a location slightly caudal to the junction 
with the olfactory nerve (Schwanzel-Fukuda et al., 1996) (Figure 1.1).
Upon reaching the anterior telencephalon, pioneer axons of olfactory neuron 
penetrate deeply into the forebrain to induce OB development proper; subsequently 
later olfactory fibres anchor at the surface of the telencephalon to form the olfactory 
nerve layer of the outmost OB. Several days prior to die arrival of the first olfactory 
neuron into the telencephalic vesicle/OB primordium, mitral and tufted cells are bom 
in this region and subsequendy proliferate. In the human, at 8 weeks the olfactory 
bulbs form a distinct structure by protruding from the forebrain in a caudo-lateral 
direction. At 15 weeks, after the appearance of an obvious OB outgrowth from the 
forebrain, specific synaptic structures called “glomeruli” start to be formed by the 
output dendrites of mitral cells with input axons of olfactory sensor neurons, combined 
with later generation of intemeurons, giving rise to the bulk of the glomerular layer. 
The axons of mitral/tufted cells proceed caudally and move ventrolaterally to form the 
lateral olfactory tract (LOT) and finally innervate their telencephalic destinations 
including the anterior olfactory nucleus, the pyriform cortex, the olfactory tubercle and 
the amygdaloid nuclei (Brunjes and Frazier, 1986). By contrast, neuroblasts from the
21
(a)
CP
'ON
NM
CP
ORN
OB
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OE
Figure LI Schematic diagram showing olfactory system development during human 
embryogenesis. (a) 4 weeks (CS 13) 8/9 mm. (b) 5.5 weeks (CS 17), 11/12 mm. (c) 6 
weeks (CS 18), 13/15 mm. OP, olfactory placode; PON, primary olfactory neurons; 
bv, blood vessel; NM, nasal mesenchyma; CP, cribriform plate; F, forebrain; ORN, 
olfactory receptor neurons; OE, olfactory epithelium; OB, olfactory bulb; TN, 
terminal nerve;A, GnRH immunoreactivity. (Taken from Gonzalez-Martinez et al, 
2004)
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ventral telencephalon and anterior subventricular zone (SVZ) migrate towards OB as 
part of the rostral migratory stream (RMS), differentiating into GABAergic 
intemeurons upon reaching the OB. The major type of these intemeurons, the 
periglomerular cells and granule cells, develop the connective network with 
mitral/tufted cells as a negative regulator and complete die layering of die OB which 
comprises external and internal plexiform and granule cell layers (Goldman and 
Luskin, 1998) (Figure 1.2).
GnRHl neurons enter the ventromedial forebrain, caudal to the anlage of the 
olfactory bulb, and course along the medial surface of the cerebral hemispheres to 
enter the septal and preoptic areas of the brain and importandy, the supraoptic 
hypothalamus. From these areas, GnRHl neuron subsequendy extend axons to the 
median eminence capillary system, where neurosecretion occurs (Ronnekleiv and 
Resko, 1990; Norgren and Brackenbury, 1993). GnRH peptide secreted in a pulsatile 
manner passes to the anterior lobe of the pituitary where it stimulates the pulsatile 
release of LH and FSH, leading to stimulating germ cell development in testes and 
ovaries, testosterone and oestrogen synthesis and secretion respectively, together with 
the ensuing development of secondary sexual characteristics (Schally et al., 1971).
The important permissive role of the olfactory nerve and indeed the cranial nerve 
1 complex in guiding GnRHl neurons into the telencephalon has been clearly 
established in olfactory transection studies which effectively disabled GnRHl 
neuronal migration into its forebrain target (Murakami et al., 1998). In X-KS patients, 
initial development of olfactory and GnRHl neurons occur normally, although 
immunohistochemical analysis of nasal epithelial biopsies from affected subjects do 
demonstrate immature olfactory epithelial neuronal bodies and persistent existence of 
GnRH 1 -immunoreactive neurons in olfactory epithelium (Quinton et al., 1997). These 
observations implicate a developmental disorder within the anterior tip of 
telencephalon during morphogenesis, rather than abnormal ontogeny of the early 
precursor neurons within olfactory placodes in X-KS. Immunohistochemical study of
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Figure 1.2 Diagram depicting the layered structure formation in mature human 
olfactory bulb. The olfactory receptor neurons enter the forebrain and form the outer 
olfactory nerve layer. Their axons synapse with output neurons of the mitral/tufted 
cells in the specialised sites called glomerulus. With the further connection of 
periglomerular cells to glomerulus, the glomerular layer is formed. Beneath the 
glomerulus is the external plexiform layer, mitral cell layer and internal granule cell 
layer. Axons of the mitral/tufted cells proceed caudally and move ventrolaterally to 
form the lateral olfactory tract before terminating at the olfactory cortex. Neural 
precursors from the subventricular zone (SVZ) migrate along the rostral migratory 
stream towards the centre of the olfactory bulb where they differentiate into 
intemeurons including granule and periglomerular cells The short arrow indicates the 
differentiation of neural precursors to granule cells; the long arrow marks the 
periglomerular cells. EPL, External plexiform layer; GCL, granule cell layer; GL, 
glomerular layer, MCL, mitral cell layer; ONL, olfactory nerve layer. (Taken from 
Murase and Horwitz, 2002).
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a 19-week KAL-1 deleted foetus has also shown an initial preserved rostral trajectory 
of olfactory axons but subsequent migratory arrest of both these axons and GnRHl 
neurons at the upper nasal sub-cribriform area (Schwanzel -Fukuda and Pfaff, 1989) 
(Figure 1.3>.
Clinical observations, including nasal epithelial biopsies and magnetic resonance 
imaging (MRI) studies in KS patients have demonstrated dysplastic OB or 
conspicuous absence of the olfactory bulbs/sulci and reduced volume of the olfactory 
cortex (Quinton et al., 2001; Vermeulen et al., 2002). Very low or absent 
gonadotrophin secretion in KS patients with preserved pituitary responsiveness to 
exogenous GnRHl, confirms the hypothalamic origin of GnRHl deficiency. Thus, the 
failed formation of OB and the disruption of the intracerebral common migratory 
pathway of olfactory and GnRHl neurons comprise the main pathological defects in 
KS patients. To date, the molecular mechanisms for this abnormal neuronal 
development are still far from being completely elucidated. Such mechanisms would 
be predicted to involve cell-cell interactions as well as axonal guidance, and will be 
discussed fully later in the introduction.
1.3 Genetics of KS
Although most cases are sporadic, three modes of familial KS inheritance have 
been identified: X- linked (X-KS), autosomal dominant and autosomal recessive. The 
gene causing X-KS, KAL-1, has been cloned and localised to the Xp22.3 region by 
classical pedigree analysis and positional cloning; cloning and validation of this locus 
was the result Of work from two independent laboratories in 1991 (Legouis et al., 
1991; Franco et al., 1991). The genomic structure of KAL-1 gene comprises fourteen 
exons encompassing 220 kb, and this generates a cDNA with a 2043 bp open reading 
frame. The 2 kb region upstream of the coding sequence shows high GC rich content 
and contains a CCAAT box, a common transcription factor binding site to a number of 
house keeping genes and tissue specific genes such as nerve growth factor (Sehgal et 
al., 1988). The promoter and enhancer sequences have not been fully elucidated; 
however, a 12 nucleotide sequence upstream of the coding sequence of KAL-1,
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CP
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Figure 1.3 Diagram depicting the disruption of olfactory neuron pathway in a 19-week 
KAL-1 deleted foetus, (a) Normal development of olfactory neuron pathway. 
Olfactory receptor neuron (ORN) and GnRH neuron (▲) migrate form their originals 
of olfactory epithelium (OE), through the cribriform plate (CP), and penetrate into 
developing forebrain, (b) The disrupted olfactory pathway in a 19-week X-KS foetus 
was identified by immunohistochemistry. The initial ontogenesis of olfactory neurons 
appears normal. However, there is arrest of GnRH neuron beneath the dura at the level 
of the cribriform plate.
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proposed to be the candidate promoter site seen in certain CNS expressed genes 
(Thompson and ZifF, 1989), may be relevant in this regard.
The genetic analysis of X-KS pedigrees has demonstrated a predominant loss of 
function mutations (deletion and nonsense mutations) within KAL-1 (Maya-Nunez et 
al., 1998a; Soderlund et al., 2002). Of relevance, five missense mutations have so far 
been identified; they are: 1) two nucleotide substitutions in exon 4 (TGT to TAT at 
codon 163, TGT to CGT at codon 172); 2) exon 6 (AAT to AAA at codon 267); 3) 
two nucleotide substitutions in exon 11 (GAA to AAA at codon 514, TTC to TTG at 
codon 517) respectively. These cause C163Y, C172R, N267K, E514K and F517L 
alterations at the amino add level (Hardelin et al., 1993; Georgopoulos et al., 1997; 
Maya-Nunez et al., 1998b; Olivdra et al., 2001; Sato et al., 2004). The absence of 
mutations in a majority of patients suggests the possibility of the existence of 
mutations within the KAL-1 promoter or enhancer region.
Homologues of KaLl genes have been identified in a wide number of species 
from vertebrates (chicken P33005, zebrafish AF163310 and AF163311) to 
invertebrates {Drosophila AF342988, Caenorhabditis elegans AF342986). However, 
the corresponding KaLl gene has not been cloned in the rodent, possibly due to the 
gene bdng located in the mouse pseudoautosomal region. Significantly, the human 
and C.elegans anosmins have the same conserved domain structure (WAP, followed 
by 4 Fnin domains), and in an in vivo transgenic experiment, the human KADI 
sequences rescued die abnormal phenotype caused by loss of the C.elegans KaLl gene 
(Bulow et al., 2002; MacColl et al., 2002a), indicating functional conservation of this 
gene product during evolution.
Recently, using genetic analysis of polymorphic markers combined with 
fluorescence in situ hybridisation (FISH) analysis, an autosomal dominant gene (KAL- 
2) has been identified on chromosome 8pll-pl2, bearing a microdeletion in two 
individuals with Kallmann’s syndrome (Dode et al., 2003). FGFR1 has been proposed 
as a dominant autosomal locus for KS based on the demonstration of potential loss-of-
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function mutations of FGFR1 in individuals from pedigrees where die mode of 
inheritance was most likely autosomal dominant. The high prevalence of cleft palate 
defects in these patients with FGFR1 mutations is striking, together with rarer 
associations such as multiple dental agenesis, hearing loss, agenesis of the corpus 
callosum, and bimanual synkinesis in one case. No renal aplasia was reported in any 
affected individual. Recendy reported loss of function mutations of FGFRJ and their 
associated clinical phenotypes are summarised in Table 1.1. Thus mutations involving 
FGFR1, appear to account for one autosomal dominant form of KS, representing a 
further important gene involved in olfactory bulb morphogenesis. The autosomal 
recessive gene (KAL-3) has not hitherto been identified,
1.4 Characteristics of anosmin-1, the KAL-1 gene encoded protein
The open reading frame of KAL-1 cDNA encodes a 680 amino adds conceptual 
modular protein, named anosmin-1, which consists of an N-terminal signal peptide, a 
cysteine-rich region, a whey acidic protdn-like four-disulfide core motif (WAP) and 
four contiguous fibronectin-like type m  domains (Fnm), followed by a histidine rich 
C terminus (Legouis et al., 1991; Franco et al., 1991) (Figure 1.4). The sequence 
characteristics with a 23 N-terminal residue signal peptide, together with the absence 
of a hydrophobic transmembrane region and glycosyl phosphotidyl inositol (GPI) 
anchorage site, suggest anosmin-1 is a secreted protein. Six potential N-glycosylation 
sites are predicted within the cysteine-rich region and the 4 consecutive Fnm domains, 
giving rise to an augmentation of molecular weight from the conceptual 74 kDa 
protein to the mature size of approximately 100 kDa observed in in vivo and in vitro 
analyses and confirmed by experiments using the N-glycosylation inhibitor 
tunicamydn C (Soussi-Yanicostas et al., 1996; Soussi-Yanicostas et al., 1998; Soussi- 
Yanicostas et al., 2002). Post-translational modification of newly synthesised proteins, 
such as glycosylation, has an important role in protein folding and secretion, as well as 
binding of ligand to receptors and in cellular recognition events (Lis and Sharon, 
1993). Hitherto, there has been no conclusive proof of which sites are glycosylated 
within anosmin-1.
28
C163YC172R N267K
H — ^
E514KF517L
Fnl I-2 Fnlll-3Fnlll-1
553 564
Fnlll-4 IHJ C
1 24 120 131 176 181 285 402 540 661 680
Figure 1.4 Schematic structure of human anosmin-1 protein and five missense 
mutations. Each domain is represented by a circle and residue numbering indicates 
the size of each domain. Hie positions of the five known missense mutations are 
indicated by arrows. The predicted six N-linked glycosylation site are also marked 
by numbered Y symbols. SP, signal peptide; CR, cysteine rich region; WAP, whey 
acidic protein-like domain; FnlQ, fibronectin type in domain; H, histidine rich 
region.
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Table 1.1 Mutation of KAL-2 gene associated with Kallmann's syndrome
Mutation Exon/Intron Kallmann's syndrome 
associated symptoms
Reference
G97D exon 3 A
Y99C exon 3 A
S107X exon 3 B
303-304 ins CC exon 3 A
A167S exon 5 cleft palate, corpus callosum 
agenesis, unilateral hearing loss
A
C277Y exon 7 A
936 G toA exon 7 (donor 
splice site)
multiple dental agenesis A
V607M exon 13 bimanual synkinesis A
R622X exon 14 cleft lip or palate A
1970-1971 delCA exon 14 A
W666R exon 15 cleft palate A
IVS15+ lG to A intron 15 (donor 
splice site)
A
M719R exon 16 A
P745S exon 17 B
P772S exon 18 cleft palate, unilateral absence 
of nasal cartilage, iris 
coloboma
A
A— Dode, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant 
Kallmann syndrome. Nat Genet. 2003;33:463-5.
B— Sato, et al. Clinical assessment and mutation analysis of Kallmann syndrome 1 
(KALI) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five 
families and 18 sporadic patients. J Clin Endocrinol Metab. 2004;89:1079-88
30
la previous experiments using both KAL-1 cDNA transfected COS-7 cells and 
Drosophila S2 cells (Rugarli et al., 1996; Robertson et al., 2001), expressed anosmin-1 
appeared to be cleaved, generating 55 kDa N-terminal and 45 kDa C-terminal 
fragments. However, in these studies, protein expression occurred in serum-containing 
medium; in contrast, only the full-length anosmin-1 has been detected in tissue-extract 
samples, suggesting that the cleavage is an experimental artefact, possibly caused by 
the supplemented serum during cell culture.
1.5 Suggested anosmin-1 functions based on in vivo and in vitro studies
1.5.1 Spatio-temporal expression of anosmin-1
Anosmin-1 was detected from the 5 human embryonic week in mitral cells and 
within the extracellular matrix of the presumptive olfactory bulb, prim* to the time 
when olfactory receptor neurons first make contact with the dendrites of basal 
tel encephalic mitral/tufted cells. Anosmin-1 was also detected in the medial wall of the 
primitive cerebral hemispheres through which GnRHl neurons migrate to their final 
destination and disengaged from their guidance fibres (Hardelin et al., 1999). 
Furthermore, anosmin-1 was also expressed along the lateral olfactory tract (LOT) 
formed by afferent axons of mitral cells and in the olfactory cortex from E14 in the rat 
(Soussi-Yanicostas et al., 2002). In addition to expression in the olfactory system, 
anosmin-1 immunoreactivity was widely detected in the basement membranes and/or 
interstitial matrices of various structures including mesonephric tubules and duct, 
branches of the ureteric bud, bronchial tubes, muscular walls of the digestive tract and 
larger blood vessels, precartilaginous models of skeletal pieces, muscle tendons, head 
mesenchyme, inner ear, and forebrain subregions (Hardelin et al., 1999). While 
expression in the developing kidney suggests a key role of anosmin-1 in nephrogenesis 
(based on the X-KS phenotype), there are no other clinical correlates of expression in 
other tissues.
1.5.2 Anosmin-1, neurite outgrowth and axon branching
Dual properties of anosmin-1 on neurite outgrowth have been observed in vitro. 
Cerebellar neurons obtained from 5-day old (P5) mice developed longer neurites when
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cultured on 3 pg/ml anosmin-1 coated wells, whereas their neurite outgrowth was 
reduced when co-cultured with anosmin-1-producing CHO cells. The opposite effects 
of anosmin-1 on neurite outgrowth observed in these experiments may be caused by 
difference of anosmin-1 concentrations used, one at constant levels as compared to the 
other with continuous secretion of anosmin-1 from co-cultured cells. These activities 
were also cell-type specific since anosmin-1 induced no phenotypic changes in £18 
hippocampal and PI dorsal root ganglion neurons under the same experimental 
conditions (Soussi-Yanicostas et al., 1998), suggesting that for functional responses 
the putative receptors or co-ligands are expressed in specific neuronal cells.
Recently, in a systematic study of rat OB explants, dissociation of OB neurons 
and organotypic cultures showed that recombinant human anosmin-1 either stimulated 
LOT neurite branching and outgrowth or attracted axons of LOT growing 
preferentially from OB explants towards the pyriform cortex (Soussi-Yanicostas et al., 
2002). Thus, absence and mis-guidance of LOT axon branches would be expected to 
lead to loss of innervation to the olfactory cortex, with a reciprocal involution of the 
OB. The transgenic invertebrate studies carried out in C.elegans have yielded results 
similar to that obtained in rat explants with respect to axon branching and neurite 
outgrowth (Bulow et al., 2002; Rugarli et al., 2002). The alteration in neuronal 
phenotype induced by the nematode KaUl orthologue (CeKall) is dosage and time- 
dependent, both in loss of function mutants and when CeKal is overexpressed in a 
number of neuronal subtypes. These findings suggest that anosmin-1 is involved in at 
least two processes in the developing olfactory system: OB development and 
convergence of LOT neurons towards their olfactory cortical destination, partially 
accounting for the pathogenesis of the olfactory deficit in KS patients.
1.5*1 Anosmin-1 as an adherent extracellular matrix (ECM) molecule
Although the dominant phenotype in X-KS relates to aberrant development of the 
nervous system, a heterogeneous collection of non-neurological focal disorders are 
also observed including renal aplasia (Oliveira et al., 2001). Indeed, anosmin-1 has 
been identified as an adhesion ECM molecule for a variety of neuronal and
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nonneuronal cell types, including rat olfactory epithelia cells, GT1-1 (mouse GnRH 
neuron-derived cell line), cerebellar neurons and canine MDCK1 kidney epithelia cells 
(Soussi-Yanicostas et al., 1998; Robertson et al., 2001). In keeping with this 
observation, the loss of function and over-expression of KAL-1 mutants in the 
transgenic C.elegans also caused at least two distinct morphogenetic abnormalities: 
defective ventral enclosure and male tail formation defects (Rugarli et al., 2002). In 
addition to disrupted development, in certain instances, variably penetrant embryonic 
lethality was also observed. Visualisation of epithelial ceil boundaries and tail 
epithelial cells indicated that, during gastrulation and tail morphogenesis, epidermal 
cells differentiated correctly and migrated along the neuroblast cell surface, but 
exhibited abnormal contacts, positioning and shape. Taken together, anosmin-1 
appears to play a determining role in providing an active signal and/or a permissive 
substrate in modulating the formation or stabilisation of epithelial cell contacts in a 
strictly dose-dependent manner.
1.5.4 WAP and FnlH domain function in anosmin-1
The high conservation of WAP domain evident in a wide number of species from 
vertebrates (chicken, zebrafish, human) to invertebrates (Drosophila, Caenorhabctitis 
elegans) suggests a crucial role of this motif in the integral protein (Figure 1.5(a)). 
Clinical evidence for this prediction is provided by the presence of a missense 
mutation generated by a C172R (cysteine into arginine at codon 172) substitution 
shared by three X-KS brothers (Oliveira et al., 2001). In addition to anosmia and HH, 
synkinesia was observed in all of them, with bilateral cryptochidism in two and 
unilateral renal aplasia in one. Another missense mutation of C163Y has recently been 
described in an X-KS family accompanied by mirror movements. These single amino 
add substitutions are predicted to disrupt the conserved C151-C163, C157-C172 
disulphide bonds within the WAP domain. These findings emphasize the functional 
importance of the WAP domain for olfactory system, corticospinal tract and renal 
development.
33
(a)
Human 
Chick 
Zebrafish 
Drosophila 
C.Elegans
(b)
Anosmin-1 130 
ps20 62
HE4 77
Elafin 72
SLPI 85
Figure 1.5 (a) Sequence comparison of anosmin-l’s WAP domain within 
vertebrate/invertebrate. The positions of the four-disulphide bridges and the identity 
of amino acid sequence to anosmin-1 are indicated. The highly conserved residues 
are indicated with grey background, (b) Multiple sequence alignment of human 
WAP domain sequences in homologous proteins. Databases accession numbers 
corresponding to SWISS-PROT or TrEMBL are P23352 (anosmin-1), Q9HC57 
(ps20), Q14508 (HE4), P19957 (Elafin) and P03973 (SLPI). Residue numbers 
correspond to the beginning of each domain. The conserved cysteine residues are 
shown in yellow type with a grey background.
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Indeed, homologous four-disulfide core motif (4-DSC) proteins have been 
identified in other members of the WAP family, namely elafin, secretory leukocyte 
protease inhibitor (SLPI), PS20, human epididymal secretary protein (HE4) Mid rat 
WDNM1 (Figure 1.5(b)). The first two proteins have been found to inhibit serine 
protease activity, a property attributed to the WAP domain (Heinzel et al., 1986; 
Wiedow et al., 1990); members of this family also exhibit fundamental roles in cell 
growth control, differentiation, and tissue remodelling (Larsen et al., 1998). For 
instance, elafin inhibits pulmonary artery smooth muscle cell proliferation by 
inhibition of elastase-mediated proteolytic release of mitogenic active FGF-2 from 
ECM (Thompson and Rabinovitch, 1996). WDNM1 gene downregulation has been 
linked with tumorogenesis in metastatic rat mammary adenocarcinomas (Dear and 
Kefford, 1991). PS20 is a novel WAP protein family member that shares about 30% 
amino acid similarity with anosmin-1 WAP domain. Its expression has been identified 
in rat prostate smooth muscle and vascular smooth muscle. It can inhibit the 
proliferation of prostate carcinoma (PC-3) and COS-7 cells, acting possibly via 
reduction of active insulin-like growth factor n  availability secondary to decreased 
serine protease activity (Larsen et al., 1998). Based on these models, it was 
hypothesised that an important function of the anosmin-1 WAP domain might be to 
regulate cell proliferation and possibly differentiation, by an interaction with a relevant 
serine protease, and that such an activity might be altered in the C172R or C163Y 
missense mutations.
By contrast, the Fnm domain was predicted to demonstrate heparan sulphate 
(HS)-binding activity, there being high homology within these motifs with a number 
of NCAM superfamily members, such as NrCAM, NgCAM, LI and neurofascin 
(Lander, 1989). These CAMs have roles in neuronal interaction, migration and axonal 
elongation (Dodd and Jessell, 1988; Lander, 1989). While the homologies with these 
CAM molecules suggest direct Fnin domain involvement in neuronal development, it 
could not be excluded that these domains possess other functional characteristics. For 
example, part of the Fnm domains in the insulin and IGF receptors determine the 
affinity and specificity of ligand binding (Kristensen et al., 1999; Molina et al., 2000),
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possibly through regulating the structure/function of N-terminal binding motifs. Thus, 
upon attachment to HS, the Fnm domain might modify the WAP domain 
configuration, exposing the active site for ligand binding. Furthermore, it might be 
expected that the Fnm domains of anosmin-1, and indeed its tertiary structure, 
determine its adherent properties as well as conferring the binding specificity of 
anosmin-1.
Recent transgenic studies using KAL-1 over-expression mutants in C.elegans are 
consistent with the multifunctional roles of these two domains (Bulow et al., 2002). 
Axonal branching and the misrouting activity of sensory neurons appear to depend on 
the different domains of the C.elegans anosmin; thus the WAP domain induces the 
misrouting phenotype whilst the Fnm domains control neurite outgrowth and 
branching, both dependent on HS interactions. Moreover, with respect to the protein 
domain alignment, the highly conserved regions of anosmins in various species from 
invertebrates to vertebrates are localised to the N-terminal WAP and the first Fnm 
domains, implicating these fragments in the molecule biological activity (MacColl et 
al., 2002a).
1.6 Molecular modelling of anosmin-1
Difficulties in generating milligram quantities of purified anosmin-1 have 
curtailed structural studies of the three-dimensional structure of anosmin-1, necessary 
for the understanding of structure-function relationships. Computer generated protein 
homology modelling has partially overcome this problem. In previous work from this 
laboratory (Robertson et al., 2001), theoretical model structures for the WAP domain 
and Fnin domains of anosmin-1 were generated based on protein homologies with the 
established elafin protease inhibitor structure and 23 structures from 12 crystal and 
NMR structures of Fnm domains respectively.
Based on the crystal and NMR structures for elafin, a WAP domain model of 
anosmin-1 was successfully generated. Elafin has four-disulphide bridges: three 
disulphide bridges are clustered together in a plane (“base” disulphide bridges) linking
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the P-sheet core of the protein to the external strands and a single disulphide bridge 
linking the inner core to the external loop interacting with the protease. In the 
homology molecular model for anosmin-1, the cluster of disulphide bonds of Cl 34- 
C164, C151-C163 and C157-C172 serve as the base disulphide bridges for the 
structural scaffold, and a single disulphide bridge of C147-C168 links the active site to 
the core. Notably, the cysteine-147 of anosmin-1 had to be relocated to the opposite 
side of the surface loop in relation to cysteine-83 of elafin. Thus, the equivalent 
position of the predicted scissile peptide bond of anosmin-1 was shifted to glycine- 
142-phenylalanine-143 in front of the second cysteine residue, but was still located on 
the outside of the bottom of the model. Although it is unknown whether this structural 
arrangement might result in an inhibitory activity similar to the serine protease 
inhibitory activity of elafin, this site is highly likely to represent a potential WAP- 
binding motif for protease or receptor.
The four anosmin-1 Fnm domains could be defined in terms of seven conserved 
P-strands (denoted A, B, C, C’, E, F and G). The GFCC’ sheet of the Fnm domain is 
functionally important for intermolecular interactions. A large basic surface 
electrostatically mapped onto the individual Fnm domain is predicted to represent a 
HS-binding site, and contains the HS binding-sequence, S278KHFRK283 on the P-strand 
G of Fnm-1 domain, V325HHYKV330 on the p-strand C of FnIII-2 domain and the 
Q421RRRPTRP428 at the beginning of Fnffl-3 domain, all of which are highly 
conserved in the human, chicken and quail. Two other predicted HS-binding sites are 
located immediately following the four Fnm domains in anosmin-1 at residues 
660±665 and residues 670±675. All three other Fnffl missense residue substitutions 
(N267K, E514K, F517L) observed in patients with X-KS could be mapped to the 
GFCC’ p-sheet of Fnm-1 and Fn-III-3 domains, in close proximity to the large basic 
surface; these might be predicted to alter the basic surface charge thereby potentially 
interfering with adherent binding to HS (Robertson et al., 2001).
1.7 Molecules involved in the olfactory system development
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Since anosmia and HH are invariable concomitants of X-KS, anosmin-1 would 
therefore appear to play an essential role in olfactory and GnRH neuronal ontogeny. 
However, anosmin-1 is only one of a large number of molecules involved in die 
ontogeny of this system. Indeed, a variety of transcription factors and growth factors 
mediate neuronal cell differentiation and proliferation, whereas other soluble and 
insoluble molecules regulate their migration, destination finding and synaptogenesis.
1.7.1 Transcription factors and growth factors
During early embryogenesis, the progenitor neuron cells throughout the CNS 
express a series of transcriptional factors of the homeodomain class and extracellular 
growth factors including the Hedgehog (HH), wingless (Wg/Wnt) and fibroblast 
growth factor (FGF) to continuously generate neurons, subdivide each CNS region 
into compartments and regulate their size (McMahon and Bradley, 1990; Hynes et al., 
1995; Meyers et al., 1998). The deficiency of Pax6 in the mouse, a homeodomain gene 
expressed as early as E10.5 (Walther and Gruss, 1991), has been shown to disturb the 
developmental formation of olfactory bulb, nasal cavities, olfactory epithelia and lead 
to the absence of GnRH-immunoreactive neurons (Walther and Gruss, 1991; MacColl 
et al., 2002b). Mutation of other homeodomain genes, including Emx, Xt, Tbrl, have 
also been shown to lead to failed generation and disrupted connections of mitral/tufted 
and OB intemeuron cells. Emx2 is expressed as early as E12.5 (Gulisano et al., 1996) 
and its mutants have been shown to cause the disorganization of mitral/tufted cells in 
olfactory bulb (Yoshida et al., 1997). hi addition, in Tbrl'7" mice, mitral cells are 
lacking, but morphogenesis of the bulb still occurs (Bulfone et al., 1998), indicating 
that mitral cell differentiation and bulb morphogenesis can occur independently of one 
another.
There are more than 20 members of the FGF family; FgfS is specifically 
expressed in the anterior forebrain from £9 to at least E12.5 (Crossley and Martin,
1995) and the partial loss of function of FgfS in E18.5 can result in a small 
telencephalon that lacks olfactoiy bulbs and a normal midline (Meyers et al., 1998). 
Fgf2 has also been implicated in cortical neurogenesis and promoting neuronal
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progenitor cell proliferation rather than in telencephalic patterning (Dono et al., 1998). 
Importantly, Fgfrl, one of four known genes encoding for the FGF receptor (FGFR), 
has been identified with morphological specificity in OB development. In the Fgfrl- 
deficient telencephalon (Hebert et al., 2003), the OB do not form and evaginate 
normally, while other anterior telecephalic structures and anteroposterior (AP) axis 
patterning are largely normal, implicating specific FGFR1 signaling-dependent 
pathways in OB morphogenesis.
1.7.2 Molecules involved in neuronal migration
At the onset of neurogenesis, neurons begin to move and migrate towards their 
final destinations and then subsequently establish the correct synaptic network. 
Several classes of molecules have been extensively studied for their potential 
influences on these pathfinding processes, including those related to local contact 
(membrane receptors and adhesion extracellular molecules) and those related to 
communication across distances (chemoattractant or repellent molecules, 
neurotransmitters) (Figure 1.6).
Several molecules are incriminated in local contact-mediated communication. 
These include: (1) Olfactory receptor (OR). OR has been demonstrated as a crucial 
molecule for accurate destination finding in OB glomerulae. Olfactory sensory 
neurons with deleted or mutated receptor expression do not converge to their original 
glomerular destination, but divert their projection to different regions (Wang et al.,
1998). (2) Cadherin-related neuronal receptor (CNRs). In the olfactory bulb, two 
different CNRs have been shown to be expressed in a single olfactory neuron while a 
small proportion of neurons expressed one or the other CNRs. Different CNR 
combinations in olfactoiy neurons could impart connection specificity (Serafini,
1999). (3) Nasal embiyonic LHRH factor (NELF). NELF has been identified on the 
surface of olfactory and GnRH neurons (Wray, 2002), and plays a role in guidance of 
these both neurons to the rostral telencephalon (Kramer and Wray, 2000). 
Interestingly, down-regulation of NELF is demonstrable when these cells enter the 
telencephalon and arrive at the outer nerve layers of the OB, suggesting that this
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Figure 1.6 Structure of the olfactory system and molecules known to mediate 
olfactory neuron migration, trajectory and convergence within olfactory bulb 
region during embryogenesis. Anosmin-1 is denoted as green dots. Group A: 
molecules expressed by olfactory neurons guide the migration and topographic 
projection of olfactory axons to the presumptive olfactory bulb. Group B: 
molecules within olfactory nerve layer are involved in specifying the olfactory 
axons projection to correspond glomeruli. Group C: molecules are expressed by 
mitral cells. Group D: molecules expressed along the olfactory tract direct 
projection of afferent mitral cell axons to the olfactory cortex. BDNF: Brain- 
derived neurotrophic factor; CC2: Cell surface glycoprotein; DCC: Deleted in 
colorectal cancer—netrin receptor; Eph: Ephrin receptor; FGF: Fibroblast growth 
factor; FN: Fibronectin; GDNF: Glial cell line-derived neurotrophic factor; IGF: 
Insulin-like growth factor; IGFBP: Insulin-like growth factor binding protein; 
LCG: Lactosamine-containing glycan; LI: Neural cell adhesion molecule; NCAM: 
Neural cell adhesion molecule; NELF: Nasal embryonic luteinizing hormone- 
releasing hormone factor, OCAM: Olfactory cell adhesion molecule; PSA-N- 
CAM: Polysialylated form of neural cell adhesion molecule; Robo: Roundabout- 
slit receptor
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molecule is location dependent and possibly induces the expression of relay cues 
specific for OB morphogenesis. (4) Ephrin and Eph receptors. From E20.5 throughout 
the early post-natal period, Ephrin-Bl and Ephrin-B2 were expressed by mitral, 
granule cell and neurons in the external plexiform layer. They then disappear in the 
adult rat olfactory system. EphB2 receptor expression is consistently stronger in the 
mitral cell layer from E20.5 to the adult. Recent data have shown that these receptor- 
binding interactions may contribute to the pruning and reorganisation of mitral cell 
dendritic trees quite apart from implicated functions in the development of the 
retinotectal map (St John and Key, 2001). (5) Olfactory cell adhesion molecule 
(OCAM) and cell surface carbohydrates including a-galactosyl-linked glycoconjugates 
(immunoreactive with CC2 monoclonal antibody) and lactosamin-containing 
glycoconjugates (LCG) are molecules expressed by olfactory neurones that 
projectaxons to the different restricted segments of the OB. OCAM* neurones project 
axons to the OB excluding the dorsomedial quadrant, which is targeted by CC2+ axons 
(Schwarting and Crandall, 1991; Yoshihara et al., 1997). In contrast, LCG (+) axons 
specifically project to the ventral nerve layer of the OB (Crandall et al., 2000). 
Interestingly, only migratory GnRH neuron cells but not hypothalamic GnRH cells 
express immunoreactive LCG, implicating the involvement of this molecule in GnRH 
migration. (6) Cell adhesion and ECM molecules including laminin, fibronectin, 
neural cell adhesion molecule (NCAM), tenascin, galectin and proteoglycans are 
known to play significant roles in development of the nervous system. The expression 
pattern of laminin, fibronectin and NCAM along the primary olfactory neuron 
migratory pathway delineate and guide olfactory neuron axons to correctly project 
towards telencephalon through cell-ECM attachment (Calof and Lander, 1991; 
Whitesides, HI and LaMantia, 1996). Laminin-induced migration of embryonic 
olfactory neurons can be mediated and enhanced by an endogenous lectin, galectin-1 
(Mahanthappa et al., 1994; Gong and Shipley, 1996). Despite providing the adhesion 
highway for olfactory neuron movement, these molecules might directly stimulate the 
neurite outgrowth as they do on neurongenesis (Moos et al., 1988; Gong and Shipley,
1996). The importance of the polysialylated form of NCAM (PSA-NCAM) has also 
been shown on progenitor neuron cell migration from the subventricular zone (SVZ)
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to their OB target. GnRHl cells migrate along the route delineated by immunoreactive 
PSA-NCAM (Murakami et al., 2000). Furthermore, there have been several studies of 
proteoglycans in the ECM of the developing olfactoiy system. The heparan sulphate 
proteoglycans (HSPG) have been proposed to provide conductive cues for axon 
growth from olfactory epithelium to forebrain whilst chondroitin sulphate 
proteoglycans (CSPG) in surrounding mesenchyme restrict this migration (Treloar et 
al., 1996). Additionally, HSPG acts as activity-regulators on a wide range of insoluble 
or soluble molecules, which are further discussed in the next section.
Soluble molecules for distance-mediated communication: (1) Semaphorin 
(Sema)/neuropilin. Semaphorin 3A has been shown to repel the olfactoiy neuron 
expressing its receptor neuropilin-1 to project medially and laterally into the OB nerve 
layer, avoiding projection to OB ventral region with abundant semaphorin 3A 
expression (Crandall et al., 2000; Schwarting et al., 2000). Interestingly, different 
functions were observed within the secreted Serna family. Serna 3F repels LOT 
axons, preventing them penetrating the cortical plate and ganglionic eminence, while 
Serna 3B attracts LOT axons retaining them to the surface of the telencephalon (de 
Castro et al., 1999). (2) Slit/ roundabout (Robo). Slit proteins are putatively secreted 
by the septum and act as a long-range diffusible factor through their functional 
receptor Robo, a member of the immunoglobulin superfamily. The dominant effect of 
these ligands and their receptor- notably Slit2 and Robo-1 is to repel the LOT axons 
migration within the certain restricted pathway along lateral olfactory tract (Li et al., 
1999; Hu, 1999; Nguyen Ba-Charvet et al., 1999). The Slit2-Robo-l interaction is 
enhanced by cell-surface associated HS; the affinity of Slit for Robo is reduced some 
threefold in the absence of HS (Hu, 2001). (3) Netrin/deleted in colorectal cancer 
(DCC). The functional receptor for secreted molecules of the Netrin family, DCC is 
strongly expressed in developing mitral cells of the OB (Shu et al., 2000). However, 
neither secreted Netrin-1 nor a secreted form of the Netrin-Gl shows any effect on OB 
axonal outgrowth (de Castro et al., 1999; Li et al., 1999; Nakashiba et al., 2000). In 
contrast, Netrin and DCC interaction has been implicated in GnRH neuron guidance
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and migration, more specifically in axon targeting to the median eminance (Deiner and 
Sretavan, 1999).
1.8 HS -  molecular cross talk with anosmin-1
Recently, Bulow et al performed a genetic modifier screen in C.elegans to 
identify loci that selectively interact with the KAL-1 expression induced phenotype. 
Modifier loci encoding heparan-6-O-sulphotransferase and C5 epimerase (Bulow et 
al., 2002), which are crucial for normal HS synthesis, were identified; these findings 
concur with the demonstration of in vitro binding of anosmin-1 to heparin (Soussi- 
Yanicostas et al., 1996). Furthermore, in this experiment, there were little or no 
demonstrable effects of mutants of netrin/DCC, Ephrin/Eph-receptor, slit/robo, 
semaphorin, a-integrin and ECM molecules such as perlecan on the KALI-induced 
phenotype (Bulow et al., 2002). From these studies it is evident that a necessary 
prerequisite of anosmin-1 function is the presence of HS with specific sulphation 
patterns. Indeed, HS is known to be involved in the binding of a wide range of ligands 
in both physiological and pathophysiological processes.
1.8.1 Synthesis and modification of the HS
HS, a unique class of the macromolecular polysaccharides known as 
glycosaminoglycans, is composed of disaccharide repeat units of alternating uronic 
acid (D-glucuronic add [GlcA] or L-iduronic acid pdoA]) and D-glucosamine (GlcN) 
residues with variable sulphation patterns. These sugar chains are anchored onto the 
spedfic “core” proteins through covalent complex formation, giving specific HS 
proteoglycans such as membrane-associated syndecanl-4, glypicanl-6, epican, 
betaglycan, and secreted forms of perlecan, agrin and collagen XVTH. (Kjellen and 
Lindahl, 1991; Iozzo, 1998; Halfter et al., 1998; Esko and Lindahl, 2001). The 
biosynthesis of HS comprises three steps: chain initiation, polymerisation and 
modification (Turnbull et al., 2001; Esko and Lindahl, 2001).
HS synthesis is initiated by attachment of tetrasaccharides (glucuronic acid- 
galactose-galactose-xylose) onto selected serine residues in the core protein.
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Tetrasaccharide linker is synthesized in a step-wise manner by the action of 
glycosyltransferases. The transfer of the next sugar residue for HS chain elongation is 
completed by specific transferases (HS co-polymerases) that add alternating [1-4] 
linked GlcA and N-acetylglucosamine (GlcNAc) residues. As synthesis proceeds, 
some regions are modified by a series of interdependent enzymatic reactions. First, N- 
acetylglucosamine GlcNAc is deacetylated and N-sulphated by N-deacetylase/ N- 
sulfotransferase (NDST). Second, GlcA residues are then epimerised to IdoA units by 
glucuronyl C-5 epimerase. Finally, these modified disaccharides will receive the bulk 
of the subsequent O-sulphation. An iduronosyl 2-O-sulphotransferase (2-OST) adds an 
O-sulphate group to IdoA at C2, followed by the O-sulphation at C6 of glucosamine 
by a glucosaminyl 6-O-sulphotransferase (6-OST). The modification reactions are 
completed with modification of a few residues by glucosaminyl 3-O-sulphotransferase 
(3-OST). In terms of die relative distribution of the major N-substituents of the GlcN 
residue, HS can be characterized as: contiguous N-acetylated disaccharide units (NA 
domain), N-sulphated sequences of variable length (NS domain), and alternating N- 
acetylated and N-sulphated units (NA/NS domain) (Figure 1.7).
1.8.2 HS structure diversity and functional specificity
HS ligand-binding was once thought to be a relatively nonspecific charged ionic 
interaction between negatively charged HS and positively charged protein. However, 
many HS ligands require HS sequences of well-defined length and structure (Table 
1.2). Van der Waals, hydrogen bound and hydrophobic interactions may also be 
involved (Thompson et al., 1994). In turn, HS binding proteins often contain 
consensus sequences consisting of clusters of basic residues. Lysine, arginine or 
glutamine are frequently involved in contacts with the HS sulphate and carboxyl 
groups, and their spacing, sometimes determined by secondary structure, may control 
binding specificity (Hileman et al., 1998).
Specific sets of variably modified di saccharides usually within the NS or NA/NS 
domains preferentially determine specific ligand binding (Jackson et al., 1991). The 
best-studied example is the interaction between HS/heparin and anti thrombin, which
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Figure 1.7 Scheme of HS chain biosynthesis. HS biosynthesis begins with the 
tetrasaccharides linkage region that composed of xylose (Xyl), two galactose (Gal) and 
a glucuronic acid (GlcA). The HS chain is then polymerised by the alternate addition of 
N-acetylglucosamine (GlcNAc, yellow square) and glucuronic acid (GlcA, black 
diamond). These simply unmodified GlcNAc-GlcA disaccharide repeats are then 
modified by a series of modification enzymes: converting GlcNAc to N-sulphated 
glucosamine (GlcNS), GlcA to IdoA (gray diamond), and finally adding 2-0 sulphate 
to IdoA, 6-0 sulphate to GlcNAc and GlcNS, and 3-0 sulphate to GlcNS residues. The 
modification of the monosaccharides is indicated by NS, 2S, 6S and 3S. The regions 
implicated in binding of FGF1/FGF2 and antithrombins are also shown. Structural 
domains (NS, NA/NS, NA) in HS are defined with regard to the distribution of GlcN 
N-substituents as indicated. (Taken from Esko and Lindahl, 2001).
45
Table 1.2 HS-protein interaction
Protein
ligand
HS binding sequence Effect Reference
o
eg0
BMP-2 Sulphated polysaccharides Ad=20nM, enhance, interaction 
to its signalling receptor
(Takada et 
al., 2003) 
(Ruppert et 
al., 1996)
FGF-2 Pentasaccharide containing IdoA (2- 
OSO3) and GlcN (6-OSO3)
Dimerization and stimulation 
of interaction with FGF receptor
(Guimond 
etal., 1993)
FGF-1 Hexasaccharide containing IdoA (2- 
OSO3) and GlcN (6-OSO3)
(Guimond 
etal., 1993)
HGF Octasaccharide containing 
IdoA (2-OSO3) and GlcNS (6-OSO3)
Growth factor sequestering (Ashikari et 
al., 1995)
PDGF-AA Sequence containing IdoA (2-OSO3) 
and GlcNS (6-OSO3)
Storage and secretion of PDGF- 
AA, affecting receptor binding
(Feyzi et 
al., 1997b)
Y-
interferon
Two N-sulphated hexasaccharide 
domains separated by 7 kDa N- 
sulphated region
Dimerization and modulation of 
proteolytic processing
(Lortat- 
Jacob et al., 
1995)
Interleukin
-8
Two hexasaccharide domains 
containing IdoA (2-0 S03>-GlcNS (6- 
OSO3) separated by less than 7 N- 
sulphated or N-acetylated 
diasaccharides
Sequesters the chemokine and 
prevents its diffusion
(Spillmann 
etal., 1998)
Platelet 
factor 4
9 kDa sequence with two terminal 
domains rich in NS and 2-OSO3 
separated by N-acetylated region
Stimulate platelet 
factor 4 activity
(Stringer
and
Gallagher,
1997)
G
FB
P
IGFBP5 Sequence containing IdoA (2-0S03) Decrease IGF/IGFBP binding 
affinity, and release IGF to bind 
its receptor
(Arai et aL, 
1994)
Meu
uPA 5 disaccharide repeats containing 
GlcNS (6-OSQ3>-IdoA (2-OSO3)
Confer specificity of uPAAiPA 
receptor interaction
(Pucci et 
al., 2001)
Antithrom 
bin in
GlcN (S/COCH3)-G1cA-G1cNS (3- 
OSOsl-IdoA (2-0S03)-G1cNS (6- 
OSO3)
Conformational change of the 
protease inhibitor, increasing its 
antithrombin activity
(Lindahl et 
al., 1984)
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Protein ligand HS binding sequence Effect Reference
ApoE Octasaccharide containing. IdoA Inhibit ApoE related, (Bazin et al.,
1 (2-OSO3), G1cNS(6-0 S03> and neurotoxicity 2002)
Is
limited 3OSO3
lipoprotein containing stabilization of immobilization, (Parthasarathy
IS lipase dimeric LPL, IdoA (2-OS03)- interalization et al., 1994)
G1cNS(6-0S03)
laminin Dodecasacchaiide composed of Adhesion to ECM (Parthasarathy
£ repeating IdoA(2-OS03>-GlcNS(6- et al., 1998)
1
e OSO3)a fibronectin 7-8 N-sulphated disaccharides adhesion, focal (Walker and
UW contaning IdoA ± (2-0S03) adhesion formation Gallagher,
1996)
GF, C: Growth factors and cytokines; GFBP: Growth factor binding protein; P, PI 
Proteases and proteases inhibitors.
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leads to inactivation of thrombin, factor Xa, and other serine proteases of the 
coagulation cascade. This interaction depends on a very specific structure of a 
pentasaccharide that contains a central 3-O-sulphated GlcN residue (GlcN(6S)-GlcA- 
GlcNS(3S)-IdoA(2S)-GlcNS(6S)) (Bourin and Lindahl, 1993). Another example is 
FGF 1 and FGF2 both of which exert their mitogenic activity by interaction with the N- 
sulphated pentasaccharide HS sequence containing IdoA2S and GlcN6S unites in 
distinct combination. 2-O-sulphate is required for high affinity binding of FGF to 
receptor whilst an additional 6-O-sulphation is required for receptor activation (Omitz 
et al., 1996). Other factors such as spacing between the protein-binding sites also play 
a role: HS chains with two binding sequences separated by a 7 kDa region with low 
sulphation is required for y-interferon dimerization, thereby modulating cytokine 
processing and biological activity (Lortat-Jacob et al., 1995). Involvement of 
discontinuous HS chain domains in protein binding has also been reported for other 
ligands including platelet factor 4 and IL-8 (Table 1.2).
The in vivo role of HS structural specificity has been demonstrated using genetic 
approaches that involve the disruption of genes for specific enzymes of HS synthesis 
and modification. In Drosophila, mutants lacking N-deacetylase/N-sulfotransferase 
(NDST) or an HS copolymerase resulted in disrupted signalling by the morphogens 
Hedgehog (HH), Wingless (Wg) and Decapentaplegic (DPP) and FGF (Perrimon and 
Bemfield, 2000; Selleck, 2000). The genetic screen of C.elegans orthologues of HS- 
modifying enzymes revealed that C5-epimerization, 2-O-sulphation and 6-0 
sulphation can affect axonal development. Two specific signalling pathways, the 
C.elegcms SLT- 1/Slit and KAL-1 ImommA  are disrupted in a 6-0- sulfatransferase or 
C5-epimerase deficient background (Bulow and Hobert, 2004). The same 
experimental approach also suggested that sulphation at C6 and C2 site might be 
important for ephrin and integrin signalling. Studies in the mouse have provided 
similar evidence. An IdoA 2-O-sulfotransferase gene mutation causes renal agenesis 
and perinatal lethality (Bullock et al., 1998). NDST1 mutants exhibit neonatal 
lethality, whereas NDST2 defects have a restricted phenotype in which only heparin
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formation in connective tissue mast cells is affected (Forsberg et al., 1999; Ringvall et 
al., 2000).
1.8.3 HS-ligand interaction
HS interacts with a wide spectrum of insoluble and soluble ligands to exert a 
variety of functions from organization of cell-cell and cell-ECM adhesion to regulation 
of cell proliferation and differentiation. In these physiological processes, HS can act as 
a dominant controller to concentrate its ligand either in the ECM or onto cell sulface, 
as a co-receptor to modulate ligand-receptor interaction or as a docking platform for 
protease-substrate complex formation (Wight et al., 1992; Bemfield et al., 1992; 
Rapraeger, 1993) (Figure 1.8).
In ECM, HS serves as a storage reservoir from which the growth factors and 
cytokines can be released in active forms to interact with high-affinity receptor. 
Specifically, the binding of these molecules to HS protects them from proteolytic 
degradation. Thus, upon introduction of the stimulus, these molecules can be released 
rapidly, avoiding de novo protein synthesis (Vlodavsky et al., 1996).
HS regulates distribution of potent morphogens, growth factors and even 
antagonists of these signaling molecules by controlling the diffusion, gradient 
formation and degradation from the cell surface. In the Drosophila wing imaginal dies, 
Hedgehog (HH) was observed to travel about 8-10 cell diameters from the site of its 
production to induce the expression of its target gene patched and decapentaplegic 
(dpp), the orthologue of vertebrate BMP (bone morphogenetic protein), along the 
anteroposterior boundary. This movement has been proposed to be dependent on a 
specific type II transmembrane HS polymerase encoded by the tout-velu (ttv) gene. 
The properly constituted HS allows Hedgehog detached from cells diffuse through 
tissues (Strigini and Cohen, 1997; Bellaiche et al., 1998). HS is also required for 
wingless (Wg/Wnt) signaling in a manner that is not directly involved in activation of 
its signaling receptors (Frizzles), but through limiting extracellular Wg diffusion 
(Baeg et al., 2001). In addition, scattering of Noggin, a BMP antagonist, appears to be
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Figure 1.8 Multifunction of HSPG in regulating protein activity, (a) HS chain 
covalently attaches onto core protein to form typical three types of HSPG. Syndecan 
contains a conserved transmembrane domain; glypican is tethered to the cell membrane 
by a GPI anchor, and perlecan is a soluble form of HSPG. In extracellular matrix 
(ECM), perlecan serves as storage reservoir from which bound ligand (growth factors) 
can be released when required, (b) HSPG can concentrate ligand (Noggin, Wg/Wnt) 
onto cell surface and determine its distribution and diffusion, (c) HSPG binds some 
soluble ligands (lipoprotein lipase and serpin) onto the cell surface and takes ligands 
into cells for degradation or recycling, (d) Through binding to the ECM component, 
HSPG immobilizes the receptor complex to the adhesion conjunction site and induce 
the reorganization of cytoskeleton. (e) As coreceptor for soluble ligand (growth factors, 
chemokines, cytokines), HSPG promotes dimerization of the ligand and receptor to 
induce signalling phosphorylation and/or stabilizing an active ligand-receptor complex 
through the formation of a ternary complex, a model best seen in FGF/FGFR. (f) A 
specific pentasaccharide sequence containing a specific 3-O-sulphated glucosamine 
residue can induce a conformational change in antithrombin III that dramatically 
accelerates its binding and inhibition of the protease thrombin. (Adapted from 
Bemfield, et al, 1999).
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restricted or modified by high affinity binding to HS, resulting in restriction of the 
pattern of the BMP activity gradient (Paine-Saunders et al., 2002). Furthermore, on the 
cell surface, HS immobilizes various ligands for internalization and degradation 
including lipoprotein lipase (LPL) and thrombospondin (Murphy-Ullrich et al., 1988; 
Berryman and Bensadoun, 1995).
Through interaction with a wide range of adhesion molecules including 
collagens, NCAM, fibronectin and vitronectin on the cell surface and in the ECM, HS 
regulates the formation of focal adhesions, cell spreading and migration. In the rat 
olfactory system, co-expression of N-syndecan and neural cell adhesion molecules 
along the common pathway by which olfactory and GnRHl neuron travel has been 
proposed to contribute to the movement of these neurons from the olfactory placode 
towards the forebrain (Toba et al., 2002). Fibronectin, an ECM adhesion protein, has 
been shown to promote local cell adhesion formation by binding to its integrin 
receptors and glypican and syndecans HS chains. The C-terminal Hep II fibronectin 
domain is considered a candidate for interacting with HS by virtue of its high binding 
affinity (Walker and Gallagher, 1996; Tumova et al., 2000).
HS can convert ligands from an inactive form to an active form through 
conformational changes. A specific example is the action of HS in regulating the 
anticoagulant activity of antithrombin ID (AT HI). A specific pentasaccharide 
sequence containing a specific 3-O-sulphated glucosamine residue can induce a 
conformational change in antithrombin in  (AT IH) that accelerates 1000-fold its 
binding and inhibition of the protease factor Xa (Shriver et al., 2000a).
Finally, HS acts as a receptor or co-receptor to regulate the signalling of HS 
binding proteins in a number of diverse ways: promoting dimerization of the ligand 
and receptor to induce signalling phosphorylation and/or stabilizing an active ligand- 
receptor complex through the formation of a ternary complex. The best studied model 
for this phenomenon is the interaction between HS and the fibroblast growth factor 
system. Crystallographic studies show that an FGF2/FGFR1 crystal is formed in the
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absence of heparin at an initial low affinity 1:1 complex, which may allow transient 
receptor dimerization enabling signalling only at high ligand concentrations 
(Wiesmann and de Vos, 1999; Omitz, 2000). However, in the presence of appropriate 
HS molecules, HS bridges FGF2 and the FGFR1 by binding to a groove formed by the 
heparin-binding sites of both the ligand and the receptor, leading to a much more 
stable 2:2 FGF/FGFR signalling conformation and higher activation of the 
intracellular signalling cascade (Yan et al., 1993). So HS enables the formation of a 
high-affinity complex that potentiates receptor signalling at low growth factor 
concentrations. The critical effect of HS in this interaction is mediated by a specific 
pentasaccharide sequence in HS containing essential IdoA2S and GlcN6S residues.
1.8.4 HSPG in cell events
Physiological and pathophysiological processes are dependent on cell responses 
to a variety of different ECM cues, and the presence of relevant molecules 
immobilized on the cell surface. HS is one molecule mediating cellular talk from an 
extracellular signal to the intracellular response, either by its ligand-binding property, 
or by virtue of its proteoglycan (HSPG) structure.
1.8.4.1 Focal cell adhesion and cytoskeletal reorganization
A specific example is the role of HSPG in physiological processes including focal 
cell adhesion, spreading and cytoskeletal reorganization. Focal adhesions are 
specialised zones of tight cell-matrix interaction located at the termini of acdn stress 
fibres present at the sites where the ECM is physically connected to a complex of 
signalling and cytoskeletal proteins via transmembrane receptors. Integrin has long 
been considered as the prototype of a signalling pathway enabling focal cell adhesion 
and full spreading (Schwartz et al., 1995; Schlaepfer and Hunter, 1998). Tyrosine 
kinases are activated following integrin (receptor) clustering after attachment to 
fibronectin, leading to phosphoiylation of several focal adhesion components. Indeed, 
inhibition of tyrosine kinase prevents full spreading of cells and focal adhesion 
formation (Burridge et al., 1992; Akiyama, 1996). However, HSPG, together with 
integrin, can now be considered a dual receptor system active in cell-matrix adhesion.
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Upon binding of fibronectin to the integrin receptor, cells attach and spread, but do not 
form stress fibres terminating in focal adhesion. The cytoskeletal reoganization 
requires the activation of protein kinase C (PKC) that is augmented by oligomerization 
of syndecan-4 (Oh et al., 1998; Saoncella et al., 1999). In addition, involvement of 
small Rho family GTPases in signalling through syndecan-4 enabling focal adhesion 
and stress fibre formation has been suggested (Saoncella et al., 1999). Further 
evidence for a direct interaction of HSPG to cytoskeletal molecules has come from the 
recent finding that the conserved cytoplasmic domain of all mammalian syndecans are 
capable of binding to PDZ domain proteins including syntenin, CASK, synbindin and 
synectin (Gao et al., 2000; Ethell et al., 2000; Bass and Humphries, 2002). The PDZ 
proteins are thought to be components of the submembrane molecular scaffold 
implicated in organising signalling complexes at defined membrane locations, such as 
cell junctions. These molecular interactions are triggered by extracellular ligands 
causing clustering of syndecans and inducing their multimerization.
1.8.4.2 Synapse formation, axon guidance and neurite outgrowth
In nervous system development, HSPG also acts as an essential component in the 
molecular orchestra in the processes of synapse formation, axon guidance and neurite 
outgrowth. Synapses can be regarded as highly specialised cell-cell contacts. Ethell et 
al demonstrated that the syndecan-2 cytoplasmic domain is tyrosine phosphorylated by 
EphB2 in neurons and phosphorylation promotes syndecan-2 clustering on the surface 
of dendrites (Ethell et al., 2001). They found that syndecan-2 phosphorylation by 
EphB receptors is a prerequisite for syndecan-2 induced dendritic spine formation. 
Thus, the cooperation of a cell surface HS proteoglycan and a receptor tyrosine kinase 
is a critical downstream event in spine formation triggered by cell surface recognition, 
most likely the receptor-ligand interactions between B-ephrins on presynaptic neurons 
and EphB receptor on postsynaptic neurons. Furthermore, the topological regulation of 
axonal extension, or axonal guidance, is one of the most crucial steps in forming the 
correct neuronal network. The involvement of HS in these processes has also been 
demonstrated using the developing Xenopus retinotectal pathway. Retinal axon 
elongation in the optic tract and penetration into the tectum was retarded by addition
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of exogenous HS or enzymatic removal of endogenous HS (Walz et al., 1997). A 
similar observation was made in the cockroach embryo system where a pathfinding 
error occurred in heparitinase-treated embryos (Nyhus and Denburg, 1998). 
Interestingly, both experiments showed similar phenotypic alterations in the presence 
of a dominant negative FGF receptor or FGF2 antibody, suggesting that HS is 
involved in axon guidance through modulation of FGF signaling. In agreement with 
these observations, in vitro studies have provided insights that HSPG can support 
neurite outgrowth by activating growth-enhancing molecules, such as laminin, NCAM 
and FGF (Dow et al., 1988; Aoyagi et al., 1994; Jung et al., 2003).
1.8.43 Cell proliferation
Well defined biological functions of HS include modulation of cell proliferation 
through interaction with a wide range of growth factors and cytokines, including the 
family of FGFs (Rahmoune et al., 1998), transfoming growth factor-p (TGFp) (Lyon 
et al., 1997), platelet-derived growth factor (PDGF) (Feyzi et al., 1997a), hepatocyte 
growth factor/scattering factor (HGF/SF) (Lyon and Gallagher, 1994) and IL-2 
(Najjam et al., 1998). Among these, modulation of HS in FGF/FGFRs actions on cell 
proliferation has been extensively studied, leading to the recognition of a number of 
mechanisms whereby HS acts as a co-receptor facilitating ligand-induced receptor 
oligodimerization and signal transduction. It has been suggested that HS induce 
conformational alterations of FGF2 leading to FGFR1 binding. However, this 
prediction has not been supported by structural analysis of co-crystals of FGF2 and 
heparin-derived oligosaccharides.
Systematic experiments using a set of size-defined HS saccharides from porcine 
mucosal HS and distinct FGFR transfected BaF3 cells have confirmed the specific 
modulating action of HS on FGF/FGFR signalling in both receptor and ligand-specific 
manner. First, some HS saccharides activated FGF2 signalling mediated by FGFRlc 
but not FGFR2c, whereas only larger HS fractions (>18 monosaccharide units) were 
able to strongly activate FGF2 signalling through FGFR3c. Second, these HS 
saccharides showed differential activation on FGF1 and FGF2 signalling through
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FGFRlc (Guimond and Turnbull, 1999). These results highlight the importance of HS 
size and sequence on FGF/FGFR-specific signalling in cell proliferation. Finally, 
specific HS fractions of distinct structural composition have been identified, with 
differences in the primary structure of the constituent saccharides. Kinetic analysis has 
further confirmed differences in HS/FGFR binding affinity with 10-fold reduction in 
association constant seen with FGFRlc as compared with FGFR2c (Powell et al., 
2002). Furthermore, neural tube derived HS from mouse embryonic forebrain and 
midbrain differentially regulates FGF signalling in a stage-specific manner (Ford- 
Perriss et al., 2002). Only HS from embryonic day 10 (E10) stage showed preferential 
activation for FGF8 via FGFR3c, whereas HS from both E10 and E13 activate FGF2 
signalling through FGFRlc with greater potency than through other receptors. These 
stage-specific HS developmental actions are thought to be closely related to 
expression patterns of HS sulphotransferase isozymes responsible for creating diverse 
sulphation motifs in HS chain.
In addition, HS plays a role in determination of cellular fate either to proliferation 
or migration by specifically regulating signalling pathways associated with 
FGF/FGFR interaction. FGF binding to the cell surface induces FGFR dimerisation, 
and subsequent activation of receptor tyrosine kinase and autophosphorylation of the 
cytoplasmic domains of cognate receptors. Tyrosine autophosphorylation sites are then 
recognised by target enzymes such as PLCy and Src themselves becoming 
phosphorylated. The autophosphorylation site also serves as binding sits for Grb2-Sos 
complex formation thereby activating the Ras. Ras activation triggers a signalling 
cascade involving the Ser/thr kinase Raf, the dual specificity MAP kinase kinase 
(MEK), and MAP kinase (ERK1/2 isoforms), which are crucial for FGF-induced 
proliferation of many cell types (Klint and Claesson-Welsh, 1999). FGF-induced cell 
migration also involves this MAP kinase pathway via ERK, accompanied by Src and 
p38 MAP kinase pathways (Rodier et al., 1995; Jaakkola et al., 1998). It has been 
reported that in breast cancer cells the defined HS chain could enhance FGF2/FGFR1 
interaction leading to proliferation by up-regulating MAPK pathway, whereas other 
defined HS specifically up-regulate MAPK, Src and its downstream FAK pathway
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leading to an increase in the initial rate of cell migration (Nurcombe et al., 2000). HS 
may thus regulate the duration of FGF/FGFR activation or extent of downstream 
signalling induced by ternary complex formation.
1.8.4.4 Tumour growth and metastasis
Tumorogenesis represents a complex process involving selected genotypic and 
phenotypic changes in cells leading to unregulated cell growth, invasion and 
metastasis. These pathological processes require sequential steps involving proper 
coordination of cell proliferation, adhesion and migration, in which, as stated earlier, 
HSPG is also widely involved during physiological processes. Indeed, growing 
evidence has shown that HSPGs plays a crucial role as modulators at each step of 
tumorogenesis.
HS is involved in initial oncogenic transformation of cells. Changes in both 
expression level and structural characteristics of cell surface HS have been shown to 
correlate with transformation in certain cell types. For example, syndecan-1 expression 
is downregulated in various malignant tumours, including uterine carcinoma and 
multiple myeloma (Sanderson, 2001). Specific structural changes of HS have been 
noted during malignant transformation of colon cancer cells from adenoma to 
carcinoma (Jayson et al., 1998). Similarly, glypican-1 is believed to act as a negative 
regulator of cell proliferation for certain tumour types (Filmus, 2001). In addition to a 
role in initial cell transformation, HS bind growth factors, cytokines and structural 
proteins that are involved in modulating autocrine and paracrine signalling loops 
important for tumour growth and angiogenesis. The diverse structural characteristics 
of HS allow them to act either as inhibitors or potentiators of these signalling loops, 
depending on the sequence context (Liu et al., 2002a). Sets of HS fragments released 
from the cell surface of B16 melanoma cells by heparinase III or heparinanse I 
treatment potentially exhibit opposite effects on primary tumour cell proliferation, 
neovascularization and secondary metastasis to the lung. Heparinase-IH-derived HS 
fragments showed inhibitory effects on tumour, whereas the opposite changes were 
observed for heparinase I-treated tumours (Liu et al., 2002b). Furthermore, malignant
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tumour cells can detach from the primary site and migrate into neighbouring tissues 
and remote locations, processes required degradation of cell-cell and cell-ECM 
adhesion. HS makes this situation more complex: on the one hand, HS along with 
structural proteins, such as collagen and laminin, form a physical barrier to prevent 
tumour metastasis; on the other hand, HS could concentrate and activate the tumour 
cell secreted proteases (plasminogen activator system, matrix metalloproteinases) for 
degradation of the basement-membrane barrier. It has been reported that HS/heparin 
could significantly enhance tumour cell invasion in vitro through stimulating 
plasminogen activation by cell-surface uPA; a 70-fold increase of HS induced 
plasminogen activation was observed (Brunner et al., 1998).
1.9 Candidate molecules interacting with anosmin-1
1.9.1 Serine proteases
As stated earlier, amino add alignment of the WAP domain of anosmin-1 has 
shown the presence of eight highly conserved cystdne residues necessary for four- 
disulphide bridge formation seen in WAP protdn family members, some members of 
which demonstrate inhibitory activity on serine proteases. Although considerable 
sequence diversity exists between members of this family, it seems pausible that serine 
proteases might constitute an interacting candidate with anosmin-1.
The serine protease family comprises a group of enzymes that catalyses 
hydrolysis of peptide bonds via a nucleophilic attack triggered by thdr active site 
containing serine, histidine and an aspartic acid residue (Figure 1.9). They are usually 
synthesized and secreted as inactive proenzymes (called zymogens) further activated 
by proteolysis. Members of this family play a role in intestinal digestion, blood 
coagulation and fibrinolysis, functions well characterized in the blood coagulation 
cascade including trypsin-like serine protease (thrombin, urokinase-type plasminogen 
activator (uPA) and tissue-type plasmingen activator (tPA)). In addition, several lines 
of evidence have pointed out the role of these serine proteases within the central 
nervous system. During neural development, serine proteases contribute to cell 
migration, axon outgrowth and synaptogenesis. In the adult, they play a role in
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Figure 1.9 Mechanism of serine proteases catalysis. The mechanism by which 
chymotrypsin cleaves protein chain is shown here as a typical example that is applied 
to all of the serine proteases. The catalytic work of the proteases is done by the 
so-called catalytic triad, Asp 102, His57, and Seri95. The first step appears to be 
His57 removing a proton from the Seri95 OH, while the O does a nucleophilic attack 
on the peptide carbonyl. The next step is the stage at which the protein chain actually 
is cleaved. The acyl part of the peptide that was cleaved, bound as an ester to Seri 95 
and the amine group of the peptide was released. A molecule of water was then 
required to hydrolysis of an ester to release the other end of the original protein and 
restore the catalytic triad to its beginning state. The yellow dot lines represent the 
hydrogen bond.
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neuropeptide processing, regulation of neuronal survival and structural plasticity 
associated with learning and memory processes (Turgeon and Houenou, 1997; 
Yoshida and Shiosaka, 1999). Their mechanism of action probably involves 
degradation of ECM components, activation/inhibition of protease activated receptors 
or activation/inhibition of other serine proteases.
In this dissertation, an attempt was made to identify a serine protease that might 
act as a possible ligand for anosmin-1. There were several theoretical approaches to 
tackling this task. Firstly, specific inhibition of serine proteases by WAP proteins 
sharing homology to anosmin-1 had previously been established; for example, the 
well-defined serine protease inhibitory activities of elafin and secretory leucocyte 
proteinase inhibitor (SLPI). Elafin and the C-terminal four-disulphide core domain of 
SPLI carry the inhibitory active centre for serine protease inhibition. The three 
dimensional structures in both molecules has been revealed by X-ray crystallography 
complexed with serine proteases (Gnitter et al., 1988; Tsunemi et al., 1996). These 
two domains share the same disulphide bridge distribution, and a methionine residue 
in the Pi* position of the inhibitory active centres. The highly variable region V has 
been demonstrated to interact with the active site of proteases (Schalkwijk et al.,
1999), suggesting that the corresponding regions of other WAP proteins might also 
serve as a specific determinant for serine protease binding. However, the inhibitory 
specificity is different between these two molecules. It is clear that elafin potentially 
and specifically inhibits the elastin-degrading serine proteases (human leucocyte 
elastase, protease 3) with a low equilibrium dissociation constant (K\) of 0.17 nM, 
while no inhibitory activity on chymotrypsin and trypsin was observed (Ying and 
Simon, 1993). In contrast, a wide range serine proteases including elastase, 
chymotrypsin and trypsin can be dramatically inhibited by SLPI (Smith and Johnson, 
1985; Ying et al., 1994). These observations suggest that even though they all have a 
highly conserved 4-disulphide bridge, the various WAP domain proteins can exert 
distinct and even opposing activities on serine proteases. However, it still provides 
useful evidence that one member of trypsin-like serine protease (plasminogen activator 
system, thrombin and trypsin) might be a good candidate for anosmin-1 interaction.
59
plasminogen
thrombin
trypsin
Figure 1.10 Structure of human trypsin-like serine proteases. SMART analysis is used 
for the comparison of domain alighment (http://smart.embl-heidelberg.deT PANAP: 
divergent subfamily of APPLE domains; GLA: Domain containing Gla (gamma- 
carboxyglutamate) residues; EGF: epidermal growth factor domain; FN1: fibronectin 
type 1 domain; KR: kringle domain; Typs SPc: trypsin-like serine protease domain.
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The domain comparisons of the members in this serine protease family are shown in 
Figure 1.10.
A second approach to identifying an interacting candidate serine protease might 
come from investigating the spatio-temporal expression patterns of these enzymes in 
the developing olfactory bulb as well as their potential role in neurogenesis where 
anosmin-1 shows preferential biological activity. The functional role of trypsin-like 
serine proteases and their early expression have been reported within the olfactory 
system. Taken together, trypsin-like serine proteases fulfil these criteria and are 
discussed next.
1.9.1.1 Thrombin
Dihanich et al. have shown that prothrombin is expressed in both the developing 
and adult rat brain, with initial low activity in the neonatal rat brain and increasing 
significantly by adulthood. After birth, prothrombin (mRNA and protein) is expressed 
in the olfactory bulb, cortex, thalamus and corpus striatum (Dihanich et al., 1991). The 
proteolytic activity of thrombin is well documented and had been shown to inhibit 
long-term morphological differentiation in serum-free cultures of several cell types, 
including spinal cord and brain neurons, astroglial and neuroepithelial cells, effects 
prevented by prior of co-treatment with the specific thrombin inhibitor, hirudin 
(Gurwitz and Cunningham, 1988; Grand et al., 1989).
In addition, the role of thrombin is somehow dependent on its cognate receptor 
characterized as a member of the G protein-coupled receptor family. Consistent with 
thrombin spatio-temporal expression pattern, die thrombin receptor is also highly 
expressed throughout the brain including olfactory bulb, hypothalamus and neocortex 
(Weinstein et al., 1995). This receptor is activated following the cleavage of its NH2- 
terminus arginine-41 residue by bound thrombin, and induces neuronal cell rounding 
and neurite retraction in various differentiating neuroblastoma NIE-115, NG108-15 
and NB2a cells (Jalink and Moolenaar, 1992; Suidan et al., 1992). Thrombin-mediated
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cell death has also been reported in spinal motoneurons in culture, which can be 
mimicked by a thrombin receptor agonist (Turgeon et al., 1998).
1.9.1.2 Plasminogen activator system
There are two types of plasminogen activators, the urokinase-type (uPA) and the 
tissue-type (tPA). Both are capable of catalysing the conversion of the inactive 
zymogen plasminogen to the active protease plasmin, which has trypsin-like broad- 
spectrum protease activity, and which activates matrix metalloproteinases (MMPs) for 
degradation of most extracellular proteins (Pittman et al., 1989; Blasi and Carmeliet, 
2002). There appears to be general agreement that the primary role of tPA is to 
generate plasmin for thrombolysis, while it is mainly uPA which generates plasmin in 
events involving degradation of ECM.
The plasminogen activator (PA) system is incriminated in tissue remodelling, 
synaptogenesis, and neurite outgrowth via its proteolytic activity. Evidence 
implicating this system in the growth of the nervous system has been obtained from 
several studies. Initially, it was demonstrated from enzymatic studies, that PA activity 
is demonstrable in association with the growth cones of sensory neurons and with 
Schwann cells as well as sympathetic neurons (Krystosek and Seeds, 1981; Kiystosek 
and Seeds, 1984). Later studies showed that the addition of PA or PA inhibitors to 
cultures of neurons had profound effects on neurite outgrowth and the direction of cell 
migration (Hawkins and Seeds, 1986; Hawkins and Seeds, 1989).
Differential expression and function of tPA and uPA in the developing CNS has 
been reported using genetic studies and immunohistochemistry. A retardation of 
granule cell migration into the cerebellar molecular layer was demonstrated in mice 
lacking the tPA gene, a phenomenon not observed in wild type mice or the mice 
lacking uPA gene (Seeds et al., 1999). Furthermore, Hayden and Seeds found 
differential expression of tPA and uPA during differentiation of mouse dorsal root 
ganglia cell cultures - tPA expression was restricted to small sensory neurons, whereas 
uPA was localized predominantly in large sensor neurons (Hayden and Seeds, 1996).
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A study by Del Bigio et al provides immunochemical evidence that uPA, its 
receptor, and its major substrate plasminogen are expressed in postnatal mouse 
forebrain neurons at a stage when development and refinement of neuronal synaptic 
connections mostly happen. The authors thus concluded that uPA might function in 
the processes of synaptogenesis and remodeling rather than in cell migration (Del 
Bigio et al., 1999). In agreement with this observation, Drapkin et al. reported that 
implantation of uPA coupled affigel blue beads into the olfactory epithelium of chick 
embryo at a very early developmental stage (stage 17) did not affect GnRH neuron 
migration (Drapkin et al., 2002). Of interest is that in mouse as early as E14.5, when 
olfactory and GnRH neurons have completed their initial migration, uPA is 
predominantly expressed within the large mitral and related tufted cells lying more 
superficially in the external plexiform layer of the immature OB (Dent et al., 1993). 
Therefore, uPA may play an important role in synapse formation and tissue 
remodelling during olfactory bulb development. In contrast, tPA was expressed within 
the rostral migratory pathway leading to the developing OB in early embryogenesis, 
and then located in the olfactory nerve fibre layer (ONL), mitral cell layer (MCL) and 
granule cell layer (GCL) of OB in adulthood (Thewke and Seeds, 1996).
1.9.1.3 Trypsin
The effect of trypsin on GnRH neuronal development has been investigated in 
chick embryo by immunohistochemistry and protein coupled bead assays (Drapkin et 
al., 2002). Trypsin immunoreactivty was present in the vast majority of cells within 
the olfactory epithelium and throughout the mesenchyme as well as within die 
olfactory nerve. Furthermore, trypsin coupled beads embedded in the migratory GnRH 
neuronal complex resulted in a global acceleration of GnRH neuronal migration out of 
the olfactory epithelium and into the brain. Although these observations implicate an 
important role of trypsin in GnRH neuronal development, there is hithero no direct 
evidence to indicate its effect on olfactory bulb morphogenesis.
1.9.2 FGF2/FGFR1
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Anosmin-1 and FGFR1 share similar properties both in their actions in OB 
development and HS binding characteristics. This raises the possibility of a direct 
interaction between FGFR1 or/and its ligand FGF2 and anosmin-1. Thus, it is 
pertinent to ask whether anosmin-1 1) participates in FGF2/FGFR1/HS complex 
formation, 2) directly stimulates FGFR1 as its cognate ligand or 3) indirectly modifies 
this specific signalling pathway.
FGF2 is a small globular protein with separate binding regions for HS and 
FGFRs, and is directly involved in receptor dimer formation. It has an internal core 
region, structurally identified as 12 antiparallel p strands (Zhu et al., 1991; Eriksson et 
al., 1991). The loop between p strands 10 and 11 contains several basic amino acid 
residues that form the primary heparin-binding site. The FGFR1 binding region of 
FGF2 include the p8-P9 loop, separate from the heparin-binding site (Zhu et al., 1991; 
Omitz, 2000; Plotnikov et al., 2000).
FGFR1 is a member of the receptor tyrosine kinase superfamily, containing three 
immunoglobulin-like (Ig-like) domains and a heparin-binding domain (Murakami et 
al., 2000). A region of FGFR1 that includes Ig-like domain II and HI and the 
intervening linker domain has been shown to bind the FGF2 ligand, whilst a stretch of 
18 conserved residues (K18K) has been demonstrated as a binding site for heparin/HS 
(Murakami et al., 2000; Wang et al., 2000). These distinct HS binding sites in both 
FGF2 and FGFR1 support a model in which the heparin/HS could form the bridge 
between FGF2 and FGFR1.
In terms of the FGF2-FGFR1-HS model, the structural assembly is sufficiently 
stable in the presence of HS containing as few as hexa or decasaccharide residues, 
leaving the first Ig-like ectodomain of FGFR1 available for anosmin-1 binding. 
Furthermore, the binding of anosmin-1 to HS and possiblely to FGF2 may help to 
further stabilize these signalling complex formation. Thus it is unclear what role of 
additional molecules might have on a preformed FGF2-FGFR1-HS complex. 
Moreover, it is theoretically possible that anosmin-1 might act as an active ligand
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directly stimulating FGFR1 signalling, as occurs when a homologous Fnin domain in 
NCAM binds to the FGFR1 Ig-like domain inducing FGFR1 activation 
(phosphorylation) and stimulating neurite outgrowth, albeit with a much lower binding 
affinity (K<j = 9.97 ± 0.37 pM) (Kiselyov et al., 2003). Finally, it would seem likely 
that anosmin-1 might modulate the FGF2/FGFR1/HS interaction indirectly, possibly 
through the modulation on serine protease activity such as uPA since the biological 
interaction between FGF2/FGFR1 and uPA has been clearly identified (Dell'Era et al., 
1999).
1.10 Hypothesis
A hypothesis for the molecular mechanism of anosmin-1 action was therefore 
developed. Namely, that the N-terminus (specially the WAP domain) of anosmin-1 
interacts with a serine protease ligand such as uPA, regulating its protease activity 
necessary for tissue remodelling and neurogenesis. I further hypothesised that the C- 
terminal Fnlll domains of anosmin-1, by interacting with immobilized cell surface HS 
or ECM-related HS, directly restrict and specify the site of serine protease activity 
(Figure 1.11).
1.11 Aims of this thesis
The clinical presentation of KS and known properties of anosmin-1 in cell 
adhesion and neurogenesis indicated that the molecules implicated in this condition 
play an important role during embryonic development including neuronal and non­
neuronal morphogenesis. However, many questions remain unanswered. First, 
although HS has been confirmed to interact with anosmin-1, it is still unclear the 
extent of binding affinity between these two molecules. Second, as serine proteases 
may constitute candidate interactants for anosmin-1, it is necessary to identify the 
specific serine protease recognized by N-terminus of anosmin-1. Third, does the 
anosmin-l/HS/serine protease cooperate in cell processes such as proliferation? 
Finally, what is the structural characteristics determining anosmin-1 activity?
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Anosmin-1
~CR | WAP|Fnlll-l|Fnlll-2|Fnlll-3|Fnlll-4
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Cell
membrane
WAP protein family
elafin, SLPI, PS20, 
HE4, WDNM1
HS
HSPG
\
serine protease inhibitor
Which serine protease might be the candidate for anosmin-1?
\
Serine protease: plasminogen activator system
(uPA, tPA and plasmin) 
thrombin
trypsin, chymotrypsin and neurotrypsin
Figure 1.11 A hypothesis of the molecular mechanism of anosmin-1.
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In this thesis, a Drosophila S2 cell expression system was used to initially 
generate anosmin-1 expression and to investigate whether HS determines anosmin-1 
S2 cell surface binding through interaction with its Fnm domains. To generate 
sufficient pure recombinant anosmin-1, stable S2 cell lines were established and 
suspension culture and one-step purification by Ni-NTA affinity chromatography were 
used. To identifiy the functional domain in anosmin-1, the full-length anosmin-1 
(PIWF4), its truncated form (PIWF1) with single Fnin domain and their C172R 
mutants were generated. To quantitatively and qualitatively measure the binding 
affinity between purified anosmin-1 and HS, the solid phase enzyme-linked 
immunosorbant assay and surface plasmon resonance (SPR) were performed. To 
identify a potential serine protease interactant, the effect of anosmin-1 on thrombin 
and uPA amidolytic activity was investigated using a specific chromogenic substrate. 
Subsequently, the functional consequences of co-operation of anosmin-l/HS/uPA 
were investigated on PC-3 cell proliferation. Finally, the overall structure of anosmin- 
1 was investigated by analytical ultracentrifugation and X-ray solution scattering 
experiments, followed by molecular modelling.
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Chapter 2
Characterisation of anosmin-1 expressed in DrosopkUa S2 cells
2.1 Introduction
Structural and functional analyses of proteins are only made possible provided a) 
sufficient quantities (up to milligram levels) can be generated from expression 
systems b) the protein is of adequate purity. Preliminary attempts in this and other 
laboratories used coupled systems but failed to generate sufficient anosmin-1 yields of 
the necessary purity. Hitherto, the only publication detailing a system fulfilling the 
above criteria is that of Soussi-Yanicostas et al (1996) using CHO cells which 
generated small recombinant anosmin-1 yields (150 pg/109 cells), still inadequate to 
enable extensive structural and functional studies of this protein.
Proteins generated in bacterial systems are widely used in structural studies 
including crystallography; however, a major limitation of these systems lies in the fact 
that proteins cannot be post-translationally modified. Thus glycosylation, which is 
known to occur in anosmin-1 (Soussi-Yanicostas et al., 1996) cannot occur in such 
systems. Insect cells appear to overcome such limitations, and have been used as an 
appropriate substitute, offering a number of advantages over other expression systems. 
For instance, insect cells can be grown to a high 2xl07 cell/ml density, and continue 
to proliferate in serum-free medium that facilitate subsequent protein purification. 
Cells can also be cultured in a suspension phase at room temperature, not requiring 
CO2 and a humidified environment. Furthermore, the generation of stable protein 
expressing cell lines is generally more rapid, usually within 2-3 weeks. Insect cells 
confer a further advantage in that they have similar post-translation modification 
capabilities as mammalian cells. Drosophila melanogaster Schneider 2 (S2) cells, 
have been used to successfully generate biologically active proteins including 
enzymes, cytokines and viral proteins with generally higher yields (0.4-2.2 mg/litre) 
(Culp et al., 1991). Moreover recent in vivo transgenic C.elegans experiments have 
shown that the human KAL-1 gene can rescue the phenotype caused by loss of
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function of the endogenous C.elegans Kal-1 orthologue, suggesting close functional 
similarities between anosmin-1 from two distant species (Rugarli et al., 2002). It 
therefore seemed highly likely that anosmin-1 generated in insect cells would be 
capable of retaining the properties of the protein expressed in mammalian cells.
In previous studies from this laboratory, S2 cells were used to transiently express 
anosmin-1: in this system, however, cleavage of the protein occurred in a Drosophila 
expression medium DES™ plus 10% foetal calf serum (Robertson et al., 2001). It had 
not been established whether anosmin-1 could be expressed in serum-free medium, 
nor whether cleavage of anosmin-1 in serum culture could be abolished in conditions 
of serum deprivation. Previous studies had shown that recombinant anosmin-1 
generated in COS7 and CHO cells was cell membrane associated. It was unknown 
whether recombinant anosmin-1 expressed in S2 cell would retain its ability to be 
anchored to the cell surface and whether this anchorage relied on HS polysaccharide 
chains from HSPG. The Fnin domains of anosmin-1 have been predicted to interact 
with HS accounting for cell membrane binding; however the minimum number of 
such repeats required for cell membrane association had to await the generation of 
truncated analogues of anosmin-1 with varying numbers of Fnin repeats. The 
generation of such truncated analogues might also shed light on the role of Fnin 
domains in both protein expression and secretion efficiency.
2.2 Aims
Five recombinant KAL-1 cDNA plasmid constructs encoding full length and 
domain-truncated versions of anosmin-1 were incorporated into an insect expression 
vector (PMTA/Bip/V5-6His) containing a copper sulphate inducible metallothionein 
(MT) promoter. The presence of a polyhistidine tag enabled 1) protein detection using 
an anti-His tag monoclonal antibody 2) subsequent protein purification. The 
preliminary studies based on the transient transfection aimed to:
(1) investigate anosmin-1 expression and secretory efficiency of transfected S2 cells 
either in a serum-dependent or in an Fnin domain-specific manner.
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(2) investigate the proteolytic cleavage site in anosmin-1 and whether this 
phenomenon occurred only in the presence of serum.
(3) investigate whether recombinant anosmin-1 retained its cell surface binding 
capability via HS using a HS competitive assay.
(4) estimate potential glycosylation sites within individual domains of the protein.
2.3 Materials and methods
2.3.1 Construction of expression plasmid:
23.1.1 PCR amplification
Five different fragments of human KAL-1 cDNA were generated based on the N- 
terminal cysteine-rich and WAP domain backbone, followed by variable numbers of 
fibronectin HI domains. These were named PIW, PIWF1, PIWF2, PIWF3, PIWF4 
(Figure 2.1) with primers flanked by BaniHX and Xbal I. The following primers were 
designed to remove the signal sequence from KAL-1 cDNA:
Forward. CCGGATCCGCGGCCGGCCCCGGCGCGGCTGCT 
PlW-rev: CCTCTAGAACCTTTGTACAGAGTCTTGGGTACTTG
PIWFl-rev: CCTCTAGAGGCAGATGGATCTTTGGAAGAACGGAA 
PIWF2-rev: CCTCTAGAGGTTGCATGTGTCGATGTGAAGTGAAG 
PIWF3-rev: CCTCTAGACTTAAGAGCAGAGCATGGTGGAGTAGT 
PIWF4-rev: CCTCTAGAGTATCTTTCTGGAGAAGGCTTGTAATG 
1 ng of PKD1 plasmid DNA (Robertson et al., 2001) containing full length KAL-1 
cDNA was used as template with 50 pmol primers, 200 pM dNTPs, lxPCR buffer, 
0.5 unit of Taq polymerase and water made up to a 50 pi final reaction volume. The 
PCR profile consisted of an initial denaturation at 95°C for 10 min, followed by 30 
cycles of 30 sec, 94°C denaturation, 30 sec, 55°C annealing and 50 sec, 72°C 
extension times, with a final 72°C extension time of 10 min. The PCR products were 
run on an agarose gel and corresponding fragments were excised and gel purified.
2.3.1.2 Purification of DNA from agarose gel
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Fnlll-1 Fnlll-2 Fnlll-3 Fnlll-4 H V5 PIWF4
Fnlll-1
If)
Fnlll-2 Fnlll-3 V5 XCD PIWF3
Fnlll-1 Fnlll-2 V5 PIWF2
Fnlll-1 vs PIWF1
Figure 2.1 Structure of five variants of recombinant anosmin-1. The functional 
domains represented are; CR, cysteine-rich region; WAP, whey acidic protein-like 
domain; Fnin, fibronectin-like type DI domain; H, histidine-rich region; V5, the V5 
epitope tag derived from simian virus 5; 6His, 6><histidine tag.
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The QIAEX II Agarose Gel Extraction kit and protocol (Qiagen) was used to 
extract PCR products. The gel slice was excised by a sterile scalpel blade, placed into 
a 1.5 ml tube, weighed and 3 volumes of buffer QX1 added to each 100 mg of gel. 10 
pi of QIAEX II was added to the tube, which was incubated at 50°C for 10 min by 
vortexing every 2 min to keep QIAEX II in suspension. The tube was then centrifuged 
for 30 sec, and the supernatant removed, the pellet washed twice, once with 500 pi of 
buffer QX1 and then PE buffer. The pellet was air dried for 15 min and then 
resuspended in 20 pi distilled H2O for 5 min. After centrifugation at 13,000xg for 1 
min, the DNA was collected into a clean tube.
2 3 .U  Restriction digest of DNA
All restriction endonucleases and buffers were obtained from Promega, UK. All 
enzymes were at a concentration of 10 units/pl and all buffers at a concentration of 
10x normal working concentration. 20 pi of purified DNA was added to 1 xmulti-core 
buffer, 2 units oiBamR I and Xba I; 10 pi of Drosophila expression vector was mixed 
with lxbuffer D, 2 units of Bgl II and Xba I, followed by incubation at 37°C 
overnight.
2.3.1.4 DNA ligation
The digested DNA was purified with the QLAquick PCR Purification kit 
(Qiagen) to remove the restriction enzymes and digested Drosophila vector was run 
on the gel followed by purification using the above protocol. All DNA ligations were 
carried out by T4 DNA ligase (Life Technologies) at 1 unit/pl and buffer at 
lxconcentration.
2.3.1.5 Transformation of recombinant DNA into DH5a competent cells
A 50 pi aliquot of DH5a cells was thawed on ice and placed into a 1.5 ml tube. 2 
pi of recombinant DNA was added to the tube and mixed with cells by gently 
pipetting up and down several times. The tube was placed on ice for 30 min, followed 
by heat shock at 42°C in a water bath for 45 sec followed by incubation at 37°C for 1 
h with addition of 900 pi LB medium. 200 pi of the 1 in 100 diluted resultant culture
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was plated out on LB plates containing ampicillin at 50 pg/ml concentration (LBamp) 
and incubated at 37°C overnight.
2.3.1.6 Recombinant DNA mini preparation
One colony was picked out from the LBamp plate and put into a flask containing 5 
ml LBamp medium; this was shaken vigorously at 37°C overnight. The Qiagen spin 
plasmid kit and protocol (Qiagen) were used to purify DNA from the ensuing 
bacterial culture. 1.5 ml of the bacterial culture was placed into a 1.5 ml tube and 
centrifuged at 13,000xg for 5 min. The supernatant was removed and the cell pellet 
resuspended in 250 pi of buffer PI. A 250 pi aliquot of buffer P2 was added to the 
tube which was then inverted gently 6 times to achieve complete mixing. After 5 min 
incubation at room temperature, buffer N3 was added to the tube, followed by gentle 
mixing 6 more times and then centrifugation at 13,000xg for 10 min. The supernatant 
was loaded onto a QIAprep column. The column was centrifuged at 13,000xg for 1 
min and washed with 750 pi PE buffer, followed by 13,000xg centrifugation, the flow 
through being discarded. The column was centrifuged for an additional 1 min to 
remove residual wash buffer. The column was then placed in a clean tube and DNA 
eluted by the addition of 50 pi of EB buffer, incubated at room temperature for 1 min 
and then centrifuged at 13,000xg for 1 min. The DNA was kept at -20°C.
2.3.1.7 Screening and sequencing of recombinant DNA
To confirm the identity of the recombinant DNA thereby generated, firstly the 
restriction enzymes BamH I and Xba I were used to digest DNA. The digest was then 
run on a gel to enable the DNA fragments generation to be compared to the DNA 
ladder, thereby ensuring the appropriate length of the inserts. Secondly, 30 pg of 
DNA was sent to MWG-Biotech (Germany) for sequencing.
2.3.1.8 Recombinant DNA maxi preparation
After confirmation of the correct sequence of recombinant DNA, the Qiagen 
Endoffee plasmid maxi kit and protocol (Qiagen) were used to purify plasmid DNA. 
A 100 pi volume of LBamp media was inoculated with 200 ml of liquid culture, and
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then incubated at 37°C overnight. Bacterial cells were harvested by centrifugation at 
6,000xg for 15 min at 4°C, and resuspended in 10 ml of cell resuspension buffer and 
pipetted up and down to separate the cells. 10 ml of cell lysis solution was added to 
the tube, mixed by inverting 6 times and then allowed to stand for 5 min. 10 ml 
neutralization solution was added to the tube, mixed 6 times immediately, and the 
lysate was then poured directly into the barrel of the QIAfilter cartridge followed by 
10 min incubation at room temperature. The lysate was filtered through the cartridge 
into a 50 ml tube and incubated on ice for 30min with addition of 2.5 ml ER buffer. 
The solution was applied to the buffer QBT equilibrated QIAGEN-tip, and then 
washed twice with 30 ml QC buffer. DNA was eluted with 15 ml QN buffer and 
precipitated by adding 10.5 ml isopropanol, mixed and centrifuged at 15,000xg for 
30min at 4°C. The DNA pellet was washed with 5 ml of endotoxin-free 70% ethanol, 
carefully decanting the supernatant and air-drying the pellet for 10 min. The DNA was 
re-dissolved in 1 ml endotoxin-free TE buffer, transferred to a new 1.5 ml tube and 
stored at -20°C.
All D N A  quantities and qualities were measured in 1:100 dilution by reading the 
optical density using a spectrophotometer at a wavelength of 260 nm (OD260) and 280 
nm (O D 280), and the D N A  concentration calculated by the formula: 
[D N A ]= (O D 26ox 100^50) pg/ml and quality estimated by the OD260/OD280 ratio.
2.3.2 Transient transfection of S2 cells by calcium phosphate precipitation
232.1 Expression in DES™ expression medium supplemented with 10% heat- 
inactived foetal bovine serum
S2 cells were seeded at a 1 x 106 cells/ml concentration in 5 ml of the DES™ 
expression medium (Gibco BRL) containing 10% heat-inactive serum in 25cm2 flasks 
and incubated overnight at 23°C. The calcium phosphate kit (Invitrogen) was used for 
transfection with 30 pg recombinant DNA. The two transfection solutions were set up 
as follows: Solution A, 60 pi of 2M CaCfe, 30 pg of DNA and water to 500 pi final 
volume; solution B, 500 pi of 2xHEPES-buffered saline (HBS, pH7.1). DNA was 
absent in solution A acting as negative control. Solution A was slowly added to
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solution B with constant vortexing followed by incubation at room temperature for 40 
min. The solution was mixed, added to the cells and incubated at 23°C overnight. The 
calcium phosphate solution was removed and cells washed three times with 
Dulbecco’s PBS (Gibcol BRL); fresh medium was added and cells replated in the 
same vessel followed by overnight incubation. Expression of the desired protein was 
induced by addition of 500 pM C11SO4. On the second post-induction day, the 
conditioned medium was collected and centrifuged at l,000xg. Cell membrane- 
attached proteins were extracted by suspending and gently shaking cells in serum-free 
medium (Gibco BRL) containing additional 350 mM NaCl (1 ml for lxlO7 cells) for 
15 minutes at room temperature, the supernatant being collected following 
centrifuging at l,000xg. The cells were lysed in 1 ml SDS sample buffer and heat- 
denatured for 10 minutes, and centrifuged at 13,000xg at 4°C and supernatant 
collected.
2.3.2.2 Expression of protein in serum-free medium
Transfections and other cell manipulations were performed according to the 
protocol detailed in section 2.3.2.1 except for cell weaning into serum-free medium. 
After removal from the transfection solution, cells were weaned into 2.5% serum 
medium, incubated overnight and then washed with PBS twice and replated with 5 ml 
serum-free medium.
2.3.2.3 HS competition assay
The method was identical to that employed in section 2.3.2.2; 100 pg/ml HS 
(Sigma, Cat# H7640) was added to the serum-free medium at the same time as the 
CuSC>4 induction.
2.33 Western Blotting
7 pi of molecular weight marker and 10 pi of each sample were mixed with 
sample buffer, denatured at 95°C for 5 min and then loaded onto the Novex Nu-PAGE 
4-12% polyacrylamide gel. The gel was run at 180V for 40 min under denaturing 
conditions using the Novex Xcell II tank and Bis-MES buffer (Invitrogen). Protein
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was transferred onto a nitrocellulose membrane (Invitrogen) using the Novex Xcell II 
blot module and 1xt r a n s fe r  buffer (Invitrogen) with methanol (BDH) and antioxidant 
(Invitrogen) at 30V for 1.5 h. The blots were blocked with 5% (W/V) fat-free milk in 
PBS with 0.01% Tween-20 (PBS/T) at 4°C overnight. After washing three times with 
PBS/T, the membrane was incubated with anti-His antibody (1:1,000, 0.2 pg/ml, 
Qiagen) in 3% bovine serum albumin (Sigma) in PBS/T for 1 h. All blots were washed 
3 xlOmin in PBS/T, and then incubated in a 1:10,000 dilution anti-mouse HRP 
conjugated second antibody (Sigma) in 5%(W/V) fat-free milk in PBS/T for lh at 
room temperature. The blots were then washed 3x15 min in PBS/T. The protein bands 
were detected using the enhanced Chemiluminescence plus kit (ECL+ western 
detection kit, Amersham, UK). Blots were covered with ECL+reagent (one volume of 
solution A: 40 volume of solution B) for 5 min at room temperature and placed into an 
X-ray film cassette. The Kodak BioMax light-2 film (Sigma) was placed onto the blot 
and developed for 1 min.
2.4 Results
Using a monoclonal anti-His antibody, Western blot analysis of recombinant 
anosmin-1 from cell lysate, salt extracts (cell surface associated) and conditioned 
medium (secreted) showed bands of the expected molecular weights, confirming the 
validity of the S2 cell expression system for recombinant protein generation (Figure
2.2 (aMc)).
As expected, more protein was demonstrable within cells, a proportion being 
secreted from cells in 10% serum medium culture; by contrast, recombinant protein 
yield was lower under serum-free condition. Of the five expressed recombinant 
proteins, only PIWF1 has been generated in a large amount, irrespective of whether 
the culture was performed in the presence or absence of serum. Using constructs 
encoding increasing numbers of fibronectin type III inserts, lower protein yields were 
obtained, the lowest yield being obtained with PIWF4 protein. It therefore appeared 
that increasing numbers of Fnm repeats could modulate the expression efficiency of 
the integral protein. Part of the explanation may reside in the fact that the longer
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PIW PIWF1 PIWF2 PIWF3 PIWF4
Figure 2.2 Western blot analysis of recombinant anosmin-1 in Drosophila S2 cells, (a) 
Transient expression of recombinant anosmin-1 was induced by 500 pM CUSO4 in 
10% serum containing medium. Recombinant anosmin-1 proteins present in cell 
lysate (L), salt extract (S) and conditioned medium (M) were identified using an anti- 
His monoclonal antibody. The molecular weight markers are shown. The generated 
proteins are attached on the cell surface (S) and secreted into the medium (M). The 
cleavage is only detected in PIWF3 and PIWF4 with 20 kDa and 45 kDa C-terminal 
fragments respectively, indicating that the cleavage site is probably either at the end of 
the 2nd fibronectin or the beginning of the 3rd fibronectin repeats. Transiently 
transfected S2 cells in serum free medium culture were induced to express proteins in 
the absence (b) and presence (c) of 100 pg/ml HS. PIW protein was present in large 
amounts inside cells, with only a little secreted into the medium. Most of PIWF1 and 
nearly all of the secreted PIWF2, 3, 4 proteins are cell surface attached, which can be 
dissociated by the addition of exogeous HS. These results indicate that HS anchors 
recombinant anosmin-1 onto S2 cell surface by interacting with Fnlll repeats. 
Positions of MW markers were as shown.
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molecules take more time to go through the full biosynthetic processes, which 
necessarily involves additional post-translation modification and protein folding. By 
contrast, although abundant PIW protein lacking any Fnin repeats was synthesized 
intracellularly, much less was secreted from cells such that the protein in salt extract 
and conditioned medium generated only a faint band (Figure 2.2 (b) and (c)), 
suggesting that serum and/or the Fnlll modules might be essential for PIW secretion. 
Taken together, these observations suggested that the Fnlll repeat is an important 
determinant not only for anosmin-1 production but also for its secretion, the best yield 
being generated by a truncated protein containing a solitary Fnin domain (PIWF1).
Anosmin-1 expressed in S2 cells is also cell-surface associated, in common with 
its properties when generated in other mammalian cells (CHO and COS-7 cells). The 
cell surface association of anosmin-1 appears to be determined by the Fnin domain 
content of the protein. Indeed, when compared to the secreted form, cell surface 
associated PIW protein generated lower band intensity, whereas increased band 
intensities were observed for cell-surface associated anosmin-1 which contained 
increasing numbers of Fnin domain. This result indicates that Fnm domains are 
necessary fen* cell surface binding. To investigate whether this phenomenon occurs as a 
consequence of an interaction with HS, exogenous HS was then used since soluble HS 
can competitively bind to anosmin-1 leading to the release of anosmin-1 into culture 
medium. As expected, addition of 100 pg/ml HS to serum-free medium resulted in 
significant dissociation of cell membrane associated anosmin-1 (Figure 2.2 (c) vs 
Figure 2.2 (b)). These data suggest that anosmin-1 binds to insect cells through an 
interaction with the HS polysaccharide chains of HSPG, as previously shown in 
mammalian cells (Soussi-Yanicostas et al., 1996). In contrast to the longer forms of 
anosmin-1 (PIWF1, 2, 3, 4), PIW protein without any Fnin domains showed little cell 
surface association, suggesting that PIW protein had less HS binding affinity. This 
concurs with the prediction that the N-terminal WAP domain is not involved in HS 
binding due to its high anionic charge, and evidence from an in vitro cell binding assay 
in which WAP domain shows less avidity for glioblastoma and glioma cells (Bulow et 
al., 2002). Thus, it can be proposed that anosmin-1 resides on the cell surface through
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interaction of its Fnin domain with HS; the more Fnin repeats there are, the less 
protein becomes detachable from cells.
Cleavage of anosmin-1 was observed under two specific circumstances 1) when 
both PIWF3 and PIWF4 proteins were expressed and 2) in serum-containing medium. 
Figure 2.2 (a) show that anosmin-1 was cleavable into small molecular weight 
fragments of about 20 kDa and 45 kDa corresponding to the C-terminal 3rd Fnffl and 
3rd plus 4th Fnin domains respectively. This implies that the cleavage site is located at 
the end of the second fibronectin in  and the beginning of the third fibronectin m  
domain. Notably, no cleavage of PIWF3 and PIWF4 was observed in serum-free 
medium, regardless of whether HS was added or not. Moreover, proteolysis occurred 
extracellularly rather than intracellulary since no corresponding cleaved fragments can 
be detected inside the cells. These observations, in their totality, indicate that cleavage 
of anosmin-1 is artificially caused by the presence of serum.
The observed bands and the molecular weights of each anosmin-1’s variants were 
estimated as follows: PIW-26 kDa, PIWF1-40 kDa, PIWF2-55 kDa, PIWF3-71 kDa 
and PIWF4-90 kDa. The deduced molecular weights of the conceptual proteins, based 
on the amino acid sequence plus vector epitope (4 kDa) are PIW-21 kDa, PIWF1-33 
kDa, PIWF2-45 kDa, PIWF3-59 kDa and PIWF4-76 kDa. From the results obtained, it 
can be speculated that the contribution of glycosylation to the final molecular weight 
of the full-length anosmin-1 (PIWF4) will be: 90-76 = 14 kDa. In addition, the 
molecular weight of each expressed anosmin-1 was slightly greater than its calculated 
value, suggesting that glycosylation might be evenly distributed in each distinct 
domain rather than clustered in limited domains.
2.5 Discussion
The present study provides evidence that, in addition to its use as an expression 
system for recombinant anosmin-1 generation, Drosophila S2 cells also provide a 
model for the investigation of molecular characteristics of anosmin-1, including HS 
binding properties, cleavage of anosmin-1, as well as glycosylation. However, it
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should be noted that, although the protein can be glycosylated in insect cells, the type 
of sugars and the pattern of glycosylation sites are unlikely to be identical to those in 
mammalian cells.
Previous studies had demonstrated anosmin-1 binding to cell membrane 
associated HS in mammalian cells; similar interactions evidently take place in 
Drosophila S2 cells, confirming conservation of anosmin-1 binding to cell surface- 
bound HS through diverse species. Hitherto, two major families of membrane-bound 
HSPG have been established: syndecan with its core protein embedded in the lipid 
bilayer and glypican attached to the cell surface via glycosylphosphatidylinositol 
(GPI)-anchorage. In contrast to mammalian cells which have four members in the 
syndecan and six in the glypican family, Drosophila has only one type of sydecan and 
two members of the glypican family named division abnormally delayed {dally) and 
dally-like {dty) (Forsberg and Kjellen, 2001; Filmus and Selleck, 2001). At present it is 
unclear which of these two types of HSPG interact with anosmin-1 and the precise 
sulphate sequence and structure involved in this interaction; it should, however, prove 
possible to investigate the nature of the HSPG-anosmin-1 interaction using this 
Drosophila cell model. Further studies to distinguish anosmin-1’s binding 
characteristics to either glypican or syndecan might employ specific enzymes and/or 
metabolic labelling studies. The use of a phosphatidylinositol-specific phospholipase 
C (PI-PLC) that cleaves the GPI anchor is a commonly employed technique for the 
identification of protein-GPI anchor associations. Metabolic labelling of cells with 
tritiated GPI anchor components such as ethanolamine and inositol might further shed 
light on these relationships (Debierre-Grockiego et al., 2003). By contrast, the 
syndecan ectodomain can be shed via cleavage of die core protein within 15 amino 
adds near to the plasma membrane. Physiological regulators such as thrombin, 
plasmin and EGF receptor family members have been shown to accelerate this 
proteolytic process (Fitzgerald et al., 2000; Holen et al., 2001). Thus, it is possible, 
using these molecules, to examine the anosmin-1-syndecan interaction. In addition, the 
use of various heparinase treatments to alter anosmin-1 cell surface binding properties 
could help identify the crudal HS sequence and structural motifs required for
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anosmin-1 recognition, since it is known that heparinase I cleaves the highly-sulphated 
epitopes, whereas heparinase III cleaves poorly sulphated sites.
There is now considerable evidence that many inactive precursor proteins are 
rendered active through endopeptidase-induced cleavage; for example, NCAM 
proteins are all formed as heterodimers by proteolytic cleavage and the activation of 
vascular endothelial growth factor (VEGF) is via uPA-mediated cleavage (Kayyem et 
al., 1992; Plouet et al., 1997). The present result confirms that anosmin-1 cleavage 
only occurs by a serum-enzyme mediated reaction since the process did not occur in 
serum-free medium. Together with the evidence that no cleaved fragment of anosmin- 
1 was observed in the rat and chicken brain extracts, this suggests that cleavage is 
most probably unnecessary for anosmin-1’s functional activity. However, a full 
understanding of in vivo anosmin-1 cleavage is incomplete, as is the identification of 
the precise cleavage site. To date, using the insect S2 cell expression system, the 
sequences K345KKRRK350 and R422RR424 which is located in the FnIII-2 domain and 
FnIII-2/-3 linker region respectively have been ruled out as candidate cleavage sites 
(Robertson et al., 2001).
The attachment of oligosaccharides to eukaryotic proteins is the most common 
post-translational modification process, and includes N- and O-glycosylation which 
regulate both the structural and functional properties of proteins, such as protein 
folding and conformation, receptor binding, modulation of enzyme activity, and 
cellular recognition events (Lis and Sharon, 1993; Apweiler et al., 1999). N- 
glycosylation occurs only at the specific amino acid sequence, Asn-X-Ser/Thr (where 
X represents any amino acid except proline), using biosynthetic pathways that are 
highly conserved. Previous experimental results using tunicamycin to inhibit initial 
steps of the dolichol N-glycosylation pathway have demonstrated that when expressed 
in mammalian cells, N-glycosylation contributed up to about 25 kDa for molecular 
weight of mature anosmin-1 (Soussi-Yanicostas et al., 1996). In contrast to this 
finding, our result indicates that the oligosaccharide side chains of anosmin-1 are 
relatively smaller in insect cells. These differences are probably caused by the high
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mannose oligosaccharide content of insect cells (Kuroda et al., 1990). The other 
possibility, such as the lower efficiency of glycosylation in insect cells, cannot be 
ruled out. Furthermore, the effects of this modification on the structural and functional 
characteristics of anosmin-1 can be investigated by using specific glycosylation 
blocking reagents such as tunicamydn to generate unmodified proteins.
2.6 Conclusions
Using transient expression experiments, Drosophila S2 cells were shown to be 
effective tools for the generation of recombinant anosmin-1 with a high yield when 
cultured in serum containing medium. The generated anosmin-1 was glycosylated and 
retains cell-surface binding characteristicsns, similar to that produced in mammalian 
cells. Fnin domains demonstrate multiple actions: first, they determine protein 
expression and secretion efficiency. Second, they mediate recombinant anosmin-1 
attachment to the cell surface through an interaction with HS. Furthermore, cleavage 
of anosmin-1 is localized to the end of 2nd Fnin and the beginning of 3rd Fnin domain 
and is caused by a serum-induced phenomenon.
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Chapter 3
Expression and Purification of anosmin-1 
from stable Drosophila S2 cell line
3.1 Introduction
The process of producing recombinant proteins of optimal quality and quantity 
requires both the generation of a stable cell line, generally using one of the more 
commonly used selection markers such as neomycin and hygromycin, as well as the 
use of an appropriate technique for protein purification, which in some cases involves 
the use of multi-step procedures using the purification strategy of capture, intermediate 
purification and polishing (CIPP). Depending on the physicochemical properties of the 
target protein, potential separation and purification techniques include affinity 
chromatography (biorecognition), ionic exchange chromatography (charge), gel 
filtration (size) and hydrophobic interaction chromatography (hydrophobicity).
Affinity chromatography separates proteins on the basis of a reversible interaction 
between a protein and a specific ligand coupled to a chromatographic matrix. Using this 
principle, the purification of recombinant fusion proteins containing an incorporated tag 
(glutathione-S-transferase or 6 consecutive histidine residues (6His)) is often 
straightforward, requiring a single step for purification. Ni-NTA affinity 
chromatography was used in the present study, to enable purification of recombinant 
anosmin-1 incorporating a C-terminal 6His tag. Ni-NTA affinity chromatography 
employs the principle of immobilized-metal affinity chromatography (IMAC), which 
exploits the binding affinity of imidazole-like histidine chains to the metal ion Ni2+. In 
this method, nitrilotriacetic acid (NTA) is chaiged with the metal ion Ni2+ and then 
coupled to Sepharose CL-6B, thereby generating Ni-NTA agarose. NTA binds tightly 
to four sites in the nickel ion, leaving two sites free to interact with the 6His-tagged 
protein. Finally, the bound protein can be eluted off the column by simple competition 
with high concentration of imidazole.
It was first necessary to establish, validate and then optimise a reliable procedure
83
for producing anosmin-1, generating the desired yield and purity. The procedure 
involved establishing a stable S2 cell line with subsequent scale-up of the protein either 
in static phase or in suspension culture, and the final step of purification and dialysis. 
Prior to attempting stable transfection with a full-length and mutated anosmin-1 
construct, PIWF1, containing the N-terminal WAP and first Fnlll domains, was used 
for initial validation studies, given that it could be generated in abundant quantities as 
evidenced by the initial transient transfection experiments. There were additional 
reasons for generating PIWF1. First, it was recognised that the WAP and 1st Fnin 
domains of anosmin-1 were likely to represent key functional motifs (MacColl et al., 
2002a). Second, it had already been shown that the Fnin domains (particularly the first 
one) participated in cell-surface association with immobilized HSPG (shown in Chapter 
2). The characteristic WAP four-disulphide core motif shares significant homology 
with other members of WAP protein family (Heinzel et al., 1986; Wiedow et al., 1990), 
which are known to act as serine protease inhibitors. The WAP domain has obvious 
functional importance since clinically, mutations that disrupt the disulphide bridges 
within this motif result in loss of function of the entire protein. Thus three brothers in a 
X-KS pedigree share with a cysteine-arginine substitution at site 172 of the WAP 
domain (C172R) demonstrated the full KS phenotype (Oliveira et al., 2001). This 
C172R missense mutation was predicted to disrupt the conserved C157-C172 bridge, 
resulting in a conformational change and loss of biological function. In the present 
study therefore, I focussed on the C172R WAP mutation to examine the apparently 
crucial role of the WAP domain of anosmin-1. The production of pure PIWF1, PIWF4 
protein and their C172R mutants is thus the main objective of this chapter, their 
constructs were shown in Figure 3-1.
3.2 Aims
1) To explore the establishment of stable cell line for relevant protein expression using 
PIWF1 transfected S2 cells.
2) To scale up recombinant protein production using static and suspension culture.
3) To purify recombinant protein using Ni-NTA affinity chromatography.
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C172R
Fnlll-1 Fnlll-2 Fnlll-3 Fnlll-4 H V 5 I PIWF4 or mPIWF4
C172R
PIWF1 or mPIWFr
Figure 3.1 Structures of PIWF4, PIWF1 and their C172R mutants. The functional 
domains represented are; CR, cysteine-rich region; WAP, whey acidic protein-like 
domain; Fnlll, fibronectin-like type HI domain; H, histidine-rich region; V5, the V5 
epitope tag derived from simian virus 5; 6His, 6xhistidine tag. Using site-directed 
mutagenesis, the cysteine residue (C) at 172 site is replaced with arginine (R) (the 
mutation obtained in X-KS patients). The missense mutation (C172R) within the WAP
1 77   idomain present in mPIWF4 andmPIWFl is indicated by the star.
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4) To generate stable cell lines for empty vector protein, GFP protein, PIWF4 and the 
two mutant proteins (mPIWFl172 and mPIWF4172) using an identical protocol to that 
successfully used to generate PIWF1 protein.
5) To generate a polyclonal anti-PIWFl antibody (AIWF1) in rabbit against purified 
recombinant PIWF1.
6) To confirm the role of HSPG in anosmin-1 association onto S2 cell surface, a HS 
competitive assay was performed using stable cell lines.
3.3 Materials and Methods
3.3.1 Hygromycin-B kill curve for S2 cells
Prior to generating a stable cell line, it was necessary to perform a cell kill curve 
to identify the optimal concentration of appropriate antibiotic for selecting 
successfully transfected cells; concentrations of antibiotics required for cell selection 
depend on both cell line and the specific antibiotic. The general principle for selecting 
stable transformants is to use the lowest concentration of antibiotic leading to 1) the 
onset of massive cell death after about five days and 2) cell kill of the entire non- 
resistant population within two weeks. To identify a suitable hygromycin-B 
concentration for transfected S2 stable cell selection, hygromycin-B at 0, 100, 300,
400,700,1,000 pg/ml concentration was used.
S2 cells at 2><106 cells/ml density were cultured into 25 cm2 flasks containing 10% 
serum culture medium with hygromycin-B (Invitrogen) at varying concentrations. 
Cells were kept growing at 23°C and then total viable cell count established by trypan 
blue exclusion after 5 and 10 days incubation respectively. 0.1 ml of trypan blue 
(Sigma) plus 0.1 ml of PBS were mixed and placed in an Eppendorf tube, followed by 
the addition of 0.1 ml of the cell suspension. Complete mixing was performed to avoid 
cell aggregation and ensure full cell suspension in solution. A small amount of trypan 
blue-cell suspension mixture was transferred by capillary action into both chambers of 
the haemocytometer. Cells were counted in the 1mm centre square and in the four 1 
mm comer squares. Non-viable cells stained blue. Computation of ceil concentration 
was as follows: Cells per ml = average cell count per square *3 (dilution factor) xlO4.
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Cell viability (%) = total viable cells/total ce llsx lO O . By the 5th day, cells selected by 
100 pg/ml hygromycin-B continued to grow at the comparable rate as in the absence 
of hygromycin-B, whilst in the presence of 300 and 400 pg/ml hygromycin-B 
concentration, about half of the original S2 cells were killed. By contrast, 700 and
1,000 pg/ml hygromycin-B concentrations were associated with higher selection
t l iactivity since at these two concentrations, about 70% S2 cells were killed. By the 10 
day, 70% cells were killed by 300 and 400 pg/ml hygromycin-B, whereas S2 
populations were almost completely killed by 700 and 1,000 pg/ml hygromycin-B 
(Figure 3.2). Therefore, it was estimated that the effective hygromycin-B 
concentration for selection of stable S2 cell lines lay within the 300-700 pg/ml range; 
300 and 700 pg/ml hygromycin-B concentrations were then chosen to investigate 
optimal selection efficiency generating the best protein yield.
3.3.2 Selection of stable P1WF1 transformants with 300,700pg/ml hygromycin-B
S2 cells at 1 x 106 cells/ml density were seeded in 3 ml medium containing 10% 
serum into a 25 cm2 flask and incubated at 23°C overnight. The calcium phosphate kit 
(Invitrogen) was used to co-transfect with 19 pg recombinant DNA and 1 pg 
pCoHYGRO selection plasmid (Ivitrogen). This selection vector contains the E.coli 
hygromycin-B-phosphotranferase gene under Drosophila copia promoter control, 
confering resistance to hygromycin-B. The two-transfection solutions were set up as 
follows: Solution A: 36 pi of 2M CaCh, 30 pg of PIWF1 recombinant DNA, 1 pg 
pCoHYGRO and sterile water to 300 pi final volume; solution B, 300 pi of 2x 
HEPES-buffered saline (HBS, pH7.1). Solution A was slowly added, drop by drop, to 
solution B, with constant vortexing, followed by incubation at room temperature for 
40 min. The solution was then mixed, added to cells and incubated at 23°C overnight. 
After centrifugation, calcium phosphate solution was removed and cells washed three 
times with Dulbecco’s PBS; fresh 10% serum medium was then added, and cells 
replaced into the same flask and incubated for a further 2 days. Cells were centrifuged 
and re-suspended in 10% serum containing medium with 300 and 700 pg/ml 
hygromycin-B respectively, this procedure being repeated every 4 days. At each 
change of medium, the total number of viable cells was counted to monitor
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Figure 3.2 Hygromycin-B induced S2 cell kill curve. S2 cells at 2x106 cells/ml density 
were cultured in 10% serum containing DES™ medium, and co-incubated in the 
absence or presence of hygromycin-B at the various concentration of 100, 300, 400, 
700 and 1000 pg/ml. On the 5th and 10th day of hygromycin-B selection, cell viability 
was determined by Trypan blue exclusion and counted by haemocytometer. The cells 
selected by 100 pg/ml hygromycin-B keep growing at a comparable rate to those 
without hygromycin-B addition (top graph). About 50% of cells were killed by 300 
and 400 pg/ml hygromycin-B, whereas hygromycin-B at or over 700 pg/ml nearly kill 
all cells by the 10th incubation day (bottom graph).
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antibiotic selection. Throughout the whole selection process, cell numbers initially 
dropped by approximately 50% and then rose to over 1*107 cells/ml, confirming that 
the resistant S2 cells had been generated. The duration of time for the selection process 
was generally about 3 weeks. Resistant cells were then split 1:2 into a new flask with 
addition of fresh selection medium, and incubated for a further 3 days before being 
split 1:2 again. To confirm PIWF1 protein expression, 2><106 resistant cells in 2.5 ml 
10% serum medium were aliquoted into 6-well plates and copper sulphate added for 
induction of protein expression. On the 2nd post-induction day, proteins were collected 
for Western blot analysis, according to the protocol described in sections 2.3.2.1 and 
2.3.3. Resistant cells with the highest PIWF1 expression were aliquoted and stored in 
liquid nitrogen, the remainder being used for protein scale up.
3.33 Scale-up of PIWF1 using stationary flask and spinner flask
The protein purification process is greatly facilitated if the relevant recombinant 
protein can be expressed in serum-free medium; in this instance, in order to avoid 
proteolytic degradation erf* full length anosmin-1, it was necessary to express the 
PIWF4 protein in the absence of serum (described in Chapter 2). This necessitated as 
first step, gradually weaning the cell line expressing PIWF1 into medium devoid of 
serum. 1 x 107 cell/ml stable cells were initially harvested in 10% serum containing 
medium, then down successively into medium containing 1% serum and finally neat 
serum-free medium. Stable cells at a final density of 2 x io6 cell/ml in 100 ml serum- 
free medium were then transferred either into a 300 cm2 stationary flask or into a 250 
ml spinner flask for suspension culture. In the latter case, 0.05% (v/v) pluronic F-68 (a 
surfactant used to protect cells from shearing damage, Sigma) was added to the 
medium. A constant stirring rate of 100 rpm was used in the spinner flask, with its side 
arms loose for a quarter (1/4) turn. After overnight incubation, cells were induced to 
express PIWF1 protein. On the 3rd post-induction day, conditioned medium was 
collected and cell surface associated protein extracted with serum-free medium 
containing additional 350 mM NaCl.
3.3.4 Protein purification by Ni-NTA affinity chromatography
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The salt extract and conditioned medium were loaded into a Vivaspin 20 ml 
concentrator (Vivascience, 5,000 MWCO membrane) in order to trap PIWF1 protein, 
while minimising the volume. The loaded concentrator was then centrifuged at 2,500 
xg at 4°C for 50 min. The concentrated solution was transferred into a new tube, and 
lOxbalance buffer (500 mM NaH2P0 4 , 50 mM Tris-Cl, 100 mM imidazole, pH 8.0) 
added. For conditioned medium, this buffer with additional 350 mM NaCl was added 
and mixed thoroughly. 200 pi 50% Ni-NTA agarose (1 volume Ni-NTA with 1 
volume PBS, Qiagen) was then added into each 4 ml mixed solution (1:20), and gently 
mixed by shaking at 100 rpm at 4°C for 1 hour. The mixture was transferred onto a 
column with filter on the bottom (Qiagen) and flow-through fraction collected. The 
column was then washed twice with 1ml wash buffer (50 mM NaH2P0 4 , 5 mM 
Tris-Cl, 300 mM NaCl and 20 mM imidazole, pH 8.0). Protein was eluted 4-6 times 
with 200 pi elution buffer (50 mM NaH2PC>4, 5 mM Tris-Cl, 300 mM NaCl and 250 
mM imidazole, pH 8.0) and analysed by Western blot and silver staining.
3.3.5 Silver staining
10 pi samples and 7 pi of molecular weight markers were loaded onto a Novex 
Nu-PAGE 4-12% polyacrylamide gel and run at 180V for 40 min. Silver staining kit 
(Invitrogen) was used for protein detection according to the manufacturer’s protocol. 
The gel was soaked in 100 ml fixing solution containing methanol and acetic acid for 
10 min, followed by soaking twice in 100 ml sensitising solution with glutaraldehyde 
for 1 hour. The gel was then rinsed in 2 x 200 ml changes of ultra pure water for 10 
min each, and then soaked in staining solution with silver nitrate and sodium 
hydroxide for 15 min prior to a further two rinses. The gel was then placed in 
developing solution until bands reached the desired intensity; staining was then 
terminated with 5 ml addition of stopper solution and the gel washed twice more with 
pure water. Water was then decanted and fresh Gel-Dry™ solution (35 ml per gel, 
Invitrogen) was added. The gels were then placed between two layers of cellophane 
sheets and assembled into a gel-drying frame for scanning and photography.
3.3.6 Quantitative Protein Assay
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The Bio-Rad protein assay (Bio-Rad laboratories, UK) used here is based on the 
Bradford method. In an acidic solution of Coomassie Brilliant G-250, absorbance 
shifts from 465 nm to 595 nm upon binding to protein. Bovine plasma albumin was 
used as protein standard and set up in serial incremental concentrations in PBS to 
construct a standard curve. PBS only was used as blank. The protein sample was also 
appropriately diluted with PBS to a final volume of 0.8 ml. 0.2 ml Dye Reagent 
concentrate was then added to each standard and protein samples and gently inverted 
several times. After 30 min, the O D595 was measured and corrected for the reagent 
blank. OD595 versus concentration of standards was plotted, enabling sample protein 
concentration to be read from the standard curve. Final protein concentration = 
protein concentration obtained from standard curve * dilution factor.
3*3,7 Mutagenesis of mPIWFl172 and mPIWF4172 incorporating C172R WAP 
domain mutation.
The QuickChangeTm site-directed mutagenesis kit and protocol (Stratagene) was 
used with the mutagenic forward primer:
GGGTGTGGACACACCCGTCAAGTACCCAAGACTC and reverse primer:
GAGTCTTGGGTACTTGACGGGTGTGTCCACACCC containing the mutated 
codon (C172R) in the middle of the primers. 10-75 ng each of PIWF1 and PIWF4 
were used as template with 125 ng of primers, 1 pi of dNTP mix, 2.5 unit of PJuTurbo 
DNA polymerase and water, made up to a final reaction volume of 50 pi. The PCR 
extension time was calculated according to the recommended formula: 2 minutes/ kb 
of plasmid length. In the case of PIWF4, the reaction was not initially successful using 
the calculated time of 11 min. Following investigation, the optimal extension time was 
determined to be 14 min. The PCR protocol was as follows:
segment cycles temperature time
mPIWFl172 1 1 95°C 30 sec
2 12 95°C 30 sec
55°C 1 min
68°C 9 min
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mPIWF4172 1 1 95°C
95°C
5 min
2 14 50 sec
57°C 1 min
68°C 14 min
Following temperature cycling, the reaction was placed on ice for 2 minutes to cool 
the reaction to < 37°C. PCR products were then treated with 1 pi of the Dpn I 
endonuclease (lOU/pl). The Dpn I endonuclease is specific for methylated and 
hemimethylated DNA with the target sequence 5’-GmATC-3’ and is used to digest the 
parental DNA template and to select for mutation-containing synthesized DNA. Each 
reaction mixture was gently and thoroughly mixed by pipetting the solution up and 
down several times. The reaction mixture was then spun down and incubated at 37°C 
for 4 hours to digest parental DNA. 2pl of Dpn I-treated DNA was added to DH5a 
competent cells and the protocols outlined in 2.3.1.5-2.3.1.8 sections then followed. 
All constructs were sequenced to confirm creation of correct mutants. The construct of 
these two mutants was shown in Figure 3 .1.
3.3.8 Optimization of expression and purification of recombinant proteins
Similar protocols to those for PIWF1 were used to scale-up PIWF4 and other 
recombinant proteins, including green fluorescent protein (GFP), PIWF4, mPIWFl172 
and mPIWF4172. A stable S2 cell line expressing empty vector protein was also 
generated for comparison of the protein cell surface association, but not used for 
protein scale-up. Some modifications were incorporated for certain steps. First, 700 
pg/ml hygromycin-B was used for selection. Second, the suspension culture method 
was optimised, since larger recombinant protein yields are dependent on this method. 
The concentration of cell protection reagent — pluronic F-68 was increased from 
0.05% (v/v) to 0.1%, whilst a constant stirring rate was decreased from 100 rpm to 60- 
70 rpm. Furthermore, the time of incubation was prolonged up to 3 days prior to 
CuSC>4 induction. Finally, since mutated proteins were expressed at lower efficiency, 
the ratio of the Ni-NTA to the mixture solution was decreased to 1:40 in order to 
minimize binding of other non-desirable proteins. All purified samples were analysed 
by SDS-PAGE and Novex Colloidal Blue stain (Invitrogen). This method is 5 times
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more sensitive than traditional Coomassie Blue techniques and easy to use, thus 
substituting for the previously used silver staining. 2 pi samples were loaded for 
electrophoresis and the gel was shaken in fixing solution (mixture of 40 ml deionised 
water, 50 ml methonal and 10 ml acetic acid for one gel) for 10 minutes. The gel was 
then soaked in staining solution containing methonal and Stainer A for 10 minutes, 
followed by the addition of 5 ml stainer B/each gel for a minimum of 3 h shaking.
33.9 Protein dialysis into PBS
Purified protein was dialysed against PBS to remove imidazole and salt prior to 
subsequent functional and structural analyses. Protein samples were injected into a 
slide-A-Iyzer Cassette with a pre-hydrated 10 kDa MWCO membrane (Pierce). 
Initially, direct dialysis against PBS resulted in significant protein aggregation and 
precipitation; aggregated protein could however be re-dissolved into the original 
elution buffer. Thus, different conditions for anosmin-1 protein dialysis were 
investigated: namely, the effects of PBS pH ranging from 7.0 to 9.0 and the effects of 
various salt or detergent concentrations. However, none of these conditions were 
capable of keeping anosmin-1 soluble. Finally, metal ion contamination was 
considered. Thus metal chelators EDTA together with imidazole were added to the 
dialysate solution for anosmin-1 dialysis. As expected, this modification abolished 
anosmin-1 aggregation, confirming that the metal ion was the key determinant of 
anosmin-1 solubility. There are a number of dialysis steps using different dialysates 
containing imidazole and EDTA. First, the dialysis was performed against PBS to 
which was added 160 mM NaCl, 100 mM imidazole and 10 mM EDTA at 4°C for 24 
h. Second, protein was dialysed into the buffer to which was added 160 mM NaCl, 20 
mM imidazole and 2 mM EDTA, followed by dialysis against PBS with 160 mM 
NaCl only. Finally, protein was dialysed into pure PBS for functional analysis and into 
PBS with additional 80 mM NaCl for structural studies. In each procedure the same 
dialysate was changed 3 times. All dialysed samples were concentrated using a 
vivascience concentrator with 10 kDa MWCO membrane.
3.3.10 Protein storage
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For structure study, the purified and dialysed anosmin-1 was kept at 4°C for 
short-term storage. For long-term storage, the protein was frozen at -80°C, lyophilized 
and reduced to dehydrated protein powder. The redissolved anosmin-1 still retained its 
biological function, indicating that the lyophilization can be used for anosmin-1 
storage and maintenance of its stability.
3.3.11 HS competitive assay using stable S2 cell lines
Established PIWF1 and PIWF4 expressing stable S2 cell lines were harvested at 2 
xlO6 cell/ml density into 6-well plates in 2.5 ml serum-free medium. After 24 h 
incubation, cells were treated with or without 100 pg/ml HS in the presence of 500 
pM CuS04 for protein expression. Conditioned medium and cell-surface associated 
proteins were collect for Western blot.
3.3.12 Generation of polyclonal antibody against P1WF1 (A1WF1)
Polyclonal antibodies were raised in rabbit by CN Bioscience (UK). 80 pg/ml of 
pure PIWF1 was injected with Freunds complete adjuvant for initial immunization and 
Freunds incomplete adjuvant for the remaining 5xboosts. Pre-immune serum was 
collected, and following immunization, test bleeds were performed to investigate the 
sensitivity and specificity of antibodies (AIWF1) generated.
33.12.1 Dot-Blot
1, 0.1, 0.01 pg of PIWF1 protein, diluted in 10-20 pi PBS, were loaded onto a 
nitrocellulose membrane and allowed to dry at 37°C for 30 minutes. The membrane 
was cut into slices and placed into 6-well plates prior to incubation with various 
dilutions of antibody. The samples were incubated in 1 ml 5% fat-free milk in TBS (15 
mM Tris, 20 mM NaCl, pH 7.6) for 1 h, and membranes then washed with 4 x l ml 
TBS-0.1% Tween-20, and incubated overnight with the AIWF1 antibodies from the 
second test serum at the following dilutions: 1:10, 1:100, 1:1,000, 1:10,000, with 
shaking at 4°C. Pre-immune sera was added without dilution as a negative control. The 
membrane was washed four times with wash buffer and incubated for two hours with 
goat anti-rabbit peroxidase antiserum, followed by 3 x wash with TBS/T and a single
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wash in 50 mM Tris-HCl pH 7.6. The reaction was developed in DAB 0.025% (50 
mM Tris-HCl, pH 7.6) with 0.005% H2O2, and the reaction terminated in 10 mM 
EDTA pH 8.0, followed by drying prior to scanning.
3.3.12.2 ELISA assay
1 pg, 0.1 pg and 0.01 pg of PIWF1 protein in 100 pi PBS were coated onto the 
96-well Immunlon 4HBX microtitre plate (Thermo Labsystems/ Thermo life science) 
and incubated at 4°C overnight. Each well was rinsed 3 times with 100 pi wash 
buffer (50 mM Tris-HCl, 150 mM NaCl, 0.05% Tween-20, pH7.6). 100 pi 1% BSA 
in PBS-0.1% Tween (PBS/T) was added to cover the remaining protein binding sites 
during a 1 h incubation at 37°C. Each well was washed with wash buffer and AIWF1 
antibody added in dilutions with PBS/T at- 1:10, 1:100, 1:1,000, 1:10,000, 
1:100,000 concentrations, followed by incubation at 37°C for 1 hour. After rinsing 
each well 3 times, the second anti-rabbit antibody labelled with alkaline phosphatase 
(1:10,000 dilution with TBS) was added and incubated at 37°C for 1 h. Each well 
was rinsed thoroughly with wash buffer 4 times and then 100 pi substrate (p- 
nitrophenyl phosphate, 0.25 mg/ml, Pierce) was added to each well and allowed to 
react at 37°C for 15 min. Optical density at 405nm was then measured.
33.12.3 AIWF1 purification
AIWF1 antibody was purified from serum obtained during the 3rd bleed with 
protein G Sepharose affinity chromatography using a MAB Trap Kit (Amersham 
Pharmacia). A syringe was filled with distilled water and connected tightly to the 
column through a Leuer adapter. The twist-off end was removed and the ethanol 
preservative washed out with 5 ml distilled water at 1 drop/sec. The column was 
equilibrated with 3 ml binding buffer. The 1:1 binding buffer diluted serum was 
applied to the column and washed with 10 ml binding buffer. Purified IgG was eluted 
with 5 ml elution buffer into 200 pi neutralizing buffer pre-loaded tubes for each 1 ml 
elution solution. The eluates were collected into 1-5 tubes separately. To measure the 
concentration of purified antibody, 20 pi of eluates were collected and mixed with 
980 pi of water and the absorbance read at 280nm. The peak optical density was
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observed in the second eluates, A280 = 0.185. The concentration of purified IgG was 
calculated as follows: 0.75 x 0.185 x 50 = 6.94 mg/ml. Purity and specificity were 
assessed by Novex Colloidal Blue stain and Western blot.
3.3.12.4 Western blot
0.01 pg, 0.1 pg PIWF1 and 0.1 pg, 0.6 pg PIWF4 proteins were loaded onto the 
Nu-PAGE gel for electrophoresis and then transferred to the nitrocellulose membrane. 
Blotting was carried out with purified AIWF1 antibody or anti-His antibody (positive 
control) in a 1:1,000 dilution. The secondary anti-rabbit antibody at a 1:10,000 
dilution was directed to polyclonal AIWF1 test, whilst anti-mouse secondary antibody 
directed to the monoclonal anti-His antibody.
3.4 Results
Based on the kill curve of S2 cells (Figure 3.2), a concentration of 300 pg/ml 
hygromydn-B was chosen as starting point and a concentration of 700 pg/ml used to 
compare the selection effidency. The PIWF1 stable cells selected by 700 pg/ml 
hygromycin-B yielded 5-10 fold more protein (250 pg/ml) than that by 300 pg/ml 
hygromycin-B selection. In contrast, 1,000 pg/ml hygromycin-B proved too high, 
bdng lethal to both transfected and non-transfected cells. These results suggested that 
the higher concentration of hygromycin-B at 700 pg/ml was optimal for selection, 
possibly because: 1) it generated a relatively pure population of polyclonal stable cells 
by killing more non-transfected S2 cells and 2) it selected out higher protdn- 
expressing cells with a greater number of copies of recombinant DNA integrated into 
the host genome. However, compared to PIWF1, the expression of PIWF4 and mutant 
proteins was much less, about 5 fold lower for PIWF4 and mPIWFl172 and >10 fold 
for mPIWF4172 even with 700 pg/ml hygromycin-B selection, the results bdng 
consistent with previous observations in the transient transfection experiments.
As shown in Figure 3.3 and 3.4, the purity of PIWF1 from the salt extract was 
extremely high, as evidenced by the silver staining assay; higher yields were evident 
with 700 pg/ml hygromydn-B selected cells as compared with that with 300 pg/ml
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Figure 3.3 Purification of salt extracted PIWF1 generated from 300 pg/ml 
hygromycin-B selected S2 cells. The stable PIWF1 cells (2 * 106 cell/ml) were 
harvested in 100 ml serum free medium and the protein expression was induced in 
static flask. 10 pi of each sample was electrophoresed through SDS/PAGE under non­
reducing conditions and stained with silver staining. Lane 1: marker; Lane 2: flow- 
though pool; Lane 3: 20 mM imidazole wash; Lane 4-7: 250 mM imidazole elution; 
Lane 8: conditioned medium; Lane 9: 350 mM NaCl extract. The molecular weight is 
shown.
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Figure 3.4 Purification of salt extracted PIWF1 generated from 700 pg/ml 
hygromycin-B selected S2 cells. The PIWF1 stable S2 cells (2 x 106 cell/ml) were 
harvested in 100 ml serum free medium and the protein expression induced in a static 
flask. 10 pi of each sample was electrophoresed through SDS/PAGE under non­
reducing conditions and stained with silver staining. Lane 1: marker; Lane 2: flow- 
though pool; Lane 3: 20 mM imidazole wash; Lane 4-7: 250 mM imidazole elution; 
Lane 8: conditioned medium; Lane 9: 350 mM NaCl extract.
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selection. Although devoid of serum in the cultured medium, more protein 
contaminants were observed when purification was performed directly from 
conditioned medium (Figure 3.5), possibly due to the presence of free copper ions. 
These observations reinforce the advantage of one-step purification by Ni-NTA 
chromatography directly from salt extraction rather than from conditioned medium. 
An alternative and complementary purification method might of course employ HS 
affinity chromatography for anosmin-1 purification from conditioned serum-free 
medium. In terms of PIWF4 and the two other mutants, even present in relatively 
lower concentrations, the silver staining shown in Figure 3.6, 3.7, 3.8 confirmed that 
Ni-NTA chromatography was capable of yielding high purity recombinant protein 
from the salt extract.
For scaling-up recombinant protein production, the suspension culture appears 
advantageous, enabling the growth and proliferation of insect cells at high density. In 
the present experiment, the doubling time of S2 cells in the spinner flask was more or 
less constant at 18-24 hours until a high viability of 15-20 x 106 cell/ml density was 
reached; in contrast, cells grew very slowly in a large static flask with a division time 
of 48-72 hours and a tendency to stop growing at 5 * 106 cells/ml. Paradoxically, the 
level of purified protein is opposite; thus, about 20 fold less protein of lesser purity 
was observed in suspension culture as compared to the stationary flask (Figure 3.9). It 
is, at first, unclear why cells maintaining a high proliferation rate and population 
subsequently generate inferior protein yields of lesser purity. The most likely 
explanation is, however, that continuous shearing stress experienced by cells exposed 
to harsh stirring, together with the deficiency of cell-membrane protection reagent 
(pluronic F-68) would cause mechanical damage to rapidly circling cells, leading to 
the secreted protein detachment from the cell surface. Another possibility is that 
copper sulphate induction of protein synthesis may be less efficient in cells that have 
been stirred. As a consequence, minor modifications to the stirring speed and 
concentration of pluronic F-68, were undertaken, these being the main factors 
determining mechanical cell damage. As shown in Figure 3.10, the best recombinant 
protein yield was obtained with a decreased constant stirring rate of 60-70 rpm and by
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Figure 3.5 Purification of PIWF1 protein from serum-free conditioned medium. The 
PIWF1 was generated by 700 pg/ml hygromycin-B selected S2 cells. Lane 1: marker; 
Lane 2: serum-free conditioned medium; Lane 3: flow-through pool; Lane 4: 20 mM 
imidazole wash; Lanes 5-8: 250 mM imidazole elution.
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Figure 3.6 Purification of salt extracted PIWF4. Lane 1: marker; Lane 2: 350 mM 
NaCl extract; Lane 3: flow-through pool; Lane 4: 20 mM imidazole wash; Lanes 5-10: 
250 mM imidazole elution.
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Figur 3.7 Purification of salt extracted mPIWFl172. Lane 1: marker; Lane 2: flow­
through pool; Lane 3: 20 mM imidazole wash; Lane 4-7: 250 mM imidazole elution.
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Figure 3.8 Purification of salt extracted mPIWF4172 Lane 1: marker; Lane 2: salt 
extract; Lane 3: flow-through pool; Lane 4: 20 mM imidazole wash; Lanes 5-8: 250 
mM imidazole elution. Purified protein is indicated by arrow.
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Figure 3.9 Initial investigations on the generation and purification of salt extracted 
PIWF1 protein using suspension culture. The PIWF1 stable S2 cells (2 x 106 cell/ml) 
were harvested in 100 ml serum free medium containing 0.05% (v/v) pluronic F-68, 
and then incubated at a constant stirring rate of 100 rpm. 10 pi of each sample was 
loaded for electrophoresis and silver staining. Lane 1: marker; Lane 2: salt extraction; 
Lane 3: flow-through pool; Lane 4: 20 mM imidazole wash; Lane 5-8: 250 mM 
imidazole elution.
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Figure 3.10 Generation and purification of salt extracted PIWF1, PIWF4 protein and 
GFP using suspension culture to validate the modified protocol. The corresponding 
protein-expressing stable S2 cells (2 * 106 cell/ml) were cultured in 250 ml serum free 
medium containing higher concentration of pluronic F-68 to 0.1% (v/v), and incubated 
at a slower constant stirring rate of 60-70 rpm. 10 pi of each sample was loaded for 
electrophoresis and Novex Colloidal Blue stain. Lane 1: marker; Lane 2: PIWF1; Lane 
3: PIWF4; Lane 4: GFP.
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increasing pluronic F-68 up to 0.1%, indicating that the importance of restricting cell 
shearing stress in the suspension culture. This modification proved extremely valuable, 
resulting in the generation of sufficient pure recombinant protein, for use in 
subsequent structural analysis.
The successful generation of large amounts of highly purified recombinant 
PIWF1 protein enabled the generation of a specific anti-anosmin-1 antibody(AIWFl). 
As expected, the dot blot and ELISA assays produced consistent results (Figure 3.11 
and 3.12), showing the highest density and absorbance at 1 in 10 and 1 in 100 antibody 
dilutions respectively. With increased dilution, there was a corresponding decrease of 
sensitivity, reaching a nadir at dilutions of 1 in lO^-lO'5. The pre-immune antiserum 
was not associated with background staining in the dot-blot assay, confirming the 
specificity of the antibody. Furthermore, immunoblot analysis using 1:1,000 AIWF1 
generated single bands of the expected molecular weights for the PIWF1 and PIWF4 
respectively, confirming the ability of AIWF1 to recognise both truncated and full- 
length proteins. Not unexpectedly, higher immuno-detection sensitivity was obtained 
in 1 pg PIWF1 and the lowest in 0.01 pg PIWF1, whereas a weak band was observed 
at higher concentration of 0.6 pg PIWF4 (Figure 3 .13).
A HS competitive assay using transient transfection (Chapter 2) had previously 
shown that anosmin-1 was attached to the cell surface by binding to the HS chain of 
HSPG. To confirm this observation, experiments were also conducted on stable 
PIWF1 and PIWF4 cell lines, which do not suffer from the disadvantage of requiring 
multiple-step cell preparation, as well as the variable efficiency of transfection. 
Exogenous 100 pg/ml HS was added at the time when stable cells were induced by 
CuSO* Western blot consistently showed a higher intensity band in conditioned 
medium upon the addition of exogenous HS, demonstrating that 100 pg/ml HS could 
dissociate PIWF1 and PIWF4 from cell surface into medium (Figure 3.14). In order to 
rule out the possible involvement of the V5 and poly-His tag in cell-surface binding, 
stable cell lines transfected either with an empty vector or the vector expressing GFP 
were established. Western blot analysis using anti-His antibody showed that the
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Figure 3.11 Dot blot analysis was performed using the recombinant PIWF1 protein 
(0.01-1 pg) as antigen on the nitrocellulose membrane. AIWF1 (1:10-1:10,000 serial 
dilutions) were used as primary antiserum and preimmune serum serving as negative 
control, (a) preimmunsera; (b) 1:10 diluted AIWF1 antibody; (c) 1:100 diluted 
AIWF1; (d) 1:1,000 diluted AIWF1; (e) 1:10,000 diluted AIWF1 antibody. 1. 0.01 pg 
PIWF1; 2. 0.1 pg PIWF1; 3. 1 pgPIWFl.
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Figure 3.12 AIWF1 antibody analysis by ELISA assay. The microtitre wells were 
coated with 0.01, 0.1 and 1 pg of PIWF1 respectively. Serial dilutions of AIWF1 
antibody (1:10-1:100,000) were added for 1 h incubation at 37°C, followed by 
incubation with second antibody conjugated with alkaline phosphatase. The optical 
density was measured at 405nm. 1.00E-01= 1 in 10; 1.00E-02= 1 in 102; 1.00E-03= 1 
in 103; 1.00E-04= 1 in 104; 1.00E-05= 1 in 105.
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Figure 3.13 AIWF1 antibody analysis by Western blot. 0.01, 0.1 pg PIWF1 and 0.1, 
0.6 pg PIWF4 were loaded for SDS-PAGE respectively. The proteins were 
immunobloted by 1:1,000 diluted AIWF1 antibody and anti-His antibody as positive 
control. The corresponding horseradish peroxidase conjugated secondary antibody was 
used: anti-rabbit secondary antibody for AIWF1 antibody and anti-mouse secondary 
antibody for anti-His antibody. The molecular weight markers are shown.
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Figure 3.14 Western blot analysis of recombinant anosmin-1, the C172R mutants, 
empty vector protein and GFP generated by stable S2 cell lines in serum free medium 
using anti-His antibody. PIWF1 and PIWF4 proteins were analysed in the presence or 
absence of HS. The proteins in salt extract (S) are cell surface associated, whereas 
secreted proteins are detected in conditioned medium (M). More recombinant PIWF1 
and PIWF4 were dissociated from cell surface by exogenous HS addition, confirming 
that recombinant anosmin-1 anchors onto the cell by interaction with HS chain of 
HSPG. The cell surface association patterns of vector, GFP and two C172R mutants 
(mPIWFI172 and mPIWF4172) using S2 stable cells are also shown. L represents cell 
lysate.
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epitope containing bands were only present in conditioned medium rather than in the 
salt extract (Figure 3.14), indicating that these epitopes alone are not able to bind to 
cell surface. To further understand the role of the evolutionarily conserved WAP 
domain and to study the effects of the C172R substitution, mPIWFI172 and 
mPIWF4172 expression constructs were generated. The expression of mPIWFI172 and 
mPIWF4172 proteins was also confirmed by Western blotting (Figure 3.14). The 
C172R substitution, however, did not disrupt the anosmin-1-HS interaction since these 
mutants were able to associate to the cell surface HS in a manner comparable to their 
wild type counterparts (Figure 3.14). This result is consistent with the conclusion that 
it is the Fnin, not WAP, which is essential for HS interaction.
3.5 Discussion
In the present study, procedures for recombinant anosmin-1 generation have 
been optimised from initial establishment of a stable cell line to the final steps of 
dialysis. The main challenges during these processes were the determination of 
optimal conditions for suspension culture, protein purification and subsequent 
dialysis. As previously described, spin rate, concentration of pluronic F-68 and even 
initial cell density had to be taken into account using the spinner flask technique. 
Although satisfactory protein purity could be obtained using a stationary flask, the 
inferior cell density generated by this method proved a major limitation when trying 
to use this method to generate a large protein yield. Furthermore, the present method 
using Ni-NTA chromatography appeared to offer the best approach for one-step 
purification of 6His fused proteins when extracted from the cell surface, thereby 
minimising the protein loss inevitably associated with the more laborious purification 
procedures. When using CHO cells, for example, to generate and purify anosmin-1, a 
three step procedure including two affinity chromatographies were required (Soussi- 
Yanicostas et al., 1996), whereas the single step purification used here with chelated 
nickel-NTA bound to the 6His-fusion anosmin-1 proved sufficient.
The next biggest challenge proved to be the protein dialysis procedure. Metal ion 
contamination associated with purification by immobilized metal affinity
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chromatography (IMAC) was considered as a key factor for protein aggregation and 
precipitation during dialysis. Proteins are highly interactive with metal ions by two 
principle types of interaction; one is based on the carboxy clusters on the protein 
surface which behave similarly to carboxy chelators such as EDTA and EGTA, the 
other related to constituent amino acid residues as the imidazolium ring of histidine. 
Protein-metal binding is 5-60 times stronger than an ion exchange interaction and the 
metal may also mediate crosslinking, leading to simple dimerization, gross 
aggregation or even precipitation. It may also alter protein properties, including 
surface charge and hydrophobidty. Thus, elimination of contaminating metal ions 
benefits not only the dialysis process but also ensures maintenance of the original 
protein properties. A two-pronged chemical strategy was therefore adopted. First, the 
inclusion of 5-50 mM EDTA in the buffers to compete with the carboxy clusters 
within protdn for chelation to metal ions. Second, along with EDTA, inclusion of 5- 
50 mM of the imidazole containing molecules histidine, or histamine in buffer to 
compete out the metal ion. In the case of anosmin-1 10 mM EDTA was required 
during the dialysis process until imidazole gradually reached a nadir level and finally 
dialysed into PBS. The procedures established here are likely to be useful during 
dialysis and scavenging of any contaminating metal ion particularly when using 
IMAC for protein purification.
High effidency PIWF1 generation was obtained using the above paradigms; 
however, the relatively poor yield of full-length PIWF4 and mutant protdns require 
further analysis. Firstly, from a structural point of view, the predicted amino acid 
sequence of PIWF4 is three times longer than PIWF1, and contains 4 additional N- 
glycosylation sites when compared to truncated PIWF1 protein. Secondly, PIWF4 
contains 4 additional heparan sulphate binding sites, making the full-length protein 
more tightly cell membrane adherent, leading to a higher salt requirement for protdn 
extraction. Furthermore, when cell membrane HSPG is saturated by secreted 
recombinant PIWF4, it is possible that protein expression becomes down regulated to 
maintain a constant balance between protdn generation and degradation. An 
additional possibility is that PIWF4 is somehow internalised and degraded
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intracellularly. The fact that PIWF4 was only detected on the cell surface but not in 
medium supports this possibility. Thus by analogy, newly synthesized Noggin protein 
has a cellular half-life of approximately 3.6 h and a proportion of cell surface Noggin 
appears to be internalised and degraded intracellularly (Paine-Saunders et al., 2002). 
In terms of mutant anosmin-1 generation using the present system, the disruption of 
the 3-dimensional structure caused by the C172R missense mutation could alter the 
efficiency of protein folding and secretory efficiency. Therefore, some approaches are 
worthy of additional consideration. Firstly, transfection of the desired cDNA and 
hygromycin-B resistant gene using a single construct might enable the generation of a 
more homogenous stable cell line, akin to the creation of a 'mono-clonal stable cell 
line’. Secondly, additional exogenous heparin might be added to the serum-free 
medium to dissociate more anosmin-1 from cell surface thereby reducing potential 
degradation. Finally, a modified single step IMAC procedure, using iminodiacetic 
acid (IDA) chelating Sepharose instead of Ni-NTA agorose, has been reported for 
protein purification from divalent ion containing medium (Lehr et al., 2000), 
providing an alternative direct approach for anosmin-1 purification from conditioned 
serum-free medium.
3.6 Conclusions
The present experimental approaches have demonstrated the efficiency, reliability 
and convenience of using a Drosophila S2 cell expression system followed by one- 
step purification using Ni-NTA affinity chromatography, for successful recombinant 
anosmin-1 generation. The generation of a stable S2 cell line for recombinant 
anosmin-1 production was optimal when using a 700 pg/ml hygromycin-B 
concentration during the selection procedure. Ni-NTA affinity chromatography 
proved ideal for purification of 6His tagged anosmin-1 from salt extract using a single 
step. Elimination of metal ion contamination during the dialysis process after IMAC 
protein purification was mandatory. The greatest protein yield was obtained with 
PIWF1, while lower yields for PIWF4 and their mutants. The quantity of PIWF1 
enabled the generation of a polyclonal antibody against anosmin-1 (AIWF1). 
Furthermore, a HS competitive assay using PIWF1 and PIWF4 stable cell line
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confirmed the dominant role of HSPG in anosmin-1 association onto S2 cell surface. 
Successful generation of purified recombinant anosmin-1 proved essential for 
subsequent function and structure analysis.
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C hapter 4
The binding affinity of anosmin-1 to heparan sulphate
4.1 Introduction
The roles of HS in physiological and pathological processes are determined by HS 
binding to an extremely broad range of soluble and insoluble molecules (Princivalle 
and de Agostini, 2002; Sasisekharan et al., 2002). Anosmin-1 appears to be one such 
interactant, both as a consequence of its predicted amino acid sequence and from 
previous in vivo/in vitro studies. There are five predicted HS-binding sequence motifs 
identified within or among four Fnlll repeats (Robertson et al., 2001), and this has 
formed the rationale for: 1) The use of a heparin-Sepharose column for anosmin-1 
purification; 2) The use of heparin/heparinase to dissociate anosmin-1 protein from 
transfected CHO cell surfaces (Soussi-Yanicostas et al., 1996). In addition, a HS 
competitive assay using a transient S2 cell transfection and stable S2 cell line (Chapter 
2 and 3) demonstrated that anosmin-1 could also be detached from the transfected S2 
cell surface by addition of HS. Furthermore, in an anosmin-1 cell adhesion assay, 
heparin at a 30 pg/ml concentration, and heparinase (1 unit/ml) were able to inhibit 
anosmin-1 induced cell adhesion by approximately 50% (Robertson et al., 2001). 
Perhaps of more relevance, a recent gene locus screen in an anosmin-1 overexpressing 
transgenic C.elegans model has demonstrated that the enzymes required for normal HS 
synthesis (6-O-sulphotransferase and C5 epimerase) are essential for the anosmin- 
1 induced phenotype (Bulow et al., 2002). The latter observations represent the first in 
vivo confirmation of HS involvement in the action of anosmin-1.
However, direct binding of anosmin-1 to HS has not previously been 
systematically investigated. Hitherto, there have been no attempts to quantify the dose- 
dependency of HS binding to anosmin-1, nor to quantify the affinity of this interaction. 
The importance of individual fibronectin type m  domains in this interaction has not 
been systematically assessed, nor indeed whether the cysteine-rich N-terminus and 
WAP domain regulate HS binding affinity through tertiary structure formation.
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Although the WAP motif has been predicted not to be directly involved in HS-binding, 
it is still unknown whether the missense C172R mutation that disrupts the highly 
conserved disulphide bridge can affect binding affinity to HS indirectly through 
alteration in tertiary structure of the whole protein.
Conventionally, biomolecular interactions are studied using techniques such as 
immunoassays (ELISA or RIA), equilibrium dialysis, affinity chromatography and 
spectroscopy. Chemically similar molecules can be detected by their biospecificity for 
an immobilized molecule. These biomolecular interactions can also be directly 
monitored using so-called evanescent field sensors, the most frequently used such 
technique being surface plasmon resonance (SPR). SPR gives two main advantages 
over traditional techniques: the binding events are monitored in real-time and it is not 
necessary to label the interacting biomolecules. Thus, molecules can be studied in their 
native state to provide results that reflect in vivo activity. I therefore used a solid-phase 
immunosorbant assay and SPR to enable complementary quantitative measurements on 
anosmin-1-HS interaction.
4.2 Alms
A solid phase immunosorbant assay was used to investigate whether purified 
anosmin-1 could bind to HS in a dose-dependent manner. SPR was used to measure 
the kinetic interaction of these two molecules in real-time.
4.3 Materials and Methods
4.3.1 Solid phase enzyme-linked immunosorbant assay
4.3.1.1 Biotinylation of HS
HS was dissolved in 0.1 M MES pH 5.6 (2-[N-morpholino] ethanesulphonic 
add) (Sigma) at 2.5 mg/ml and then added to 2.5 mM EZ-link biotin hydrazine 
(Pierce) and 0.5 mM EDC [1-Ethyl-3-(3-Dimethylaminopropyl)carbodiimide 
hydrochloride] (Pierce), and mixed thoroughly by constant shaking at room 
temperature for 24 hours. The mixture was dialyzed against water to remove unreacted 
biotin and freeze-dried, re-dissolved in 200 pi 0.3 M NaCl.
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4.3.1.2 Effects of varying the concentration of biotinylated HS on binding to a 
fixed concentration of protein
Immunlon 4HBX plates containing 96-well microtitre wells (Thermo 
Labsystems/Thermo life science) were coated with 0.1 pg PIWF1, PIWF4, 
mPIWFI172 and mPIWF4172 in 100 pi PBS respectively, and incubated overnight at 
4°C. Control wells were coated with 0.1 pg BSA and 2 pg purified rabbit apoE (kindly 
provided by Prof. Jim Owen). Each well was rinsed with 3x100 pi wash buffer (50 
mM Tris, 150 mM NaCl, and 0.05% Tween-20, pH 7.6). The wells were then 
incubated with 100 pi 1% bovine serum albumin in PBS to block the remaining 
protein binding sites for 1 h at 37°C. Each well was rinsed with 3x100 pi wash buffer. 
Biotin-conjugated HS was successively diluted in 1 in 4 with PBS and 100 pi added 
into each well, followed by incubation at 4°C for 18 h. The wells were then rinsed with 
3x100 pi wash buffer, and 100 pi alkaline phosphatase-conjugated avidin (1 pg/ml) 
added, followed by incubation for 1 h at 37°C. Wells were then rinsed thoroughly with 
4x100 pi wash buffer, followed by incubation with 100 pi of 0.25 mg/ml alkaline 
phosphatase substrate (sigma 104 phosphatase substrate) (Sigma) at 37°C. Absorbance 
at 405 nm was read at 5,10,15,20 min time intervals.
4.3.13 Effects of varying protein concentration on binding to a fixed biotinylated 
HS
Microtitre wells were coated with 0.2 nM, 1 nM, 5 nM, 25 nM, 50 nM and 100 
nM each of PIWF4, mFIW4172, PIWF1, mPIWFI172 and BSA and then incubated with
12.5 pg/ml (1 in 200 dilution) biotinylated HS, according to the above method.
4.3.1.4 In vitro HS competitive assay
To confirm the specificity of HS binding to the protein, unlabeled HS at 0,1, 10, 
100 pg/ml concentrations were mixed with 12.5 pg/ml biotinylated HS into the wells 
coated by 0.1 pg PIWF4 using the same protocol as above.
4.3.2 SPR assay
43.2.1 The principle of SPR
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SPR is an optical-electrical phenomenon based on the interaction of light with a 
metal surface. Under certain conditions, the energy carried by photons of light is 
transferred to packets of electrons, called plasmons, on a metal’s sensor surface. This 
surface is generally made of gold.
The coupling of light with a metal surface results in the creation of a plasmon, a 
group of electrons that behave like a single electrical entity. The plasmon, in turn, 
generates an electrical field that extends about 100 nanometers above and below the 
metal surface. The interaction between the plasmon’s electrical field and the matter 
within the field determines the resonance wavelength. Any change in the composition 
of the matter within the range of the plasmon’s field causes a change in the wavelength 
of light that resonates with the plasmon. The magnitude of the change in resonance 
wavelength, the SPR angle shift, is directly and linearly proportional to the change of 
the amount of bound macromolecules. Scanning mirror biosensors thus can measure 
the SPR angle shift in millidegrees as a response unit (RU), to quantify the binding of 
macromolecules to the sensor surface (Figure 4.1). A change of 120 millidegrees 
represents a change in surface protein coverage of approximately 1 ng/mm2, or in bulk 
refractive index of approximately 10'3.
43.2.2 The SPR sensor surface and analytical application
In SPR biosensors, the gold surfaces can be coated with a layer of biomolecules 
that are capable of binding with a selected analyte target. The binding molecules may 
be antibodies, DNA probes, enzymes of other reagents that react exclusively with their 
analyte molecules. However, in general, immobilization of biomolecules directly on 
the metal surface is not suitable for biosensors because it leads to low coverage of 
biomolecules with reduced activity and non-specific adsorption. Alternatively, various 
sensor surface chemistries can provide appropriate chemical properties for stable and 
defined ligand binding. One approach is to use a streptavidin monolayer immobilized 
onto a gold film that can be further functionalised with biotinylated biomolecules. The 
gold surface may also be coated by spreading out liposomes to make hydrophobic 
character of the surface. Another approach is to form a self-assembled monolayer of
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Figure 4.1 The schematic mechanism of SPR. Fixed wavelength light, in a fan-shaped 
form, is directed at the sensor surface and biomolecular binding events are detected as 
changes in the particular angle where SPR creats extinction of light. This change is 
measured continuously to form a sensorgram, which provides a complete record of the 
progress of association or dissociation of the interactants.
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thiol molecules (e.g. 16-thiohexadecanol, alkanethiols) used to enable covalent 
binding of a dextran layer. The carboxylic groups of dextran can be activated by 
means of N-hydroxy succinimide (NHS) and ethyl-methyl-diaminopropyl- 
carbodiimide (EDC), making it possible to couple a ligand with a functional group 
such as -NH2. Another possibility is the immobilization of nitrilotriacetic add (NTA) 
onto sensor surface, followed by Ni-chelation to capture polyhistidine tagged ligands.
During binding analysis, SPR changes occur as a solution is passed over the 
surface of a sensor chip covered with the appropriate ligand. Sample containing the 
analyte molecules is injected over this surface in a precisely controlled flow. Analyte 
binds to the surface-attached ligand during sample injection, resulting in an increase in 
signal, corresponding to the association interaction. At the end of the injection, the 
sample is replaced by a continuous flow of buffer and the decrease in signal now 
reflects dissociation of interactant from the surface-bound complex (Figure 4.2).
4*3.2*3 Immobilising biotinylated heparin onto streptavidin sensor chip
A Biacore 3000 surface plasmon response-based biosensor (BIAcore AB) was 
then used to measure binding parameters between anosmin-1 (analyte) and 
immobilized heparin ligand. A streptavidin sensor chip (Biosensor AB, Uppsala, 
Sweden) was pretreated with 5 pi injection of 50 mM NaOH in 1M NaCl to remove 
non-specifically bound contaminants. 5 pi biotinylated heparin (1 pg/ml) from porcine 
intestinal mucosa (CalBiochem, Cat# 375054) in HEPES-buffered saline (10 mM 
HEPES, 150 mM NaCl, 3.4 mM EDTA, pH 7.4, containing 0.005%(v/v) P-20) was 
injected at a flow rate of 5 pl/min, giving low levels of immobilized ligand (200 
resonance units) to minimize mass transfer effects. Three flow cells were coupled and 
one flow cell contained a blank sensor chip to serve as a reference surface. The 
coupling was monitored by injection of purified rabbit apoE at 0.5 and 1 pM since 
apoE has been shown to be a heparin-binding molecule; 2% BSA was run as a 
negative control and 2 M NaCl was injected to remove bound apoE.
4.3.2.4 SPR kinetic measurement of the heparin interaction with anosmin-1
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Figure 4.2 Typical SPR-plot of the specific interaction of biomolecules to a single spot 
of the biochip surface. After equilibration with the buffer the sample is injected. A 
binding of the biomolecule to the surface is the result (association phase). After 
removing the sample, the bound biomolecule will dissociate slowly (dissociation 
phase). The sensor chip can be regenerated by injection of a solution to get rid of the 
specific interaction (regeneration phase). The biochip can be reused for a new binding 
event, in the case the non-specific interaction is still relatively low (the baseline should 
be stable).
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Purified wild type and mutated anosmin-1, typically at six different 
concentrations (15 pi, in HEPES-buffered saline), were injected at a flow rate of 5 
pl/min to ensure recovery of data prior to curve fitting: 25, 37.5, 50, 75, 100, 200 nM 
for truncated anosmin-1 (PIWF1 and mPIWFI172) and 12.5, 25 37.5 50, 75, 100 nM 
for full-length anosmin-1 (PIWF4 and mPIWF4172). Each experiment was performed 
from the lowest to the highest concentration, followed by injection in the reverse 
order. This procedure was designed to confirm the specificity of the molecular 
interaction and the complete recovery of binding property of ligand on the sensor 
surface. The same buffer was circulated over the sensor surface to facilitate 
dissociation. Between binding cycles, the coated chip was regenerated by a 10 pi 
injection of 2 M NaCl. The bulk shift due to changes in refractive index was measured 
using a reference surface and was subtracted from the binding signal at each 
concentration to correct for nonspecific signals. Sensorgrams and kinetic parameters 
were analysed by curve fitting using a BIA Evaluation software version 3.0. Curve 
fitting conformed to a 1:1 Langmuir model and this resulted in excellent fits with 
random small residuals.
4.4 Results
The sensitivity and specificity of the solid phase enzyme-linked immunosoibant 
assay was initially evaluated using increasing concentrations of HS coupled to the 0.1 
pg protein-coated plates. ApoE and bovine serum albumin (BSA) were used as 
positive and negative controls respectively. As shown in Figure 4.3 (a), HS did not 
bind to BSA-coated wells, whereas apoE binding to biotinylated HS was increased 
dramatically with the addition of > 3.1 pg/ml biotinylated HS. Subsequently, the HS 
interaction with immobilized fixed concentrations of anosmin-1 (at 0.1 pg) was 
investigated. HS binding to all tested anosmin-1 variants was observed in a 
concentration-dependent manner, higher affinity binding was evident for full-length 
PIWF4 and PIWF4172 (Figure 4.3 (b)). Binding sensitivity was high as a minimum 
tested HS concentration < 0.2 pg/ml resulted in the detectable HS/anosmin-1 binding. 
To further confirm the specificity of HS/anosmin-1 interaction, the unlabeled HS was 
co-cultured with biotinylated HS since it can competitively attenuate labelled
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Figure 4.3 Investigation of immunosorbant method for protein-HS binding affinity 
assay. 0.1 pg apoE and BSA (a) and 0.1 pg wild-type, mutated PIWF1 and PIWF4 (b) 
were coated respectively onto microtiter wells. Soluble biotinylated HS at increasing 
concentrations were added and incubated at 4°C. Alkaline phosphate-conjugated 
avidin and an alkaline phosphatase substrate were added, and the plates were 
incubated at 37°C. Absorbance was measured at 405nm. (c) Competitive inhibition 
assay using unlabeled biotinylated HS binding to 0.1 pg PIWF4. 0, 1, 10, lOOpg/ml 
HS without biotin-conjugate were co-incubated with a constant concentration of 
biotinylated HS (12.5 pg/ml) onto 0.1 pg PIWF4 coated microtiter wells.
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HS/anosmin-1 binding. Different concentrations of unlabeled HS were mixed with
12.5 fig/ml labelled HS and then added onto 0.1 pg PIWF4 coated wells. As expected, 
10-100 pg/ml non-biotin labelled HS resulted in an about 50% attenuation of the HS- 
PIWF4 interaction (Figure 4.3 (c)). Taken together, these results confirm the 
sensitivity and specificity of the immunosorbant assay in ansomin-l-HS interaction, 
validating this model for subsequent quantitative analysis.
Increasing concentrations of purified anosmin-1 were then coated onto microtitre 
wells, followed by the addition of a constant concentration of biotinylated HS (12.5 
pg/ml) as soluble component. As shown in Figure 4.4, significant binding to BSA 
coated wells was not observed. However, HS bound effectively in a dose-dependent 
manner to the wells coated with all the anosmin-1 in the 5 nM to 100 nM 
concentration range. These data suggested high affinity binding of anosmin-1 to HS. 
Both wild type (PIWF4) and mutated (mPIWF4172) full-length anosmin-1 exhibited 
higher HS binding affinity than their truncated counterparts, an observation consistent 
with previous experimental results. Therefore increasing numbers of Fnin domains 
lead to greater HS binding.
The kinetic measurements of the binding affinity between anosmin-1’s variants 
and heparin were then carried out using SPR technology, which enables ligand/analyte 
interaction measurements in real-time. Representative sensorgrams for binding of 
truncated and full-length proteins to the immobilized heparin are shown in Figure 4.5. 
The initial rising portion of the binding curve represents association of injected 
proteins with immobilized heparin, the final portion of the curve corresponding to 
dissociation of bound proteins from the sensor chip surface. The relatively steep 
association phase with shallow dissociation phase in all four recombinant anosmin-1 
indicated their high heparin-binding affinity. The dissociation constant (Ad) was 
calculated as the ratio of the rate of dissociation constant (£0fr) to the rate of association 
constant (*«,) (Table 4.1). Ad values were all less than 10 nM, indicating high heparin- 
binding affinity for the full range of proteins tested. The truncated PIWF1 protein, 
containing a single 1st Fnin domain, had a lower binding affinity (Ad, 4.31±0.99 nM)
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Figure 4.4 Immunosorbant assay analysis of anosmin-l-HS binding. Immobilized 
proteins at the indicated concentrations were coated onto microtiter wells and 
incubated with soluble 12.5 pg/ml biotinylated HS. Alkaline phosphate-conjugated 
avidin and an alkaline phosphatase substrate were added and absorbance was 
measured at 405 nm.
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Figure 4.5 BIAcore analysis of anosmin-1 interaction with heparin. Representative 
sensorgrams are shown for the interaction of immobilized heparin with soluble PIWF4 
(a), mPIWF4172 (b), PIWF1 (c) and mPIWFI172 (d). Six different concentrations of 
analyte were used for these analyses: 25, 37.5, 50, 75, 100, 200 nM for PIWF1 and 
mPIWFI172, 12.5, 25, 37.5, 50, 75, 100 nM for PIWF4 and mPIWF4172 (color lines, 
upper panel) The top sensorgram line in each graph represents the highest 
concentration of proteins, and the bottom line the lowest concentration. Residual plot 
showed the difference between measured and calculated responses (bottom panel in (a) 
- (d)). The artifact fragment in association curve was removed from PIWF4 
sensorgram.
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Table 4.1. BIAcore kinetic data for binding of 
anosmin-1 to heparin
Soluble analyte U M -' S'1) M S ' 1) ^d(nM)
PIWF4 4.36 ±0.7 xlO5 1.04 ±0.12 xlO'3 2.51 ±0.60
mPIWF4172 5.72±1.92 xlO5 1.14 ±0.47 xlO'3 1.97 ±0.42
PIWF1 7.71 ±3.57 xlO5 3.09 ±0.97 xlO'3 4.31 ±0.99
mPIWFI172 1.82±0.80xl05 1.37 ±0.47 xlO'3 7.89 ±1.49
Association rate constants (Kvd, dissociation rate constants (&0ff) and apparent 
dissociation constants (Ka) for soluble anosmin-1 binding to immobilized heparin are 
shown. Values are shown as mean ± standard deviation derived from triplicate 
measurements.
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than full-length protein (K& 2.51±0.6 nM). These results appear to be consistent with 
the previous data obtained by immunoabsorbant assay. The WAP mutation increased 
the PIWF1 Kd value, with less impact on full length PIWF4; thus the C172R 
substitution has an effect only on the heparin binding kinetics of truncated protein.
4.5 Discussion
The affinity and specificity of HS-protein binding are determined by its 
polysaccharide sequence, the 2-0, 3-0 and 6-0 monosaccharide sulphated residues, 
and the peptide sequence of protein ligand (Esko and Lindahl, 2001; Merry and 
Wilson, 2002). More than 100 proteins are known to interact with HS via three 
specific mechanisms: 1) ionic interaction based on the XBBXBX and XBBBXXBX 
(where B represents basic residues, including lysine, arginine and histidine, X 
represents a hydropathic residue) consensus sequences, 2) hydrophobic interaction and 
3) hydrogen bond formation. In lipoprotein metabolism for example, HS plays a 
crucial role in complex formation of apoE and lipoprotein via certain polysaccharide 
residues of IdoA(2 -OS0 3 )-GlcNS(6 -OS0 3 ). The N-sulpho groups on the GlcN 
residues of HS and O-sulpho groups contribute to high binding affinity (Libeu et al., 
2001). Furthermore, the consecutive alignment of basic amino acid in apoE containing 
Arg-142, Lys-143, Arg-145, Lys-146, and Arg-147 has been shown to be necessary 
for its high HS-binding. The Lys-146 participates in an ionic interaction with the 
heparin fragment, whereas Lys-143 is implicated in hydrogen bond formation.
In a previous study, all anosmin-1 analogues could be dissociated from S2 cell 
surface by the serum-free medium containing additional 350 mM NaCl (Chapter 2 and 
3); moreover 2 M NaCl also eluted bound anosmin-1 from an immobilized heparin 
sensor chip surface, indicating that charged residues are crucially involved in the 
anosmin-1-HS interaction. The large positively charged surfaces of the Fnin domains 
are likely to participate in an ionic interaction with the negatively charged HS, 
whereas the WAP domain is unlikely to be involved due to its higher acidic residue 
components leading to a large negative charged surface. This prediction was 
confirmed both in a cell-based measurement using a S2 cell HS competition assay
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(Chapter 2 and 3) and in a solid-phase analysis using an immunosorbant assay and 
surface plasmon resonance techniques (Figure 4.4 and Table 4.1). The protein with 
greater numbers of Fnin repeats exerts higher cell-surface association via HSPG 
interaction and great HS-binding affinity, whereas the WAP domain mutant does not 
alter the HS-binding characteristics shared by PIWF4 and mPIWF4172.
Dose-dependent, high nanomolar affinity binding was demonstrated between 
anosmin-1 and HS. The PIWF1-HS binding affinity is only slightly lower than the 
binding affinity of the full-length PIWF4 (4.31 ± 0.99 nM and 2.51 ± 0.60 nM 
respectively), indicating that the 1st Fnin domain constitutes the main HS binding 
module. These results are consistent with previous studies by Saoussi-Yanicostas et al. 
who previously reported that a synthetic 32 amino acid peptide derived from the 1st 
Fnin domain induced heparin associated cell adhesion (Soussi-Yanicostas et al., 
1998), and by Bulow et al who observed that the introduction of a missense mutation 
(corresponding to the human N267K substitution) in the 1st Fnin of the C. elegans 
Kal-1 abolished heparin-dependent cell binding and axon branching activity (Bulow et 
al., 2002). In addition, our data show that a structural alteration in the WAP domain 
interferes with the Fnffi domain-HS interaction when incorporated in a truncated 
(PIWF1) but not full length (PIWF4) anosmin-1, suggesting that the structural 
alteration of the WAP domain probably influences the charged residue distribution in 
the 1st FnDI domain, especially when not followed by additional Fnin repeats. Thus, 
the impact of a disrupted WAP domain on the anosmin-1-HS interaction is dependent 
on the number of FNHI repeats present, with less interference associated with 
increasing FNin repeats. One explanation for this observation could be that if the 
WAP and 1st Fnin domains form a stereochemically compacted structure, whereas an 
elongated conformation is assumed by the full-length protein. To further unravel these 
observations will require further studies using experimentally based molecular 
modeling coupled with higher resolution structural analysis.
The specific polysaccharide sequences and the extent of monosaccharide 
sulphation of HS required for anosmin-1 binding remains to be elucidated. Two HS-
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binding sites have been identified in fibronectin: the N-terminus HEPI with weak 
affinity of a dissociation constant between 10'6 to 10‘5M, and the C-terminal HEPII 
with a higher 10'8 to 10'7M affinity constant. The HEPII site is located in the Fnin 
repeats of fibronectin, the homologous domain present in anosmin-1. Thus, its high 
HS-binding affinity is consistent with the kinetic K& value (2 nM) shown in anosmin- 
l ’s Fnin domain. The sequence of HS for HEPH site was identified as the GlcA- 
GlcNS0 3 -[IdoA(±2 S)-GlcNS0 3 ]5-6-IdoA-GlcNAc (Walker and Gallagher, 1996). This 
may also provide a useful clue for identifying the specific HS component for anosmin- 
1 binding.
The present results provide the first biochemical evidence that anosmin-1 binds to 
HS in a dose-dependent manner with high nanomolar binding affinity, suggesting that 
the interaction between these two macromolecules is likely to be functionally relevant. 
The main action of HS on protein function is thought to be mediated through 
modulation of free protein ligand concentration, modulation of cell-cell/cell-ECM 
adhesion, and the regulation of ligand dimerization and the possible stabilization of 
ligand-receptor complexes. A detailed mechanism of HS involvement in anosmin-1 
function can be proposed based on the known interaction of HS with other proteins. 
Firstly, given the high binding affinity of HS to anosmin-1, one can speculate that HS 
modulates the gradient concentration of anosmin-1 by regulating the diffusion from 
either cell surface or extracellular matrix; a similar mechanism has been proposed in 
the Noggin and BMP system in which HS retains BMP on the cell surface and 
establishes an activity gradient (Paine-Saunders et al., 2002). Secondly, the interaction 
with HS perhaps induces a structural rearrangement of anosmin-1 and subsequently 
stabilises complex formation between the WAP domain and a putative extracellular 
serine protease, resulting in the increase of protease inhibitory activity. The role of HS 
in the anticoagulation system reinforces this prediction. Upon binding to the specific 
HS pentasaccharide sequence on the surface of endothelial cells, anti-thrombin IE 
subsequently forms an inhibitory protein-protein complex by inducing a 
conformational change, leading to 1000-fold increase of inhibitory activity on serine 
protease Xa and Ea (Shriver et al., 2000a; Shriver et al., 2000b). Furthermore, in a
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molecular model of apoE, the shallow groove on the apoE molecular surface can be 
widened by the interaction with 2-O-sulphation of IdoA5 in HS (Libeu et al., 2001). 
This observation raises the possibility that HS may induce a conformational alteration 
in anosmin-1. Finally, anosmin-1 might interact with an unknown receptor (perhaps 
FGFR1) through HS, followed by ligand and receptor dimerization as occurs with the 
FGF2-FGFR-HS system. HS facilitates specific binding of FGF2 to FGFR and serves 
as a platform for FGF2, FGFR oligomerization and dimerization, followed by 
transphosphorylation of specific tyrosine residues which lead to cell proliferation and 
migration. The absence of HS reduces FGF2-induced cell proliferation significantly 
due to loss of contact between two FGF2 molecules and FGFR (Kwan et al., 2001). It 
therefore can be proposed that anosmin-1 may 1) stabilize FGFR1/FGF2/HS complex 
formation, 2) recruit FGF2/HS to their high-affinity receptor and 3) even determine 
HS specificity for cell-specific intracellular response to extracellular FGF2/FGFR1 
signal.
4.6 Conclusions
Consistent with cell-based HS competitive assay (Chapter 2 and 3), an 
immunosorbant assay and SPR analysis have shown the interaction between 
anomsin-1 and HS: 1) their binding is in a dose-dependent manner, 2) quantification 
of kinetic interaction was at 2 nM (Kd). In addition, the Fnin repeats, particularly the 
first one, has been identified as a dominant HS binding site.
In addition to the HS/FnlQ domain interaction, prior to this study the identity of 
ligands interacting with the N-terminal CR and WAP domains was still unknown. 
Members of the serine protease family might represent putative candidates. The 
identification of a serine protease interactant, together with the investigation on their 
functional interaction with the anosmin-l/HS complex is addressed in the next 
chapter.
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C hapter 5
Interaction between anosmin-1, HS and urokinase-type plasminogen 
activator in prostate carcinoma PC-3 cell proliferation
5.1 Introduction
The interaction between the Fnin domains of anosmin-1 and HS was previously 
shown to occur at nanomolar affinity with K& values < 10 nM. An outstanding 
question remains the identity of potantial ligands that might interact with anosmin-rs 
N-terminal CR and WAP domains as well as the functional relevance of such 
interactants.
The WAP domain of anosmin-1 has been hypothesized to function as a serine 
protease inhibitor based on its homology with other WAP family members. Thus 
elafm and SLPI are well-defined serine protease inhibitors whose substrates are 
elastase, chemotrypsin and trypsin respectively. A highly variable V region and a 
conserved methionine residue in the Pi’ position have been identified as the active 
binding centre for complex formation with elafin and chemotrypsin (Grutter et al., 
1988; Tsunemi et al., 1996). Based on these data, it was hypothesized that anosmin-1 
might regulate cell processes via the interaction of its WAP domain with an as yet 
unidentified serine protease. In this respect, it is pertinent that several trypsin-like 
serine proteases are expressed in the developing OB including the urokinase 
plasminogen activator (uPA), tissue plasminogen activator (tPA) and thrombin 
(Dihanich et al., 1991; Dent et al., 1993). Of these, in the olfactory bulb, uPA 
expression is predominantly within the large mitral and related tufted cells lying more 
superficially in the external plexiform layer as early as E l4.5, a time at which the HS 
proteoglycan N-syndecan, is expressed by migrating olfactory and GnRH neurons 
(Dent et al., 1993). Early expression of uPA has also been observed in the spinal cord, 
central neurons (by embryonic day 12.5) and epithelial cells of the kidney (Sumi et al., 
1992), where anosmin-1 might also be biologically active. uPA has been reported to 
influence tissue remodelling, synaptogenesis, neurite outgrowth and cell proliferation
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(Hantai et al., 1989). A proteolytic cascade involving uPA may underpin its potential 
role in tissue remodelling and angiogenesis through the primary degradation of ECM 
and secondarily through the activation of transforming growth factor-P or basic FGF 
release from extracellular matrix (Pepper, 2001). In addition, uPA expression has been 
reported to correlate with synapse elimination in developing skeletal muscle (Hantai et 
al., 1989). A critical role of uPA in mediating neural synaptic plasticity has also been 
supported by evidence from transgenic mice overexpressing uPA, which resulted in 
reduction in spatial olfactory capability as well as taste-aversion (Meiri et al., 1994). 
The molecular mechanism by which uPA exerts its biological function appears to be 
either through the pericellular conversion of the zymogen plasminogen to plasmin, 
which in turn catalyses the activation of the pro-matrix metalloproteinases (MMPs), or 
via a proteolysis-independent mechanism whereby secreted uPA binds with its high 
affinity cell surface receptor (uPAR) and other classical signalling receptors to activate 
related signalling pathways (Pittman et al., 1989; Blasi and Carmeliet, 2002). uPA was 
thus considered a putative serine protease candidate ligand for the N-terminus of 
anosmin-1.
uPA is secreted as an inactive single-chain protein (known as pro-uPA or sc-uPA) 
activated into a two-chain uPA molecule following a single proteolytic event. The 
overall folding topology of the uPA and pro-uPA molecules can be divided into three 
functionally independent regions: an amino-terminal epidermal growth factor (EGF)- 
like domain, a kringle domain and a carboxy-terminal catalytic domain (known as 
low-molecular-weight uPA). The first two domains comprise the amino-terminal A- 
chain fragment (ATF). The receptor (uPAR)-binding module resides in the growth 
factor domain, in residues 21-32 (Appella et al., 1987). In addition, both the kringle 
and proteolytic domains are recognised by the I domain of the (Xm subunit within 
integrin <XMp2> which is distinct from the uPAR binding site. The trimolecular complex 
of uPA, uPAR and integrin, in which uPA binds to both receptors, appears to occur on 
the cell surface and mediate its unique functional properties including cell adhesion 
and migration (Pluskota et al., 2003).
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uPAR is a three-domain (Dl, D2 and D3) GPI-anchored protein with high 
affinity for uPA, pro-uPA and the ATF (Ploug and Ellis, 1994). Binding of uPA to 
cell-surface-located uPAR leads to activation of cell signalling. A common finding in 
uPA signalling resulting in chemotaxis, is the activation of intracellular tyrosine 
kinases (Src, Hck, FAK) and serine/threonine kinases such as ERK/MAPK. uPA also 
causes membrane translocation of Raf, Src and Fak, and of the Rho family GTPase 
Rac, and nuclear localization of ERK/MAPK1/2 (Nguyen et al., 2000; Degryse et al., 
2001; Kjoller and Hall, 2001). The functional importance of these interactions has 
been shown in studies of uPA/uPAR dependent cell proliferation and cytoskeletal 
reorganization. uPAR-dependent tumour growth involved both integrin and 
ERK/MAPK signalling, as high levels of uPAR activated the ERK/MAPK1/2 pathway 
and suppressed growth-inhibiting p38 MAPK (Aguirre Ghiso et al., 1999). 
Furthermore, treatment of cells with uPA causes uPAR-and integrin-dependent cell- 
shape changes and cytoskeletal reorganization with membrane ruffling, formation of 
actin rings and lamellipodia, and localization of integrins, uPAR and Src to the 
lamellipodia (Degryse et al., 1999). uPA is, however, able to stimulate vascular 
smooth muscle growth in the absence of uPAR in vivo (Carmeliet et al., 1998).
Therefore, I hypothesized that the molecular mechanism for the biological 
function of anosmin-1 might be via an interplay between two cross-talk molecules- 
HS and uPA. I further hypothesized that the N-terminal anosmin-1 (WAP domain) 
might modulate the catalytic activity of uPA and its signalling pathway, whereas HS, 
the Fnin domain ligand, might determine cell surface localisation of the anosmin- 
1/uPA complex. To test these hypotheses, it was first necessary to determine whether 
anosmin-1 could regulate uPA catalytic activity in vitro. Secondly, a human PC-3 
prostatic carcinoma cell line was thus employed as a model to investigate the 
functional relevance of an anosmin-1 /HS/uPA interaction. I tentatively chose the PC-3 
cell line based on a number of characteristics: first, PC-3 cell growth can be inhibited 
by a novel member of the WAP protein family, PS20, which shares a 30% amino acid 
similarity with the WAP domain of anosmin-1 (Larsen et al., 1998). Second, the role 
of uPA/uPAR in tumourogenesis has been well established, processes known to be
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modulated by HS. Finally, PC-3 cells have been shown to produce HS either onto the 
cell surface or into the cultured medium (Kosir and Quinn, 1995), and to express high- 
level uPA and uPAR (Lyon et al., 1995; Forbes et al., 2004).
5.2 Aims
(1) To investigate the effect of anosmin-1 on uPA and thrombin amidolytic activity 
using specific chromogenic substrates.
(2) To investigate the functional consequence of an anosmin-1/uPA/HS interaction; 
actions of anosmin-1 on the PC-3 cell proliferation were examined in the presence and 
absence of exogenous HS, heparinase HI and anti-uPA antibody.
(3) To further characterize WAP domain function; WAP mutated proteins 
(mPIWFI172, PIWF4172) were investigated in the presence and absence of exogenous 
HS.
(4) To identify whether anosmin-1 was either cell membrane associated or inside cells: 
immunocytochemistry was used with purified AIWF1 antibody.
(5) To identify complex formation between anosmin-1 and uPA, co- 
immunoprecipitation was performed in PC-3 cell lysate and their direct binding was 
investigated by SPR.
5.3 Materials and Methods
5.3.1 uPA and thrombin amidolytic activity assay
uPA and thrombin activities were quantified in PBS containing 20 mM Tris HC1, 
using the specific chromogenic substrate S2366 (Glu-Pro-Arg-pNA*HCl, pNA: p- 
Nitroaniline hydrochloride) (Enzyme Reach Laboratories) for thrombin and S2444 
(Glu-Gly-Arg-pNA*HCl) (Chromogenix) for uPA. Cleavage of synthetic chromogenic 
substrate releases pNA (S2366 or S2444 —> Peptide + pNA), which can be quantified 
by measuring an increase in absorbance at 405 nm. For the thrombin assay, the hirudin 
(NOVARTIS), a specific thrombin inhibitor, was first used to validate the system and 
to determine the optimal enzyme concentration. Hirudin in serial 1 in 2 dilutions (from 
0.007 gg/ml to 1 pg/ml) was mixed with 0.8 nM thrombin and then loaded onto 96- 
well plate for 2 min incubation at 37°C. The reaction was initiated by addition of
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substrate S2366 (0.42 mg/ml), and the absorbance was recorded every 1 min on a 
microtiter plate reader. For the preliminary uPA activity assay, 1 nM uPA was used 
and the hydrolysis reaction measured every 1 h. Triplicates of 50 pi of anosmin-1 at 
varying concentrations were pre-incubated with 50 pi of 0.8 nM thrombin and 1 nM 
human high molecular weight uPA (American Diagnostic Inc) in the absence and 
presence of 10 pg/ml HS at 25°C for 2min or 15min incubation respectively. 50 pi 
specific substrates were then added to start the reaction at 37°C and substrate 
hydrolysis was measured at 405 nm every 1 min for thrombin and every 1 h for uPA. 
Residue amidolytic activity of proteases was calculated as the ratio between the initial 
reaction velocity with anosmin-1 treatment and that of a control group without 
anosmin-1. To confirm the specificity of anosmin-1 on uPA amidolytic activity, a 
negative control was set up. First, purified GFP was used to replace anosmin-1 for the 
uPA interaction. Second, purified anosmin-1 was incubated with chromogenic 
substrate without addition of uPA.
5.3.2 Proliferation assays
5.3.2.1 Anosmin-1 on PC-3 cell proliferation
PC-3 cells were seeded in a 100 pi volume in 96-well flat bottom microtitre plates 
(Nunclon, NY, USA) at 5.0><104 cells/ml density in Coon’s modified Ham’s F12 
medium (Sigma) containing 7% FBS, 100 U penicillin/ml, 100 pg streptomycin/ml 
and 2 mM glutamine, and were allowed to adhere overnight. On the following day, the 
medium was removed and replaced with serum-free medium. After a 24 h period of 
serum starvation, cells were treated with set anosmin-1 concentrations in replicates of 
5 (purified and freeze-dried recombinant anosmin-1 was dissolved in serum-free 
medium). Cells were cultured for 2 days at 37°C, with 5% CO2 humidified incubation. 
At the end of the incubation period, cell proliferation was measured by the Cell Titer 
96 AQueous non-radioactive cell proliferation assay using tetrazolium compounds 
(Promega, Southampton, UK) which measures the activity of the mitochondrial 
enzyme, succinyl dehydrogenase, expressed only in living cells (Mosmann, 1983). 20 
pi of the MTS/PMS solution was added directly to the each well and incubated for 1.5 
h. Absorbance of optic density (OD) was measured at 492 nm using an ELISA plate
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reader (Anthos ht HI). Each experiment was performed several times (n>2). The 
culture without any treatment was used as negative control. Effects of different 
treatments were measured as percentage of absorbance compared to control group set 
to 100%. To prove that this assay directly correlates with cell proliferation, actual cell 
counting was also performed. After treatment with 10 nM PIWF1, PIWF4 and GFP 
proteins, cells were washed twice with PBS and trypsinized with lxTrypsin EDTA. 
Tiypsinized cells were thoroughly resuspended in PBS to avoid cell aggregation and 
checked under the microscope to ensure collection of all the cells. Intact cells, 
determined by trypan blue exclusion, were counted by hemocytometer as described in 
section 3.3.1.
5.3.2.2 Function-blocking experiment
Purified polyclonal anti-anosmin-1 (AIWF1) antibody and anti-uPA antibody at 
a 50 pg/ml concentration were added respectively into PC-3 cell culture with PIWF1 
treatment. Non-specific rabbit antiserum (Santa Cruz Biotechnology) was used as 
negative control.
5.3.2.3 Effect of HS on anosmin-1 function using exogenous HS and heparinase 
HI
After serum starvation, cells were incubated with anosmin-1 in the presence of 
100 pg/ml HS or 2.5 units/ml heparinase HI; in an additional experiment, an increased 
500 pg/ml HS concentration was used for PIWF4 and 5 units/ml heparinase HI for 
PIWF1. Furthermore, to investigate whether HS regulates anosmin-1 function in a 
dose-dependent manner, HS at concentrations of 1, 5,10, 25, 50, 100,250, 500 pg/ml 
were co-incubated with 10 nM truncated and full-length proteins and their mutants 
respectively.
5.3.3 Immunocytochemistry
In vitro immunofluorescence technique using specific antibodies against 
anosmin-1 (AIWF1) was used to localise recombinant anosmin-1 in PC-3 cells.
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5.3.3.1 Fluorescence labelling of cell surface associated anosmin-1
After 48 hours incubation with 10 nM and 100 nM PIWF1 in serum-free 
medium, cells were rinsed several times in PBS and incubated in 0.5% blocking 
reagent (BSA in PBS) for 30 minutes. 1:1000 AIWF1 antibody was used for 
overnight incubation at 4°C. After several rinses in PBS, extra-cellular protein- 
antibody complex was immunodetected using an anti-rabbit Texas Red fluorescent 
secondary antibody (Jackson, PA, USA). Cells were then fixed in a chamber slide 
with 2% paraformaldehyde and 2% glutaraldehyde in PBS. A PIWF1/HS binding 
interference assay was carried out by immunofluorescent labelling of cells treated by 
co-culturing 100 pg/ml exogenous HS with 10 nM and 100 nM PIWF1 respectively. 
Controls consisted of replacing primary antibody with rabbit pre-immune sera for 100 
nM PIWF1 treated cells. Control cells revealed no cross-reactivity between the first 
and second labelling procedures.
5.33.2 Fluorescence labelling of intracellular anosmin-1
For intracellular protein detection, cells were rinsed in PBS+0.1% Triton X-100 
and fixed in a chamber slide with 2% paraformaldehyde, 2% glutaraldehyde in PBS. 
Subsequently, cells were incubated in 0.5% blocking reagent in PBS/T for 30 minutes. 
The same conditions were used for antibody incubation. Cells were mounted in 
glycerol and immunophenotyped by confocal microscopy (Bio-Rad Radiance 2100).
5.3.4 Immunoprecipitation
After 48 hour incubation in serum free medium, 6xl06PC-3 cells were scraped 
and lysed in 0.5 ml lysis buffer (50 mM Tris-HCl, 350 mM NaCl, 1% Triton X-100, 
1% NP-40, 1 mM EDTA, 1 mM EGTA, pH 7.4, protease inhibitor cocktail 
(Boehringer Mannheim), 0.02% NaN3) at 4°C for 30 min. The cell lysate was spun at 
10,000 xg for 15 min and supernatant harvested. Protein A beads (Amersham 
Phamacia, UK) were washed 3 times with lysis buffer for the next cell lysate pre­
clearing and immunoprecipitation. For cell lysate pre-clearing, 200 pi protein A beads 
was mixed into 2 ml cell lysate and incubated on ice for 1 h. After spinning at 10,000 
xg for 10 min, supernatant was collected. 0.5 ml of cleared cell lysate was then
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incubated with 1 jig PIWF1 at 4°C for 2 h before immunoprecipitation with 5 pg of 
polyclonal or monoclonal anti-uPA antibody (American Diagnostica Inc) and anti- 
anosmin-1 antibody (AIWF1). The mixed solution was then incubated at 4°C 
overnight and 50 pi pre-cleared protein A beads added for 1 h incubation at 4°C. The 
protein A beads were collected by centrifugation at 10,000 g for 30 sec, followed by 4 
washes with lysis buffer. 50 pi of 1 x Laemmli sample buffer was added to the bead 
pellet, followed by vortexing and heating to 90°C for 10 min. The supernatant 
containing the precipitated proteins was collected by centrifugation at 10,000 xg for 5 
min, and then separated by SDS-PAGE and probed with anti-uPA and anti-His 
antibodies respectively.
5.3.5 SPR kinetic measurement of the uPA interaction with anosmin-1
For the measurement of anomsin-l-uPA binding, uPA at 20 pg/ml in 10 mM 
sodium acetate buffer, pH 5.0, was covalently immobilized by amine coupling to a 
CM5 - certified grade sensor chip (Biosensor AB, Uppsala, Sweden) preactivated with 
N-hydroxysuccinimide (NHS)/l-ethyl-3-[3-dimethylaminopropyl] caibodiimide 
hydrochloride (EDO). Coupling was achieved by injection of uPA at a flow rate of 5 
pl/min for 6 min, resulting in a coupling yield of 5,000 resonance units. Unreacted 
groups were blocked with 1 M ethonolamine, pH 8.5. A flow cell without protein 
coupling but with same treatment of activation and blocking served as a control. 
Binding was measured at a flow rate of 5 pl/min using different concentrations of 
PIWF1 and PIWF4 dissolved in HEPES-buffered saline, followed by dissociation for 
10 minutes. Sensor chips were regenerated at the end of each run by injection of 0.1 M 
acetic acid containing 0.5 M NaCl.
5.4 Results
5.4.1 Anosmin-1 increases uPA amidolytic activity, but does not alter thrombin 
activity
To investigate whether the N-terminal WAP domain of anosmin-1 has serine 
protease inhibitoiy activity, the effect of anosmin-1 was tested on two serine proteases, 
uPA and thrombin. First, the enzymatic activity of 0.8 nM thrombin on the
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chromogenic substrate S2366 was measured spectrophotometrically every 1 min. 
Absorbance increased linearly over the time range of 4 min (Figure 5.1 (a)), whereas 
hirudin, a specific thrombin inhibitor exhibited a dose-dependent inhibition on 
thrombin amidolytic activity, complete inhibition being observed at over 0.25 pg/ml 
hirudin concentration (Figure 5.1 (b)). These results confirmed the reliability of this 
system for the study of anosmin-1-thrombin interaction. As shown in Figure 5.1 (c) 
and (d), thrombin activity was not altered by increasing concentration of PIWF1 and 
PIWF4 treatments regardless of die presence or absence of HS, indicating that 
anosmin-1 did not interact with thrombin in vitro.
uPA enzymatic activity was then analyzed using die chromogenic S2444 
substrate; 1 nM uPA treatment resulted in a linear increase of absorbance measured 
every 1 h (Figure 5.2 (a)), enabling subsequent analysis of the anosmin-l-uPA 
interaction. In the absence of uPA, no discernible stimulation of amidolytic activity 
was demonstrable in purified PIWF1 treatment; furthermore, purified recombinant 
GFP caused a negligible effect on uPA activity (Figure 5.2 (b)). However, as 
compared with thrombin, in vitro amidolytic activity of uPA was significandy 
enhanced by addition of all anosmin-1 analogues at concentrations of 10 nM and 
above. Up to 300% enhancement of activity was induced by both wild type and WAP 
mutated full-length anosmin-1, PIWF4 and mPIWF4172 (Figure 5.2 (c) and (d)). The 
truncated PIWF1, however, showed only 100% maximum enhancement, about 60% 
less than full-length proteins (Figure 5.2 (e)). These results demonstrate that the wild 
type and WAP mutated full-length anomin-1 variants behave similarly in induction of 
uPA activity. Thus the C172R substitution per se does not cause significant 
impairment on this particular function of anosmin-1. Alternatively, disruption of a 
single disulfide bond may not be enough to significandy block the interaction between 
anosmin-1 and uPA. However, loss of the other three Fnin domains as in the PIWF1 
seems to cause reduction of anosmin-l’s effect in this assay. Notably, the truncated 
WAP mutant mPIWFI172 exhibited a higher magnitude of activation compared to full- 
length proteins (Figure 5.2 (f)). The reason why the truncated WAP mutant further 
enhances uPA activation is not clear.
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Figure 5.1 Effect of anosmin-1 on thrombin amidolytic activity, (a) Thrombin 
amidolytic activity was firstly assessed. 0.8 nM thrombin in PBS containing 20 mM 
TrisHCl was loaded onto microtiter wells, followed by addition of specific substrate 
S2366 (0.42 mg/ml). The absorbance was recorded every 1 min at 405 nm. (b) Hirudin 
(a specific thrombin inhibitor) in a serial of dilution was co-incubated with 0.8 nM 
thrombin. The absorbance was measured every 1 min. Triplicates of PIWF4 (c) and 
PIWF1 (d) at the indicated concentrations were pre-incubated with 0.8 nM thrombin in 
the absence and presence of 10 pg/ml HS. Residual amidolytic activity of thrombin was 
calculated as the ratio between the initial reaction velocity with anosmin-1 treatment 
and that of a control group without anosmin-1.
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Figure 5.2 Effect of anosmin-1 on uPA amidolytic activity, (a) uPA amidolytic activity 
was first assessed using 1 nM uPA in PBS containing 20 mM Tris HCl and the specific 
substrate S2444 (0.42 mg/ml). The absorbance was recorded every 1 h at 405 nm. (b) 
Negative control analysis of amidolytic activity. Purified PIWF1 was incubated with 
S2444 substrate without uPA addition, and GFP at the indicated concentrations was 
incubated with 1 nM uPA and substrate S2444. The absorbance was recorded every 1 h. 
Triplicates of PIWF4 (c), mPIWF4172 (d), PIWF1 (e) and mPIWFI172 (f) were pre­
incubated with 1 nM uPA in the absence and presence of 10 pg/ml HS. Residual 
amidolytic activity of uPA was calculated as the ratio between the initial reaction 
velocity with anosmin-1 treatment and that of a control group without anosmin-1.
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HS is known to modulate the proteolytic activity of serine proteases through 
interaction with its inhibitors; binding of HS to antithrombin HI increase its inhibitory 
activity on thrombin by 1,000 fold in the coagulation cascade (Shriver et al., 2000a). 
The effects of HS on anosmin-1 induced uPA amidolytic activity were then 
investigated. When anosmin-1 was co-incubated with 10 pg/ml HS, the catalytic 
activity was unchanged except that a slight increase was observed with mPIWFI172; 
thus anosmin-1 induced enhancement of uPA activity is independent of HS in this 
assay (Figure 5.2). Taken together, although the finding that anosmin-1 enhances uPA 
activity rather than inhibits is contradictory to the initial expectation and previous 
suggestions of the role of the conserved WAP domain as a serine protease inhibitor, 
these data provide the first evidence identifying uPA as a putative anosmin-1 
interactant whose activity is regulated by anosmin-1.
5.4.2 Effects of anosmin-1 on promoting PC-3 cell proliferation are HS dependent
The effects of PIWF1 and PIWF4 on PC-3 cell proliferation were assessed using 
the non-radioactive tetrazolium cell proliferation assay, which measures total viable 
cell number. PC-3 cells incubated for 48 h in serum free-defined medium without 
recombinant protein supplementation (control cells) were arbitrarily designated as 
100% growth. Figure 5.3 (a) shows that, at all tested concentration from 1 nM to 100 
nM, PIWF4 significantly increases PC-3 cell proliferation by 20%. Compared with 
PIWF4, PIWF1 stimulated PC-3 cell replication in a dose-dependent manner with a 
statistically significant 20-30% increase, whilst this activity was not observed at higher 
(lOOnM) concentrations (Figure 5.3 (b)). Peak activity was observed following 10 nM 
PIWF1 and PIWF4 treatments. These observations were confirmed by direct cell 
counting, in which total viable cell number was significantly increased by 10 nM 
PIWF4 and PIWF1 treatments, whereas purified GFP had no effect (Figure 5.3 (c)). 
To demonstrate the functional specificity of anosmin-1, purified polyclonal AIWF1 
antibody was incubated with the PC-3 cells in the presence of PIWF1 and this 
abolished the stimulant activity of PIWF1 on cell growth (Figure 5.3 (b)). The 
quantitatively similar cell proliferative responses to PIWF1 and PIWF4 indicate that
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Figure 5.3 Effect of anosmin-1 on PC-3 cell proliferation. PC-3 cell proliferation was
determined by MTT assay with PIWF4 and mPIWF4172 (a), PIWF1 and mPIWFI1' ^ )  
respectively in the absence or presence of heparinase III (hep. Ill), exogenous HS and 
anti-PIWFl antibody. Culture without addition of anosmin-1 was used as control. The 
graph shows the percentage change in optical density (OD) compared to control 
cultures, (c) Following 10 nM anosmin-1 or GFP treatment, cell viability was 
determined by Trypan blue exclusion and counted by haemocytometer. Student’s T-test 
(2-tailed) was used to analyze the difference between treatment and control; ** P<0.01. 
Each value represents the mean ± S.D (n=5).
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the N-terminal fragment with a solitary fibronectin domain is sufficient for stimulating 
cell division.
In a previous study, it was shown that a difference in HS binding affinity existed 
between truncated and full-length proteins (PIWF1 and PIWF4), PIWF1 having the 
lowest affinity and the highest binding affinity being associated with PIWF4; these 
properties may underlie the differences in proliferative responses to the two proteins. 
To examine the functional relevance and specificity of the HS/ anosmin-1 interaction, 
cell proliferation induced by anosmin-1 was assessed in the presence of heparinase HI, 
an enzyme that specifically degrades under-sulphated regions of HS. Figure 5.3 (a) 
shows that cell proliferation induced by PIWF4 was blocked by 2.5 unit /ml 
heparinase HI treatment. By contrast, 2.5 unit /ml of heparinase HI failed to alter the 
effect of PIWF1 on PC-3 cell proliferation (data not shown), whereas doubling the 
concentration of heparinase HI to 5 unit/ml significantly abolished this function - i.e. a 
higher concentration than that necessary to block PIWF4 action (Figure 5.3 (b)). These 
data confirm that the mitogenic effects of anosmin-1 on PC-3 cells are HS dependent, 
the effects being more demonstrable with full-length PIWF4 protein. HS has 
previously been reported to be immobilised on the PC-3 cell surface and secreted into 
the culture medium (Kosir and Quinn., 1995), suggesting that anosmin-1 effected its 
actions on PC-3 cell growth either through soluble HS within cultured medium, or 
immobilized HS chains anchored on cell surface proteoglycans. While confirming the 
specificity of HS in these actions, the heparinase HI experiments do not clarify the site 
of action of HS.
5.43 Soluble exogenous HS triggers anosmin-1 inhibitory activity on PC-3 cell 
growth
If cell-surface associated HS mediates anosmin-1 function, excess exogenous HS 
in the culture medium should be able to neutralise anosmin-1 activity by competitively 
detaching anosmin-1 from the cell surface. As expected, 100 pg/ml HS attenuated 
PIWF4 induced cell proliferation, whereas 500 pg/ml HS began to elicit an anti­
proliferative effect of PIWF4, observed initially at 1 nM and more evident at 10 nM
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with a 20-40% decrease (Figure 5.3 (a)). By contrast, in the presence of 100 pg/ml HS, 
a 20% decrease was observed following PIWF1 treatment at all tested concentrations 
(Figure 5.3 (b)). This result indicated that the reversal of cell proliferation by PIWF1 
requires less exogenous HS, consistent with the anosmin-l-HS binding characteristics. 
The higher binding affinity of PIWF4 to HS leads to a need for greater exogenous HS 
concentration in order to detach protein from cell surface, thereby abolishing PIWF4 
induced proliferation. It is noteworthy that an inhibitory activity of anosmin-1 is 
evident on the addition of higher exogenous HS concentrations. These results 
demonstrate that anosmin-1 promotes PC-3 cell growth through cell surface HS and 
also raises the possibility that anosmin-1 possesses biphasic biological functions, with 
proliferative activity when binding on the cell surface and with inhibitory effect in the 
presence of more soluble HS.
5.4.4 Recombinant anosmin-1 is associated with PC-3 cell surface via HS binding
The fact that anosmin-1 might stimulate PC-3 cell proliferation via cell surface 
HS and the previous results that anosmin-1 was S2 cell-surface associated via an HS 
interaction lead to the question as to whether anosmin-1 was also localised to the PC-3 
cell surface through HS binding. PC-3 cells were incubated with 10 nM and 100 nM 
PIWF1 in the presence and absence of HS respectively, followed by the 
immunofluorescence staining with AIWF1 antibody. In membrane labelling analysis 
(without Triton X-100 induced membrane permeability), recombinant PIWF1 was 
shown to bind to the cell surface in a dose-dependent manner with no labelling being 
observed in the negative control groups with pre-immune serum, thereby directly 
confirming the cell-surface associated localization of recombinant anosmin-1 (Figure 
5.4). Notably, the staining of PIWF1 is punctuated rather than evenly spread out on the 
cell surface, suggesting that anosmin-1 may be involved in complex formation in the 
certain localisation. PIWF1 labelling was significantly decreased by 100 pg/ml 
exogenous HS, further indicating anosmin-1 attachment to cell-surface associated HS 
(Figure 5.4). Further analyses were performed to investigate if anosmin-1 could be 
internalised following attachment to cells, prior to possible protein degradation. 
Following cell permeabilisation thereby disrupting the cell membrane (the procedure
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Figure 5.4 Immunofluoresence analysis of PIWF1 dissociation from PC-3 cell and 
internalisation following addition of exogenous HS. Following incubation with 10 nM 
and 100 nM PIWF1, with or without addition of exogenous 100 pg/ml HS, PC-3 cell 
surface protein was detected using ATWF1 antibody and Texas Red conjugated 
secondary antibody. The preimmune serum was used to replace AIWF1 as negative 
control for 100 nM PIWF1 treated cells. The permeabilisation operation to disrupt cell 
membrane allows antibody enter cells for anosmin-1 internalisation assay. The bar scale 
represents 5 pm.
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allows antibody to enter cells), no PIWF1 staining signal could be detected inside 
cells, suggesting that anosmin-1 was unlikely to be internalised (Figure 5.4).
5.4.5 WAP mutated anosmin-1 blocks cell proliferative activity
To identify the potential roles of the N-terminal WAP domain in anosmin-1 
function, the effects of a loss of function mutant of the WAP domain on cell growth 
was investigated. Both mPIWF4172 and mPIWFI172 had no effect on PC-3 cell 
proliferation either with or without 100 pg/ml HS (Figure 5.3 (a) and (b)). To 
investigate this phenomenon further, the effects of increasing HS concentrations with 
constant 10 nM wild type and mutated anosmin-1 were studied. Figure 5.5 (a) shows 
that 10 nM PIWF4 decreased cell proliferation in the presence of 250 and 500 pg/ml 
HS while the corresponding mutated protein exerted no effect on cell proliferation. 
Similarly, 10 nM PIWF1 inhibited cell growth in a HS dose-dependent manner, while 
mutated mPIWFI172 showed the opposite effect in the presence of over 50 pg/ml HS 
(Figure 5.5 (b)). Thus, based on these findings, it appears that the WAP domain is 
essential for anosmin-1 action.
5.4.6 Anosmin-1 induces PC-3 cell proliferation through interaction with uPA
I next questioned whether uPA is directly involved in anosmin-1-induced PC-3 
cell proliferation. Since our results showed that proliferative activity induced by 
PIWF4 was retained by its truncated version, I opted to firstly use PIWF1 in the 
subsequent studies of uPA/anosmin-1 interaction since it had a higher yield of 
recombinant protein production. Addition of anti-human uPA antibody along with 10 
nM PIWF1 resulted in total abolition of PIWF1-induced PC-3 cell proliferation, while 
non-specific rabbit anti-sera did not show this effect (Figure 5.6 (a)); thus uPA seems 
to be required for anosmin-1 induced mitogenesis. To further investigate the physical 
association between anosmin-1 and uPA, a co-immunoprecipitation assay was 
performed using total cell lysates in the presence and absence of PIWF1. As shown in 
Figure 5.6 (b), both monoclonal and polyclonal anti-uPA antibody co-precipitated 
PIWF1 and uPA as detected by Western blotting with anti-His (for PIWF1) or anti- 
uPA antibody. Anti-PIWFl immunoprecipitation also generated the corresponding
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Figure 5.5 Growth suppression effect of anosmin-1 in PC-3 cells. PC-3 cells were 
treated with 10 nM PIWF4 and mPIWF4172 (a), PIWF1 and mPIWFI172 (b) in the 
presence of increasing concentrations of HS. Cell proliferation was measured by 
percentage change in O.D. compared to control.
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Figure 5.6 Involvement of uPA in anosmin-1 induced PC-3 cell proliferation, (a) 
Proliferation of PC-3 cells treated with 10 nM PIWF1 in presence of anti-uPA antibody 
or non-specific rabbit anti-sera, (b) PC-3 cell lysate were incubated with PIWF1 and 
immunoprecipitated with the corresponding antibodies. The immunoprecipitated 
complex was analysed by SDS-PAGE and Western blot using anti-His or anti-uPA 
antibody. Although polyclonal and monoclonal anti-uPA antibody (pAb and mAb) can 
pick up different forms of uPA, both of them visualise HMW uPA as indicated. Bands 
corresponding to PIWF1 and uPA are shown.
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uPA and PIWF1 bands. These reciprocal immunoprecipitations clearly demonstrate a 
complex formation between these two proteins, an effect absent in negative controls. 
Since uPA has also been previously reported to have high HS binding affinity 
(Herndon et al., 1999; Pucci et al., 2001), I sought to investigate whether anosmin-1 
can directly interact with uPA independent of HS. To assess the direct binding 
properties between these two proteins, SPR was performed using uPA coupled sensor 
chips. The sensorgrams shown in Figure 5.7 indicated &on = 2  x 105 ]VT1S 1 and k0s  -  
1.38 x 10‘3 S*1 for PIWF4, whereas kon = 1.33 x io4 NT1 S'1 and koff ® 4.36 x 10"3 S'1 
for PIWF1. The calculated dissociation constant Ad was 6.91 nM for PIWF4 and 328 
nM for PIWF1, demonstrating a relatively high uPA binding affinity. The mass 
transport limitation leading to an underestimation of the intrinsic kinetics can be 
associated with the low flow rates, high association rate constants and high levels of 
immobilized ligand. Since higher flow rate data are not available, the possibility of 
mass transport due to a high association rate of PIWF1 with uPA should be 
considered.
5.5 Discussion
A crucial functional role for the WAP domain is supported by the cell-based 
evidence in which PIWF1, with its solitary FnlH domain, can fully recapitulate the 
biological actions of the full-length protein, and yet WAP mutants with similar HS 
binding affinity have completely lost their mitogenic activity in PC-3 cells.
Prior to this study, the identity of a serine protease ligand that interacts with 
anosmin-1 was unknown. Our data show that anosmin-1 augments uPA amidolytic 
activity in vitro and participates in a direct protein-protein interaction with uPA, 
indicating that the serine protease uPA represents a potential molecular target for 
anosmin-1 action. Although the C172R mutation did not abolish anosmin-l’s effect on 
in vitro uPA activity, one cannot exclude the possibility of the WAP domain 
representing an active uPA binding site. A single C157-C172 disuphide-bond 
disruption may only affect the WAP domain structural scaffold, but not be sufficient to 
interrupt the sequence necessary for interaction with uPA. Indeed, previous homology
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Figure 5.7 BIAcore analysis of anosmin-1 binding to uPA. Representative 
sensorgrams are shown for the interaction of immobilized uPA with soluble PIWF4 (a) 
and PIWF1 (b). Five different concentrations of analyte were used for these analyses: 
50, 100, 175, 250, 375 nM for PIWF4, 250, 375, 500, 750, 1000 nM for PIWF1 (color 
lines, upper panel). This allowed global fitting to the 1:1 binding model (black lines, 
upper panel). The top sensorgram line in each graph represents the highest 
concentration of proteins, and the bottom line the lowest concentration. Residual plot 
showed the difference between measured and calculated responses (bottom panel in (a) 
and (b)).
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modelling has shown that the predicted scissile peptide bond resides in the opposite 
loop surface far from the C157-C172 disuphide bond, suggesting that this bond 
disruption may exert a lesser effect on the reactive site for ligand binding. On the other 
hand, although four-disulphide core motifs are present in the WAP family proteins, 
they do not all exhibit similar serine protease inhibitory activities. For example, elafin 
and the C-terminal SLPI share the same distribution of disulphide bridges and a 
methionine residue in the PI’ position of the inhibitory active centre; SLPI inhibits a 
far wider range of serine proteases than elafin (Schalkwijk et al., 1999). The 
sodium/potassium ATPase inhibitor (SPAI), with an identical four-disulphide bonds 
location to elafm and SLPI, shows inhibitory activity on Na+, K+-ATPases but not on 
other serine protease (Araki et al., 1990). Compared with elafin, the WAP domain 
homology model in anosmin-1 suggests a structural rearrangement of cysteine-147 in 
relation to the cysteine-83 of elafin, resulting in this cysteine residue and predicted 
scissile peptide bond being relocated to the opposite side of the protein surface loop 
(Robertson et al., 2001). This structural alteration may explain why anosmin-1 
increases rather than inhibits uPA activity as previously hypothesized.
In addition to WAP proteins, specific serine proteinase inhibitors belonging to 
the structural class of serpins (serine protease inhibitors) also show differential 
specificity and activity on trypsin-like serine protease. Members of this serpin family 
include plasminogen inhibitor 1 and 2 (PAI-1, -2), anti-plasmin, anti-thrombin HI (AT 
IE), protease nexin-1 (PN-1) and neuroserpin; their inhibitory specificity and activity 
critically depend on their amino acid composition at the reactive centre (Sherman et 
al., 1992; Osterwalder et al., 1998). Although an arginine residue at the PI position is 
highly conserved in these serpin family members, the PI’ position is mostly occupied 
by a methionine residue, other reactive positions being more promiscuous. For 
instance, neuroserpin specifically binds to tPA, uPA and plasmin and inhibits their 
amidolytic activity, but have no effects on thrombin; the putative reactive site PI-PI’ 
(Arg362 and Met363) was proved to interact with all target proteases (Osterwalder et al., 
1998). In contrast, PN-1 with arginine and serine at P l-P l’ site is directed against 
thrombin (Liu et al., 1994). Based on these observations, one would expect that
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anosmin-1 must cany arginine as a crucial residue for trypsin-like serine protease 
binding. In the anosmin-1 WAP domain, there are five arginine residues (at 136, 140, 
144-146 position respectively), very close to the predicted active site of glycine-142- 
phenylalanine-143, further suggesting that these regions may act as a putative binding 
site for uPA. Further demonstration of the WAP domain role in uPA catalytic activity 
will depend on the generation of a mutant that deletes this region or even the entire 
WAP domain.
Functional HS/uPA co-operation was revealed by anosmin-1’s mitogenic activity 
on PC-3 cells, where a biphasic HS dependent action was demonstrated. Specifically, 
1) stimulation of cell proliferation via a cell-surface HS associated mechanism, 2) 
inhibitory effect on cell proliferation when exogenous HS was added. These 
conclusion were based on the following experimental results: (1) heparinase HI and 
addition of increasing doses of HS decreased or abolished anosmin-1 induced 
stimulation of cell proliferation, whereas significant inhibition was achieved with 
higher concentrations of HS. (2) immunofluorescence analysis provided direct 
evidence that anosmin-1 was cell surface associated via HS. (3) an anti-uPA antibody 
blocked anosmin-1 activity and uPA-anosmin-1 complex formation as confirmed by 
co-immunopredpitation. These data are the first to demonstrate that anosmin-1 can 
modulate cell proliferation via an HS-dependent and uPA related mechanism.
Central questions remain as to how: 1) the HS/uPA/anosmin-1 complex mediates 
a biphasic effect on PC-3 cell proliferation and 2) which domain of anosmin-1 
mediates these biphasic activities. It is notable that the N-terminal truncated protein 
comprising the WAP and 1st fibroneetin type IQ demonstrates similar biological 
activities to its full-length counterpart, with the exception that it has a lower HS 
requirement. These data are consistent with the notion that the major functional part of 
anosmin-1 is located at WAP and 1st fibroneetin type HI repeat (MacColl et al., 
2002a). Since the Fnin domain is a major HS binding site, and given its HS dependent 
effect on cell proliferation, anosmin-1’s mitogenic activity appears to depend upon the 
Fnin domains (especially the first one) via attachment to cell-surface associated HS.
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The WAP domain, on the other hand, is also functionally important for integral 
anosmin-1 action, although it remains unclear whether the WAP domain binds directly 
to uPA.
It is known that cell surface HS chains act as receptor or co-receptor to regulate 
binding protein signalling by diverse mechanisms: converting ligands from inactive to 
active forms through conformational changes, promoting ligand and receptor 
dimerization inducing signal transduction and stabilising the active ligand-receptor 
complexes through ternary complex formation (Kwan et al., 2001). The best example 
is the significant role of HS in FGF2 activation through FGFR signalling. PC-3 cells 
have been shown to generate endogenous HSPG on the cell surface (Jarrard et al., 
1994; Kosir and Quinn, 1995). Therefore, with respect to anosmin-1, through Fnin 
domain binding, HS could serve at least three functions: (1) acting as co-receptor or 
stabilisation platform determining ligand distribution, (2) concentrating N-terminus 
(CR and WAP domain) in a location-specific manner in preparation for uPA binding, 
(3) acting as modulator, inducing conformational alterations of the anosmin-1 N- 
terminus, thereby exposing its ligand specific binding site. Thus, the effect of 
anosmin-1 on PC-3 cell proliferation appears dependent on the uPA receptor and uPA 
related proteolysis. Anosmin-1 may act as a transporter and bridge to facilitate a 
uPA/uPAR interaction thereby stimulating the uPAR signalling transuction pathway 
for cell proliferation. Moreover, an increase in uPA proteolytic activity may lead to 
activation of a number of growth factors such as the insulin-like growth factor, basic 
fibroblast growth factor, and transforming growth factor-p (Jarrard et al., 1994), all of 
which have been shown to be expressed in PC-3 cells (Angelloz-Nicoud and Binoux, 
1995). Disruption of the normal WAP domain structure may attenuate wild-type 
anosmin-1 interaction with the uPA/uAPR complex and proteolytic activation of the 
growth factors.
On the other hand, the attenuation of stimulation and even inhibitory effect of 
anosmin-1 on PC-3 cell proliferation was observed in the presence of exogenous HS. 
This observation might be explained in terms of the HS structure, its specific form
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(soluble or immobilized) and uPA related proteolysis. In the best-studied FGF2 
signalling loops, HS have been demonstrated as either inhibitors or potentiators 
according to their diverse specific sequences and structures (Liu et al., 2002a). 
Heparinase Ill-treated HS fragments from B16BL6 melanoma cell surfaces inhibit 
tumour cell proliferation in vivo and in vitro by preventing activation of the FGF2 
mediated signalling pathway, principally the MAP kinase pathway, whereas 
heparinase I derived HS fragments exert the opposing effects. Furthermore, specific 
form of HS also demonstrate diverse activities; cell-bound heparin stimulates FGF2- 
receptor binding whereas soluble heparin exhibits the opposite effect, both correlating 
with changes in FGF2-induced tyrosine kinase activity and cell proliferation (Fannon 
et al., 2000). Importantly, HS with certain 5 dimeric repeats of GlcN(3 -0 S0 3 )(6 - 
OS0 3 )-IdoA(2 -OSO3) has been shown as an adaptor molecule to confer specificity on 
uPA/uPAR binding (Pucci et al., 2001). Therefore, it can be proposed that an 
alteration in the sequence and structural arrangement of HS binding to signalling 
molecules such as uPA/uPAR might be regulated by anosmin-1, leading to up or down 
regulation of binding affinity and specificity between mitogenic molecules and their 
cognate receptors. In addition, it has been reported that cell surface uPAR can be 
cleaved by uPA (Hoyer-Hansen et al., 1997). One might then expect that elevated uPA 
activity induced by anosmin-1 could down-regulate uPAR related proliferation by 
proteolytic cleavage on uPAR. Finally, it should be noted that the proteolytic products 
of mitogenic signalling-related molecules caused by serine proteases have biphasic 
effects on cell proliferation. For example, the two fragments of IGFBP-3 generated 
after cleavage by uPA and plasmin, corresponding to 160 and 95 residues of IGFBP-3, 
possess dual effects on PC-3 cell proliferation, in which the laige fragment stimulates 
cell growth and the smaller one shows the opposing activity (Angdloz-Nicoud et al., 
1998).
The identification of HS and uPA as “cross-talk” partners for anosmin-1 provide 
novel potential insights into the molecular basis of the neuronal and non-neuronal 
manifestation of X-KS. In the developing OB, early expression of anosmin-1 and uPA 
is detected (Dent et al., 1993), whereas conditional disruption of the HS-
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polymerization enzyme Ext-1 in embiyonic mouse brain results in absence of major 
commissural tracts and OB (Inatani et al., 2003). In human kidney, uPA expression is 
mainly detected in tubular epithelial cells in the deep cortex and the outer medulla (Xu 
et al., 1996). Furthermore, uPA can induce Madin-Darby canine kidney (MDCK) 
epithelial cells to form branching tubules in fibrin gel (Pepper et al., 1992). These 
observations suggest that uPA increases extracellular proteolysis, required for 
epithelial morphogenesis in kidney. The immunohistochemical study on X-KS patients 
with disrupted anosmin-1 has revealed the appearances of dysplastic tubules and cysts 
(Deeb et al., 2001). The dysfunction of gly pi can-3 results in decreased proliferation of 
medullary collecting duct cells and medullary degeneration (Grisaru and Rosenblum, 
2001). Thus, any interruption of the interaction among these three molecules 
(anosmin-1, uPA and HS) may lead to the olfactory as well as the renal developmental 
defects seen in X-KS patients.
In conclusion, I postulate that uPA-induced activation of the plasmin cascade 
system on the cell surface causes proteolytic degradation of ECM components 
enabling cell-cell and cell-ECM adhesion and release of activated growth factors, 
thereby facilitating cell migration, tissue remodeling, angiogenesis and neuronal 
synaptogenesis. Anosmin-1 may modulate these processes by increasing uPA catalytic 
activity, whereas the role of HS may be to concentrate and restrict uPA/anosmin-1 
distribution on the cell surface (Figure 5.8). HS may further help and stabilize 
anosmin-1 and uPA complex formation through binding to both of these two 
molecules as seen with antithrombin/thrombin and FGF/FGFR. It is likely that 
uncontrolled uPA activity is potentially harmful; the developmental stage specific and 
tissue specific activation of uPA requires a careful balance between proteolysis and 
anti-proteolytic actions regulated by several known activators (plasmin) and inhibitors 
(plasminogen activator inhibitor 1,2, antiplasmin, neuroserpin). Our results clearly 
identify anosmin-1’s role as a novel activator of uPA; anosmin-1 /HS/uPA may 
therefore mediate different functions in a tissue and developmental stage specific way 
leading to different phenotypic outcomes, such as tubulogenesis during kidney 
epithelial tissue morphogenesis or cell differentiation in neuronal development.
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Figure 5 .8 Hypothesis of molecular mechanism of anosmin-1 action. HS side chains of 
HSPG anchor anosmin-1 to the cell surface via binding to FnlH domains, thus 
facilitating N-terminal anosmin-1-uPA interaction. HS may further help and stabilize 
anosmin-1 and uPA complex formation through binding to both of these two 
molecules as seen with antithrombin/thrombin and FGF/FGFR. Increased uPA 
proteolytic activity induces plasmin/MMPs mediated ECM degradation releasing a 
number of growth factors involved in cell proliferation, migration and tissue 
remodeling. Different functional domains of uPA are schematically represented: 
growth-factor-like domain (circle); kringle domain (rectangle); catalytic domain 
(triangle).
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5.6 Conclusions
Prior to the present study, the identity of serine protease ligands for anosmin-1 
was unknown. Our data showed that anosmin-1 could increase uPA amidolytic activity 
in vitro, but has no effect on thrombin, and that co-immuoprecipitation has 
demonstrated anosmin-l/uPA complex formation in PC-3 cell lysates and their high 
binding affinity was determined by SPR, indicating that the serine protease uPA 
represents a potential molecular target for anosmin-1. The functional consequence of 
co-operation of anosmin-l/HS/uPA was demonstrated in PC-3 cell proliferation; 
anosmin-1 mitogenic activity was blocked by heparinase m, exogenous HS addition, 
anti-uPA antibody and the WAP mutant. I thus propose that anosmin-1 modulates 
uPA’s catalytic activity and its signalling pathway, whereas HS interacts with 
anosmin-1’s Fnin domains to determine distribution of anosmin-l/uPA complex.
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C hapter 6
Structure analysis of anosmin-1 by analytical 
ultracentrifugation and X-ray scattering
6.1 Introduction
The elucidation of the structural conformation of a molecule can assist in the 
understanding of its biological functions; by establishing the overall 3-dimensional 
structural parameters, it may identify surface-exposed residues and reveal ligand- 
binding sites in the presence or absence of ligand. Although the biological activity of 
anosmin-1 has been extensively studied in a variety of in vivo and in vitro paradigms, 
prior to the present study, no attempt at an experimentally based structural 
determination had been undertaken in the past decade, limiting our ability to 
understand its structure-function relationship. Homology molecular modelling of 
individual WAP and Fnin domains has been established by our group previously; 
thus, the availability of the atomic structure of the homologous protein elafin enabled 
the three-dimensioned visualization of the WAP domain of anosmin-1. In these 
studies, it was also possible to model the fibroneetin type ffl repeat of anosmin-1 on 
the known fibroneetin seven-stranded p-sheet sandwich structure with its ABE-GFCC’ 
configuration (Robertson et al., 2001). However, the assembly of multidomain arrays 
of CR, WAP and Fnin domains, either in a compacted or extended fashion, remained 
unknown.
On present evidence, a fully elongated conformation can be proposed for full- 
length anosmin-1. First, it was established that disruption of the WAP domain exerted 
an impact only on the HS binding affinity (Xa) value of PIWF1, which lacks three C- 
terminal Fnin domains, whereas the same disrupted WAP domain did not alter HS 
binding affinity when part of a full-length anosmin-1 molecule. These data suggested 
that the effects of a structural alteration in the WAP domain might influence the 
charge distribution in the first FnlH domain, but only when not followed by additional 
Fnin repeats. This model would be given greater credence if it could be demonstrated 
that full-length PIWF4 had an elongated structure. In addition, full-length anosmin-1
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induced enhancement on uPA amidolytic activity was affected neither by the addition 
of HS nor the presence of a WAP mutation, suggesting that a compacted multidomain 
conformation was unlikely. An extended structure of multidomain FnlH domains has 
been revealed both in fibroneetin and tenascin using electron microscopy (Engel et al., 
1981; Erickson et al., 1981). High-resolution structures of a fragment of neuroglian 
(Drosophila homology of LI) containing two Fnin repeats and a fragment of 
fibroneetin containing four such repeats also showed an extended configuration 
(Huber et al., 1994; Leahy et al., 1996). To investigate whether the conformation of 
anosmin-1 is in an extended configuration, structural studies were performed including 
X-ray solution scattering and analytical ultracentrifugation, both of which are 
discussed in the following sections.
6.2 Methods for protein structural analysis
The structures of proteins are commonly determined using spectroscopic or 
diffraction methods complemented by other techniques. Spectroscopy is the study of 
the diffraction of electromagnetic radiation with matter, excluding chemical effects. 
The diffraction of neutrons and electrons by matter is commonly included in a 
discussion of spectroscopy because, like electromagnetic radiation, they can be 
described by wave functions. X-ray crystallography involves the diffraction of X-rays 
by a crystallized molecule, whereas the effect of an applied magnetic field on nuclei 
that possess a magnetic moment or spin is determined in NMR spectroscopy. Both 
methods complement each other and currently provide protein structure at atomic 
resolution.
Other spectroscopic and non-spectroscopic low-resolution techniques that 
provide information on the overall dimensions of a molecule include small-angle 
solution X-ray scattering, analytical ultracentrifugation and electron microscopy. 
Small-angle solution X-ray scattering is used to study gross structural parameters of 
macromolecules in solution to a resolution of 2 to 4 nm. Information on the gross 
structure of a protein molecule can also be obtained from hydrodynamic analyses. The 
basis of ultracentrifugation experiments is that, for a solution subjected to a centrifugal
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force, the movement of the macromolecule is dependent on the mass (Mr) and shape. 
Electron microscopy can visualize the whole macromolecule down to a resolution of 
around 2 nm, although the images are studied in a vacuum and after staining, both of 
which may cause structural artifacts.
X-ray solution scattering and analytical ultracentrifugation are versatile and 
powerful techniques for characterizing the solution-state behaviour of 
macromolecules. The structural arrangement of domains or subunits in multidomain or 
oligomeric proteins in dilute solutions can be determined by X-ray study in near- 
physiological conditions (Perkins, 1988). X-rays visualize the macromolecule in a 
high positive solute-solvent contrast and provides structural parameters at low 
resolution. It is complementary to analytical ultracentrifugation, which provides more 
limited information on macromolecular elongation from sedimentation coefficients.
Traditional solution scattering is seen as an enabling method that provides the 
first gross macromolecular structural information on a newly purified protein. From 
the data collection, one can obtain scattering curves I(Q) and their analysis can yield 
the overall radius of gyration R g , the radius of gyration of the cross-section Rxs. The 
distance distribution function P(r) will provide structural information in real space. 
These will yield a set of dimension for the macromolecule. Thus the molecular 
modelling of scattering curves will verify the correct interpretation of scattering data 
and enable visualization of the structure. The known multidomain protein volume and 
the known atomic structure of small domains or subunits from crystallography and 
NMR can be applied in modelling to generate a model of the full macromocule as well 
as enabling the calculation of a scattering curve to determine whether it is compatible 
with the experimental data. It can also be refined by complementary information from 
sedimentation coefficients derived from analytical ultracentrifugation.
Analytical ultracentrifugation methods are capable of rigorously determining 
sample purity, characterizing assembly and disassembly mechanisms of biomolecular 
complexes, determining subunit stoichiometries, detecting and characterizing
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macromolecular conformational changes, and measuring equilibrium constants and 
thermodynamic parameters for self- and hetero-associating systems (Schuster and 
Toedt, 1996; Hensley, 1996; Laue and Stafford, m, 1999). Two types of experiments 
in analytical ultracentrifugation can be performed, to generate 1) the sedimentation 
velocity and 2) the sedimentation equilibrium. Sedimentation velocity is a 
hydrodynamic technique and is sensitive to the mass and shape of the macromolecular 
species. In a sedimentation velocity experiment, a moving boundary is formed on 
application of a strong centrifugal field and a series of scans are recorded at regular 
intervals to determine the rate of movement and broadening of the boundary as a 
function of time. In contrast, sedimentation equilibrium is a thermodynamic technique 
that is sensitive to the mass but not the shape of the macromolecular species. This 
experiment is performed at lower speeds than sedimentation velocity experiment and 
measures the equilibrium concentration distribution of macromolecules that eventually 
form when sedimentation is balanced by diffusion. The sedimentation velocity and 
equilibrium measurements provide complementary information, and it is often useful 
to apply both techniques to a given problem.
6.3 X-ray solution scattering
6.3.1 X-ray scattering theory
Small angle X-ray methods examine the scattered waves produced from the 
diffraction of an incident beam by protein molecules in solution. It is a diffraction 
technique that can be used to study the overall structure of proteins. An X-ray 
scattering experiment is performed by irradiating a sample with a highly collimated 
beam of monochromatic X-rays, and measuring the intensity of scattering /  as a 
function of Q, where Q corresponds to the scattering angle 20, from which the 
scattering curve 7 (0  is obtained (Figure 6.1). Scattering is due to interaction of X-rays 
with electrons in the sample: upon irradiation, each electron oscillates and emits 
electromagnetic waves of the same wavelength X in all direction, but phase-shifted by 
n with respect to the incident X-ray beam. This type of scattering is known as coherent 
scattering. The intensity of scattering by an electron is proportional to the X-ray 
scattering length/ of the electron, which has a value of 2.81 fin. For an atom, the X-
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Q (nm’1)
Figure 6.1 General features of a solution scattering curve In 7 (0  measured over a Q 
range, exemplified using an antibody molecule. At low Q range (In 7 (0  vs. Q2 at low 
Q value, 0.1- 0.5 nm-1) Guinier plot results in the overall radius of gyration Rq and the 
intensity 7(0) at zero scattering angle. At larger Q (In [ 7 ( 0 0  vs. Q2, Q within 0.3-1.0 
nm-1) the cross-sectional R g  (R xs)  can be calculated. For “T-shaped” protein 
structures such as the immunoglobulins, the cross-sectional plot exhibits two linear 
regions, a steeper innermost one and a flatter outmost one (Pilz et al., 1975) and in this 
type of analysis the two regions are referred to as Rxs-i and Rxs-2 respectively.
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ray scattering length is the atomic number (the number of electrons it contains) 
multiplied by the scattering length of an electron.
6.3.1.1 The Debye equation
The form of the scattering curve 7 (0  is described by the Debye equation. An 
incident planar wave of wavelength X is scattered by a macromolecule in the form of a 
spherical wave. The intensity of the radiation is measured with a planar detector as a 
function of the scattered angle 20, relative to the direction of the incident wave. 
Diffraction phenomena arise from interference between scattered waves and 
consequently the scattering curve 7 (0  is determined by the spatial arrangements of 
electrons in the protein. X-ray scattering from two points on a protein is depicted on 
Figure 6.2. The incident X-ray beam is defined by the unit vector So and is scattered 
from an origin point O in a direction denoted by die unit vector S. Since scattering is 
elastic, So and S have the same amplitude, and for convenience, this is set as 2n/X. Q is 
the scattering vector (S - So) and its amplitude is 4n sin Q/X (Figure 6.2). When the 
scattering angle is zero, waves scattered from all points in the protein will be in phase 
and the intensity of scattering is the sum of all scatterers. When the scattering angle is 
non-zero, interference is produced by phase differences between scattering points. In 
Figure 6.2, the incident X-ray beam is scattered by a second point P, and the path 
difference between waves scattered by points O and P is AO + OB. This path 
difference corresponds to a phase difference of 2 % (40+ BO)IX. If the vector between 
O and P is r, then AO=-rSoand OB=rSi and the phase difference is r(Si- So), or more 
simply rQ. The phase difference rQ between each individual scatterer in a 
macromolecule determines its scattering curve 7(0, and this relationship is contained 
within the Debye equation:
p * n i  Eq. 6.1
F*(0 is the square of the structure factor F{Q) of the macromolecule, F(Q) is a 
regulation of the scattering curve 7 (0  to the intensity of scattering by one electron at
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Incident
radiation
Figure 6.2 Schematic representation of X-ray scattering from two points in a protein 
molecule. Diffraction is by two points O and P separated by a distance r within a 
single particle in a solution scattering experiment. A and B correspond to the 
perpendiculars to the incident and scattered beams. The unit vectors So and S define 
the incident and scattered radiation, and Q defines the scattering vector (S - So). 
(Adapted from Perkins, 1998).
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zero scattering angle Ie[I(Q) = Ie 7^(0], and the summations are performed over all 
points p and q, where fp and f q are the respective X-ray atomic scattering lengths. The 
Debye equation gives the average of i^ ( 0  for all possible orientations of the 
molecule, and this would therefore require that scattering is spherically symmetrical 
about the incident beam. It can be seen that the Debye equation is only dependent on 
the magnitude of Q. For this to be true in a scattering experiment, the scattering 
sample would have to consist of a monodisperse solution of identical molecules that 
occupy all orientations equally, and act as independent scattering entities. A limitation 
of the Debye equation is that it describes particles in vacuo and it therefore needs to be 
modified in order to consider aqueous protein solutions.
6.3.1.2 Two-phase model of solution scattering
The simplest consideration of an aqueous protein solution is as a two-phase 
system of solute and solvent. The Debye equation is modified to consider the contrast 
Ap between the scattering density of the macromolecule in vacuo pv and the scattering 
density of the solvent ps, where Ap = pv - ps. The Debye equation can also be revised 
according to the resolution limits of the solution scattering experiment. In an X-ray 
solution scattering experiment, data are typically collected to a maximum usable Q of 
approximately 2.0 nm"1. The maximum Q value can be used to calculate the structural 
resolution of scattering, i.e. the smallest distance d  measured in the experiment. 
Bragg’s Law (X -  2*/sin0) is used for this calculation. A Q value of 2.0 nm"1 
corresponds to a structural resolution of around 3 nm. At this resolution, a few large 
volume elements dvp of scattering density p(rp) can be used to replace individual X-ray 
atomic scattering lengths fp in the Debye equation (fp = p(rp)dvp = p(rp)(frp). Thus the 
intensity of scattering is:
~F(Q)= f„ f„ (P(rp) - p ,)(  p(rq) - p.) d3rPd3 r, Eq.6.2
where the integration is taken over the macromolecular volume V.
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6.3.2. Experimental X-ray solution scattering 
63.2.1. Sample preparation
X-ray solution scattering experiments were designed according to the two-phase 
model of solution scattering. The first requirement was for a pure, monodisperse 
solution of protein at a concentration that was high enough for its scattering curve to 
be measured. The tendency of protein samples to aggregate necessitated that each 
sample was subjected to gel filtration to remove non-specific aggregates, then 
reconcentrated as shortly before data collection as possible. The choice of buffer was 
also important. In X-ray scattering experiments, the closer the buffer density is to that 
of pure water, the higher the sample transmission becomes, and hence better counting 
statistics can be obtained. Phosphate buffered saline (PBS; 12 mM phosphate, 140 
mM NaCl, pH 7.4) was used for X-ray scattering experiments. To ensure appropriate 
accurate corrections were made for solvent scattering, the protein sample was dialysed 
against its buffer, and the scattering of the buffer was subtracted from the scattering of 
the protein solution. Ideally, a sample of volume 0.5 ml and concentrated to 10 mg/ml 
should be used for X-ray experiments.
6.3.2.2 X-ray scattering at ESRF Grenoble
X-ray scattering experiments were performed at the European Synchrotron 
Radiation facility (ESRF) at Grenoble, France. Synchrotron radiation is emitted from 
electrons that are accelerated while moving at speeds close to the speed of light. 
Several stages are involved in the production of synchrotron X-rays. Electrons are 
produced by a hot cathode source and then accelerated to almost the speed of light in a 
linear accelerator (Linac). The energy of the electrons leaving the Linac is increased in 
a booster synchrontron from 200 to 600 million electron volts (MeV). In the storage 
ring, the electrons are forced by 64 bending magnets and 320 quadrupoles to follow a 
circular orbit with 844.4 m circumference. As the electrons are deflected by the 
magnetic field, they emit ‘white* X-rays of all wavelengths down tangential beamlines 
where experimental stations are set up to use the X-ray beam for dedicated 
experiments. The beam current at the start of its ‘life time* in single bunch mode is
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typically at 40 mA, but the current continually decreases as electrons are lost. The 
electrons are usually kept in orbit for up to 8 hours before the beam has to be 
regenerated. Small angle X-ray solution scattering experiments were performed on 
Station ID02 in single bunch mode in order to reduce the incident flux on the sample. 
A Si-111 channel-cut monochromator is used to monochromate the X-ray beam to a 
wavelength of 0.1 nm. The X-ray beam is then focused by a toroidal mirror. This 
monochromatisation method produces an X-ray beam that has negligible wavelength 
spread. Experiments were performed with beam currents within 200 mA and a ring 
energy of 6.0 GeV.
Samples were placed in a specially designed Perspex cell with 10 to 20 pm thick 
ruby mica window. The ruby mica windows were held in place with Teflon plugs, and 
the windows were regularly changed during data collection sessions. The sample cell 
had a 1 mm path length, a surface area of 2 mm (vertical) by 8 mm (horizontal) and 
holds a maximum volume of 25 pi. The sample cell was positioned in the X-ray beam 
by a brass sample holder which was maintained at 15°C using a water bath. The 
scattering intensities of the sample were measured using a FRELON CCD camera 
coupled with the Thomson X-ray intensifier (TH49-427) lens. This detector has an 
active area of 1024 x 1024 pixels with a dynamic range of 14 bit and high count rate 
capability of 14-35 frames/sec, enabling millisecond range time-resolved experiments 
(Narayanan et al., 2001). The sample is aligned by scanning across the beam to 
monitor the transmitted intensity profile. This allows to position the sample with an 
accuracy of 10 pm. For each data collection session the X-ray diffraction pattern of the 
powder silver behenate [CI^CH^oCOOAg] was measured for calibrating the Q 
range based on a diffraction spacing of 5.84 nm (Huang et al., 1993). The distance 
between the detector and the sample was set so that intensities were measured from a 
minimum Q value of 0.07-0.09 nm'1 to a maximum Q value of 2.0-2.2 nm'1. X-rays 
produce free radicals that can be destructive to proteins, causing them to aggregate 
quickly on exposure. To check for this possibility, the scattering intensity of each 
sample was measured for 0.5-1.0 second in 10 equal time frames, and the time frames 
were inspected for radiation-damage effects. The protein samples were measured in
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alteration with their respective buffers in order to minimize buffer subtraction errors as 
the incident beam decreased in intensity. The product of incident flux and the sample 
transmission was measured using calibrated silicon p-i-n photodiodes embedded in the 
beamstop.
6.3.2.3 Reduction of ESRF scattering data
ESRF scattering data were reduced to obtain scattering curves I(Q). The data 
reduction routines include the correction of detector artifacts such as dark current, 
image distortion and spatial inhomogeneties, as well as normalization of intensities to 
incident photon flux and sample transmission. The online data reduction was 
automatically applied after exposure using the SPEC acquisition program and several 
important correction steps (Figure 6.3). The raw data image and the dark data image 
were saved to disk and a dark image was subtracted from the raw image as the first 
correction step. The spatial distortion of the image was then corrected using a set of 
spline functions to describe die distortion and generated an undistorted virtual image. 
In the third step, the flat field correction was performed through the division of the 
spatially corrected intensity pattern by the quantum efficiency of the detector (flat 
field). Finally, the normalization converted the raw data to absolute scattering intensity 
as the ratio between the numbers of scattering photons per spherical angle and the 
number of incident photons during exposure. A Lupolen sample was used as a 
standard scatterer to calibrate the absolute scattering intensities. The silver behenate 
diffraction pattern used for calculating the Q value of the detector consists of 13 well 
defined peaks (Figure 6.4). The spacing between successive peaks corresponds to a 
diffraction spacing d  of 5.84 nm, and this enabled the Q values of the detector to be 
calculated (Q = 2n/d) for combining with the intensities. The combination of the 
resulting intensity data files with the Q axis file produce scattering curve files.
6.33 Analysis of reduced scattering curves I(Q)
633.1 Guinier analyses
At low Q values, the Debye equation is reduced to a Gaussian curve, and this
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Beam Exposure
Normalization
Scattering curve I(Q
Dark image data
Flat field correction
Spatial distortion correction
Dark image subtraction
Figure 6.3 Flow diagram of the reduction procedure for ESRF X-ray scattering data.
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Figure 6.4 The X-ray diffraction pattern of silver behenate. A total of 13 well defined 
peaks at 20 < 20° are plotted. The peak separation is 2n/5.84 nm*1. (Taken from 
Huang et al, 1993).
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becomes the Guinier approximation. In this, the Rq is the radius of gyration and is 
defined as the root-mean-square distance of all scattering centres in the macromolecule 
from its centre of gravity
In I(Q) = h / ( q ) - £ £
3 Eq6.3
and 7(0) is the intensity at zero scattering angle (Figure 6.1). This expression is valid in 
a Q'Rq range up to 0.7-1.3 depending on the macromolecular shape. Rq and 7(0) are 
determined from an experimental scattering curve by plotting In 7 (0  against Q2 to 
give a straight line of slope- Rq2/3 and intercept In 7(0). Rq is a measure of elongation 
if the internal inhomogeneity is negligible, and a useful application of Rg  is in the 
calculation of the anisotropy ratio of a macromolecule. The anisotropy is R g/R q, where 
Ro is the R g of the sphere of volume equal to that of the macromolecule. For typical 
globular proteins, the anisotropy ratio is approximately 1.28 (Perkins, 1988). The 
intensity at zero scattering angle 7(0) is proportional to Mr2, i.e. 7(0)/C is proportional 
to Mr; where C = protein concentration.
Guinier plots were performed using the FORTRAN program SCTPL7 (J.T. Eaton 
& S.J. Perkins, unpublished software). The Q range selected for line-fitting returned a 
maximum Q-Rq of approximately 1.5. Nonspecific aggregated proteins were identified 
by steeply curved Guinier plots at low Q values and were discarded.
6.3.3.2 Cross-sectional radius of gyration
If the protein has an elongated structure, Guinier-type analyses of the scattering 
curve at larger Q will give the mean radius of gyration of the cross-section Ra and the 
mean cross-sectional intensity at zero scattering angle U(Q)Q]q-*o (Hjelm, 1985):
ln [ /(0 0  = [ln (/(0 0 ]^ o  -  ZdL
Eq. 6.4
Rxs and [7(00g->o are determined from an experimental scattering curve by plotting 
[7 (0 0  against Q2 to give a straight line of slop - Rxs2/2 and intercept [I(Q)Q]q-+o-
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Generally, elongated proteins have a single Rxs value, and this was the case for 
anosmin-1 (Figure 6.1).
Cross-sectional plots were performed using SCTPL7. The Q range selected for 
line-fitting went from a minimum Q value which was greater than the largest Q values 
used in the Guinier Rq fits to a maximum Q-Rxs of 1.5.
6.3.33 Estimation of macromolecular dimensions
Assuming a protein is shaped like an elongated elliptical cylinder, the Rg and Rxs 
values can be combined to determine its length L (Glatter O and Kratky 0 , 1982):
The consistency of these two calculations of L is a useful control of a correct cross- 
sectional analysis for a rod-like particle.
633.4 Real space distance distribution function
The scattering curve I(Q) represents the macromolecular structure in reciprocal 
space. The experimental I(Q) curve can be converted into real space by a Fourier 
transform over Q = 0 < Q< c o :
P(r) is the distance distribution function and corresponds to the number of distance 
between any two volume elements within the macromolecule weighted by the product 
of their respective scattering densities. The maximum in P(r) is the most frequently 
occurring intramolecular distance. P(r) offers an alternative calculation of Rg.
Eq 6.5
Alternatively, L is given by (Perkins et al, 1986):
j r  _ **(0)
[KQ)Q]g^
Eq6.6
\l(&Qrsm(Qr)dQ
Eq 6.7
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^  = -*-=---------
l\P (r)dr
* Eq 6.8
In practice, P(r) calculations result in termination errors because the experimental I(Q) 
curve cannot be measured at zero angle or at very large Q, and in addition high signal 
to noise ratios are associated with measurements at large Q. Mathematical procedures 
are needed to minimize these termination errors by the fitting of the experimental 
curve to B-splines, which are then transformed. This was performed using the GNOM 
program which is relatively automated and easy to use (Semenyuk and Svergun, 1991; 
Svergun, 1992). Dmax is the maximum macromolecular dimension, and therefore 
corresponds to the length L. In GNOM, the P{r) curve was selected according to 
several criteria: (1) P(r) should exhibit positive values; (2) the Rg from GNOM and 
Guinier analyses should agree; (3) P(r) should be zero when r is zero; (4) P(r) should 
be stable and reproducible for different experimental I(Q) curves when Dmax is varied 
over a reasonable range. The length L was determined from P(r) when this became 
zero at large r, however errors in L can be significant as a result of the low intensity of 
P(r) in this region.
6.4 Analytical ultracentrifugation
6.4.1 Sedimentation velocity experiments
One of the two major types of analytical ultracentrifugation experiment is the 
sedimentation velocity experiment. Movement of the solute away from the air-solvent 
interface (i.e. the meniscus) in sedimentation velocity experiment leads to formation of 
a solute concentration gradient, called the boundary. Because it is a concentration 
gradient, the boundary sediments and diffuses with time, leading to ‘boundary 
spreading’ over the course of the experiment. After a sufficient centrifugal force is 
applied, the boundary forms and subsequently moves toward the bottom of the cell at a 
rate proportional to the sedimentation coefficients of the components in the sample
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(Figure 6.5). The rate of sedimentation in a centrifugal field is described by the 
Svedberg equation:
SVw = v/co2r = M (1 -  vp)/N/ Eq 6.9
S°2o,w is the sedimentation coefficient, v is the velocity of the molecule (v = dr/dt), <»2r 
is the strength of the centrifugal field (go is 27t*rpm/60 and r is the radial distance from 
the centre of rotation), M is the molecular mass,/is the fiictional coefficient (which is 
directly related to macromolecular shape and size), p is the density of the solvent, N is 
Avogadro’s number (6.023 x 1023), and v is the partial specific volume of the solute (M 
and v can be calculated from the molecular composition using SLUV) (Perkins, 1986).
The sedimentation coefficient of a glycoprotein is useful as this is a shape 
parameter that leads to the calculation of its frictional coefficient /  that can then be 
compared with/ calculated for a molecular model. The frictional coefficient can also 
be used to calculate the frictional ratio flfo of the glycoprotein. / 0 is the frictional 
coefficient of the sphere with the same volume as the glycoprotein, which is given by 
Stokes law:
fo -  6rcqrs Eq6.10
where q is the viscosity of the solvent, which is assumed to be 0.001002 N s m'2 for 
aqueous protein solutions and rs is the radius of the sphere. The frictional ratio is a 
measure of the elongation of the glycoprotein, and it is analogous to the use of the 
solution scattering anisotropy ratio Rg/Ro- The only quantity that needs to be measured 
is the sedimentation coefficient, re-expressed as:
a * -  1 *S 20,w at =  —  ------
<0 r Eq 6.11
Integration over the distance travelled by the particle from r0 (t=0) to r (t=t) gives:
r
r« Eq 6.12
S<2o.. =  — -rln  —
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Figure 6.5 Sedimentation velocity cell design and data collection. The sample is 
placed in one sector (sample), and an aliquot of the solvent in the other sector 
(reference). The samples are centrifuged at high rotational velocity, generating a 
boundary that moves toward the bottom of the cell. As the boundary progresses down 
the cell, the concentration in the plateau region decreases from radial dilution and the 
boundary broadens from diffusion. The position of the boundary is indicated. A set of 
10 scans (ti represents the first scan, and tio - the 10th scan) is collected at set time 
intervals using the absorbance optical system. (D2r is the strength of the centrifugal 
field, and is also indicated above.
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Because co is known, S°2o,w is calculable (Chang, 1981). Suitable optical means such 
as refractive-index measurements using classical Schlieren optics or scanning 
absorption optics are used to measure the movement of the sedimenting boundary as a 
function of time and thereby results in the sedimentation coefficient (Harding, 1994).
Hydrodynamic analyses can be used to relate the effect of a centrifugal force on a 
protein in solution to the size and shape of the protein. Therefore the sedimentation 
coefficient S°2o,wof a protein provides structural information that is complementary to 
Rg measurements determined by solution scattering (Perkins, 1998). Hydrodynamic 
theories have been developed to allow modeling of structures using the sedimentation 
coefficient, frictional ratios and corresponding equivalent ellipsoid of revolution 
(Harding, 1994). Velocity centrifugation can also give information on how the 
molecules interact with each other (self-association) and on the flexibility of the 
molecule.
6.4.2 Sedimentation equilibrium experiments
The second major type of analytical ultracentrifuge experiments involves 
sedimentation equilibrium for determining molecular weights and consequently the 
oligomeric state of biomolecules. When the centrifugal force is sufficiently small, the 
process of diffusion significantly opposes the process of sedimentation, and an 
equilibrium concentration distribution of macromolecules can eventually be obtained. 
In diffusion, solute molecules move from a higher concentration to a lower one, while 
sedimentation reverses this process (Figure 6.6). When an equilibrium is established, 
no net flow occurs. For an ideal non-interacting single component system, the 
equilibrium distribution obtained is an exponential function of the buoyant mass of the 
macromolecule, M (1 -  vp), as described by the equation:
In C(r)/Co= M (1 -  vp) a>V-r02)/2RT Eq 6.13
C(r) is the sample concentration at radial position r, C0is the sample concentration at a 
reference radial distance r0, and R and T represent the gas constant and absolute
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Figure 6.6 Schematic representation of sedimentation equilibrium. A six-channel 
sedimentation equilibrium cell is illustrated. Three sample-reference pairs are loaded 
into the cell. The samples are subject to centrifugation at moderate rotational velocity. 
The flow of solute due to sedimentation (black arrows) increases with radial distance. 
This process is balanced at equilibrium by the reverse flow from diffusion (open 
arrows), which increases with concentration gradient.
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temperature, respectively. As with sedimentation velocity ultracentrifugation, optical 
techniques measure the protein concentrations C(r) and Co at r and ro. If v, p, and © are 
known, M can be calculated. Unlike velocity ultracentrifugation, the technique does 
not require any knowledge of the shape of the molecule or its diffusion coefficient. It 
is therefore one of the most accurate methods for the determination of molecular mass 
(Chang, 1981).
Sedimentation equilibrium is accurate to ± 3% for absolute molecular weights. 
They are not subject to complications from matrix interactions, sample dilution, and 
assumption of globular shape that accompany determination of M by techniques such 
as gel filtration chromatography. When various oligomeric species are in reversible 
equilibrium, the stoichiometries, equilibrium constants and even the thermodynamic 
parameters that define the interactions between dissimilar partners (hetero-association) 
can be obtained.
6.5 Materials and methods
6.5.1 Purification of PWF1 and PIWF4
The generation and purification of PIWF1 and PIWF4 have been described in 
Chapter 3 and their schematic structures are shown in Figure 6.7. The eluted fractions 
containing the highest concentration of the desired protein were harvested and dialysed 
into phosphate-buffered saline (total 220 mM NaCl), followed by concentrating to 0.5 
ml using a 5,000 Da cut-off concentrator (Pierce).
6.5.2 X-ray scattering data acquisition at ESRF
X-ray scattering data was measured in three independent sessions at the ESRF, 
Grenoble, France, at the solution scattering cameras on Station ID02. Experiments 
were performed with beam currents in a range between 9 and 12 mA for PIWF1 and 
26 to 41 mA for PIWF4 with a ring energy of 6.0 GeV in single bunch mode to reduce 
radiation damage. PIWF1 between 0.6 and 1.2 mg/ml and PIWF4 between 0.2 and 0.4 
mg/ml were measured at 15°C in 10 time frames with checks for radiation damage in 
Perspex cells, contained within mica windows of thickness 25 pm. Data reduction
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Figure 6.7 Domain structure of recombinant anosmin-1. Each domain in the truncated 
analogue PIWF1 (a) and the mature protein PIWF4 (b) is represented by a circle, 
followed by V5 and 6His epitope at its C-terminus. Residue numbering indicates the 
size of each domain. The location of six putative N-glycosylation sites is indicated by 
numbered Y symbols. The signal peptide is not shown but contributes residues 1-23. 
CR, cysteine-rich region; H, histidine-rich region; V5, the V5 epitope tag derived from 
simian virus 5; 6His, 6><histidine tag.
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included the use of the Lupolen sample for the calibration of detector intensities, and a 
silver behenate salt standard for the calibration of the Q range.
6.53 Analysis of reduced X-ray data
In a given solute-solvent contrast, the radius of gyration Rg is a measure of 
structural elongation if the internal inhomogeneity of scattering densities has no effect. 
Guinier analyses at low Q give the Rg and the forward scattering at zero angle 7(0) (Eq 
6.3). This expression is valid in a Q'Rg range up to 0.7 for extended rod-like particles, 
and is approximate in a Q Rg range up to 1.5 for more spherical particles in which it 
slightly underestimates the true Rg value. The relative 7(0) values for samples 
measured in the same buffer during a data session gives the relative molecular masse 
Mr of the proteins when referenced against a suitable standard. If the structure is 
elongated, the mean radius of gyration of the cross-sectional intensity at zero angle 
(7(0*0 q —o is obtained from Eq 6.4. The Rg and Rxs analysis lead to the triaxial 
dimensions of the macromolecule and give the length of a protein if shaped like an 
elongated elliptical cylinder (Eq 6.5). Indirect transformation of the scattering data 
7(0  in reciprocal space into real space to give the distance distribution function P(r) 
was performed using GNOM. This offers an alternative calculation of the Rg and 7(0) 
that is based on the full scattering curve, and gives a model-independent maximum 
dimension of the macromolecule L.
63.4 Analytical ultracentrifugation data acquisition and analysis
Analytical ultracentrifugation was performed on a Beckman XL-I instrument in 
which the protein concentration distribution within the cell was monitored using its 
absorbance monitored at a single wavelength set between 280 nm and 295 nm, and its 
refractive index was measured by interferometry. Sedimentation equilibrium 
experiments were performed for PIWF1 at three concentrations between 0.24 mg/ml to
0.8 mg/ml in PBS + 80 mM NaCl and for PIWF4 at three concentrations between 0.12 
mg/ml to 0.4mg/ml in PBS + 80 mM NaCl. Data were acquired over 45 hours using 
six-sector cells in an AnTi 50 rotor with column heights of 12 mm at rotor speeds of
11,000 rpm, 14,000 rpm, 17,000 rpm and 20,000 rpm until equilibrium had been
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reached at each speed, as shown by the perfect overlay of runs measured at five hour 
intervals. The molecular mass (M) was analyzed on the basis of a single species using 
Beckman software provided as an add-on to Origin Version 4.1 (Microcal Inc), for 
which the partial specific volume v for PIWF1 and PIWF4 were calculated to be 0.720 
ml/g and 0.723 ml/g, respectively, from their sequences (Perkins, 1986a).
Sedimentation velocity data were acquired over 16 hours at rotor speeds of
35,000 rpm and 42,000 rpm in two-sector cells in an AnTi 50 rotor with solution 
column heights of 12 mm. The PIWF1 concentration was 0.8 mg/ml, and that for 
PIWF4 was 0.4 mg/ml, both being in PBS + 80 mM NaCl. For the g(s*) analysis, 
successive absorbance and interference scans were recorded at eight minute intervals. 
In time derivative analysis, the five pairs of concentration scans within 10 scans were 
subtracted from each other and averaged to eliminate systematic errors arising from 
baseline distortions. The extrapolation of individual subtractions to the start time gives 
the g(s*) function, which was computed using the DCDT+ program, from which the 
sedimentation and diffusion coefficients were determined from the peak position and 
width, respectively. The fits were determined in conditions when the maximum 
permissible measurable molecular mass was over 16 times the expected value, 
meaning that time broadening effects were negligible.
6.6 Experimental results and discussion
The preparations of PIWF1 and PIWF4 proteins for scattering and 
ultracentrifugation studies resulted in single bands in silver staining, indicating their 
high purity. X-ray scattering experiments were performed on PIWF1 and PIWF4. In 
Guinier analyses to determine the overall shape of the proteins from the radius of 
gyration Rg (a measure of elongation), the fits in Guinier plots were linear in an 
appropriate Q'Rg range up to 1.2 for PIWF1 and PIWF4 (Figure 6.8 (a) and (b)), 
where Q = 4rc sin 0/X (20 = scattering angle; A, = wavelength). With PIWF1, the ten 
successive time-frames obtained during each X-ray data acquisition for each sample 
were unchanged, and therefore showed that no radiation damage effects had occurred. 
Radiation damage on PIWF4 was observed with successive sessions; however, the
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Figure 6.8 Guinier Rg and Rxs analyses of PIWF1 and PIWF4. The Guinier plots are 
displaced arbitrarily on the intensity axis for reason of clarity. The 7 (0  data used to 
obtain Rg and Rxs values are denoted by filled circles in the Q'Rg and Q-Rxs enclosed 
by arrows depicted on the curves, (a) X-ray Rg fits using a Q range of 0.19-0.38 nm'1 
for PIWF1 at a concentration of 0.68 mg/ml (upper graph) and 0.34 mg/ml. (b) X-ray 
Rg fits using a Q range of 0.1-0.2 nm'1 for PIWF4 at a concentration of 0.4 mg/ml 
(upper graph) and 0.2 mg/ml. (c) X-ray Guinier Q-Rxs fits using a Q range of 0.6-1.0 
nm'1 for PIWF1. (d) X-ray Guinier Q'Rxs fits using a Q range of 0.3-0.6 nm'1 for 
PIWF4.
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first time-frame for each diluted sample was consistently measured, and thus only the 
first acquisition time frames were analyzed. The mean final X-ray Rg of PIWF1 was 
3.09 ± 0.21 nm, and that for the X-ray Rg of PIWF4 was 7.78 ± 0.97 nm.
In cross-sectional Guinier analyses to determine the shorter axes of the two 
proteins from the cross-sectional radius of gyration Rxs, a single linear fit range at Q 
values higher than those used for the Guinier Rg plots above was identified for both 
PIWF1 and PIWF4 (Figure 6.8 (c) and (d)). These Q range results in mean cross- 
sectional radii of gyration Rxs of 1.49 ±0.13 nm for PIWF1 and 1.88 ± 0.07 nm for 
PIWF4. The similarity of Rxs value shared by these two proteins suggested that it 
monitors the interdomain orientations between adjacent N-terminus CR, WAP domain 
and Fnm domains. It can therefore be inferred that this interdomain orientation is 
similar between these two proteins. If the solution structures of PIWF1 and PIWF4 are 
approximates as an elongated elliptical cylinder, the length of the cylinder L was then 
calculated. The Rg and Rxs values resulted in a length of 9.6±0.7 nm for PIWF1 and 
an equivalent length estimate of 26.1±3.5 nm for PIWF4.
The indirect transformation of the scattering curve 7(0) (measured in reciprocal 
space) into real space gives the distance distribution function P(r). This represents the 
summation of all the distances r between every pair of atoms within the protein. The 
Rg, 1(0) and L values that are calculated from the P(r) curve are now based on the full 
scattering curve in the Q range between 0.013 nm'1 and 2.2 nm"1, and give another 
determination of L that is now independent of shape assumptions. The Rg values 
calculated from the P(r) were in good agreement with the Guinier values. The most 
frequently occurring distance for PIWF1 is r = 2.5 nm from the maximum M in the 
P(r) curve, and its length L was determined to be 11 ± 1 nm at the point when P(r) 
becomes zero at large r (Figure 6.9 (a)). The P(r) curve gives the maximum M at an r 
value of 4 nm and length L of 24 ± 1 nm for PIWF4 (Figure 6.9 (b)).
Analytical ultracentrifugation provided an independent monitor of the solution 
scattering results. Molecular masses were determined using equilibrium experiments
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Figure 6.9 Distance distribution functions P(r) for PIWF1 (a) and PIWF4 (b). The 
maximum of the P(r) curve is denoted by M, the most frequently occurring distance 
within PIWF1 and PIWF4. The maximum dimensions of PIWF1 and PIWF4 are 
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(Materials and Methods). Curve fits assumed the presence of a single species, and this 
resulted in excellent fits with random small residuals (Figure 6.10 and 6.11).
The sedimentation coefficient S°2o,w from sedimentation velocity experiments 
monitors macromolecular elongation and complements the Rg determination. Typical 
time-derivative analysis using the g(s*) method to analyse pairs of sedimentation 
boundaries resulted in S°2o)W values of 2.46 S (absorbance) and 2.32 S (interference) 
for PIWF1 (Figure 6.10 (a) and (b)), 3.31 S (absorbance) and 3.26 S (interference) for 
PIWF4 from the peak centres in Figure 6.10 (c) and (d). In the final analyses, the mean 
S°2o,w values was determined to be 2.40 ±0.13 S from a total of 15 determinations for 
PIWF1, and 3.27 ± 0.77 S from a total of 18 determinations for PIWF4.
Molecular masses were determined using sedimentation equilibrium experiments 
(Materials and Methods). Curve fits assumed the presence of a single species, and this 
resulted in excellent fits with random small residuals (Figure 6.11 (a)-(d)). Based on 
curve fits for rotor speeds of 17,000 rpm, 20,000 rpm and 25,000 rpm, the molecular 
masses of PIWF1 were similar at 38,000 ± 700 Da for interference and 38,000 ± 1,200 
Da for absorbance (Figure 6.11 (a) and (b)). A systematic decrease in the molecular 
mass of PIWF4 was observed with increasing rotor speed. A rotor speed of 14,000 
rpm gave PIWF4 molecular mass values of 90,000 ± 1400 Da and 17,000 rpm for 
77100 ± 500 Da respectively, and the representative curve fits were shown in Figure 
6.11 (c). Consistent with the predicted molecular mass, the slow rotor speed of 
ll,000rpm gave 94,500 ± 8,300 Da for more diluted PIWF4 (Figure 6.11 (d)). These 
experiments confirmed that anosmin-1 is a monomer, but the decrease in molecular 
weight is consistent with some polydisperity, which is attributed to variable 
carbohydrate contents at the six glycosylation sites in anosmin-1 (Figure 6.7).
The length of 11 nm for PIWF1 and 24 nm for PIWF4 gave a difference of 13 
nm which corresponds to the total length of the C-terminal three Fnin domains. In 
fibronectin the dimensions of individual Fnin domains have been measured by 
crystallography, resulting in an average length of about 3.5 nm. The presence of these
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Figure 6.10 Sedimentation velocity fit of the g(s*) distribution for PIWF1 and PIWF4. 
Ten scans recorded at eight minute intervals were recorded using absorbance (a, c) and 
interference (b, d) optics at 280 nm and a rotor speed of 35,000 rpm for PIWF1 (a, b) 
at 1.12 mg/ml and PIWF4 (c, d) at 0.32 mg/ml. Analysis gave s°2o,w values of 2.46 S 
(a) and 2.32 S (b) for PIWF1 and 3.31 (c), 3.26 S (d) for PIWF4 respectively, as 
arrowed.
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Figure 6.11 Sedimentation equilibrium fit for PIWF1 and PIWF4. Best-fit curves for 
PIWF1 at rotor speeds of 17,000 rpm, 20,000 rpm and 25,000 rpm using interference
(a) and absorbance optics (b). Best-fit curves for PIWF4 at rotor speeds of 14,000 
rpm, 17,000 rpm (c) and 11,000 rpm (d) using interference optics. The residuals of the 
curve fits are shown in the upper panels respectively.
three Fnin domains would measure -10.5 nm in total length if arranged head to tail, 
compatible to the 13 nm obtained in the present X-ray scattering experimental results. 
This result is consistent with the expectation for the elongated conformation of the C- 
terminal Fnin domains in anosmin-1.
Although hydrodynamic analysis is less straightforward for evaluating the shape 
of a protein molecule, it is still considered as a complementary method for X-ray 
scattering and electron microscopy analysis. The most useful hydrodynamic parameter 
is Smax/S, where Smax/S is the maximum possible sedimentation coefficient for a 
protein of the given mass, corresponding to a sphere of the minimum diameter to
contain the given mass of protein, with no water of hydration. The ratio Smax/S is the
same as/Xmn, where/is the actual frictional ration of the hydrated protein, and/nin is 
the friction coefficient of the unhydrated protein (Schurmann et al., 2001). The 
theoretical value of Smax can be calculated by the equation: Smax = 0.00361 xM2/3 
Svedberg unit. Some typical numerical values for protein from 10,000 to 1,000,000 Da 
are sphere (Protein structure, Harold P. Erickson, Jan. 2003, 
http://www.cellbio.duke.edu/Facultv/Erickson):
Protein Mr (kDa) 10 25 50 100 200 500 1,000
Smax 1.68 3.1 4.9 7.8 12.3 22.7 36.1
The guideline for estimation of protein overall structures is
1. No protein has Smax/S smaller than 1.15-1.2.
2. Globular proteins has Smax/S between 1.25-1.4
3. Moderately elongated proteins is in the range of 1.6-1.9
4. Highly elongated protein is in the range of 2.0-3.0.
5. Very long, thread-like molecules can have Smax/S in the range of 3.0-4.0.
PIWF1 is 38 kDa, and has a measured sedimentation coefficient of 2.4 S, whereas 
PIWF4 with 90 kDa has a 3.27 S. The predicted Smax for a 38 kDa protein is 4.03 S 
and for 90 kDa is 7.22 S. Smax/S can be calculated as 1.68 for PIWF1 and 2.21 for 
PIWF4. These results suggest a moderately elongated conformation for PIWF1 and a 
higher elongation for PIWF4. This result is consistent with the observation derived
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from the X-ray scattering data that the C-terminal three Fnin domains in anosmin-1 
should be fully extended.
6.7 Homology modelling of anosmin-1 domains
There are six domains to be modelled (Figure 6.7 (b)). Their sequences and the 
linkers are defined in Figure 6.12. Homology models of the WAP and four fibronectin 
domains in PIWF1 and PIWF4 were generated previously in our laboratory by Dr A. 
Robertson using Insightn and its packages (Biosym/San Diego) on Silicon Graphics 02 
workstations as previously described (Robertson et al., 2001). Briefly, the Fnin 
domains were modelled using the known structures of Drosophila neuroglian (PDB: 
1CFB), human fibronectin (PDBs: 1FNF, 1TTG, 1TTF and 1FNA), human tissue factor 
(PDBs 2HFT, 1BOY and 1DAN), tenascin (PDB: 1TEN), erythropoietin (PDB: 1EBP), 
human growth hormone (PDB: 3HHR), and murine granulocyte colony-stimulating 
factor (PDB: 1GCF). The WAP domain was based on the crystal and NMR structures 
of the closely homologous WAP domain from elafin (PDB codes: 1FLE, 1REL and 
2REL).
The sixth domain is the N-terminal 107 residues of both PIWF1 and PIWF4 that 
comprised the CR which is attached to the WAP domain by a short linker (Figure 6.12). 
Its structure was unknown, and database searched were performed in collaboration with 
Dr. J.T.Eaton. A psi-BLAST search of the CR sequence against a non-redundant 
database of protein sequences identified the subtilisin-like proprotein convertase (gi: 
7435770) as a homolog sharing 28% sequence identity and 38% similarity with an 80 
residue section of the CR where seven of the ten CR cystines were conserved. This 
convertase in turn shared 38% sequence identity and 45% similarity over the same 
region with rat epidermal growth factor receptor (EGFR, gi: 24987353, PDB: 1N8Y), 
whose structure has been determined by X-ray crystallography. Consequently, the CR 
was aligned with EGFR. No significant alignment was found using the program 
BLAST. However, alignment with the program lalign, performed using the less 
stringent gap opening penalty of -10 (default = -14) produced the alignment shown in
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(a) Sequence of PIWF1 for modelling
30 40 50 60 70
CR AAGPGAAAARRLDESLSAGSVQRARCASRCLSLQITRISAFFQHFQN
80 90 100 110 120
NGSLVWCQNHKQCSKCLEPCKESGDLRKHQCQSFCEPLFPKKSYECLTSC
130 1 +
Linker 1 EFLKYILLVK
140 150 160 170
WAP domain q g d c p a p e k a s g f a a a c v e s c e v d n e c s g v k k c c s n g c g h
TCQVPK
180
Linker 2 t l y k g v p l k p r
190 200 210 220
F n I I I - 1  — l— —- 1— +------- | -------+------- | - —-+
KELRFTELQS GQLEVKWS S KFNISIE P V I Y W Q  
230 240 250 260 270
RRWNYGIHPSEDDATHWQTVAQTTDERVQLTDIRP S RWYQFRVAAVNVHG 
280
TRGFTAPSKHFRSS
285
KDPSA
GKPIPNPLLGLDSTRTG 
HHHHHH
Linker 3
V5-epitope 
6-His tag
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(b) Sequence of PIWF4 for modelling
The CR + WAP domain + FnIII-1 are the same as in PIWF1 shown in (a).
290
I-----+—
Linker 3 k d p s a p p a
300 310 320 330 340
FnIII-2 PANLRLANSTVNSDGSVTVTIVWDLPEEPDIPVHHYKVFWSWMVSSKS
350 360 370 380 390
LVPTKKKRRKTTDGFQNSVILEKLQPDCDYWELQAITYWGQTRLKSAKVSLHFT 
400 410 420
 -+ ----- | ---------+------- | ----- +-------- | -
Linker 4 s t h a t n n k e q l v k t r k g g iq t q l p f q r r r p t
430 440 450
FnIII-3 RPLEVGAPFYQDGQLQVKVYWKKTED
460 470 480 490 500
PTVNRYHVRWFPEACAHNRTTGS EAS S GMTHENYIILQDLS FS CKYKVTVQPIRP 
510 520
KSHSKAEAVFFTTPP
530 540 550
Linker 5 c s a l k g k s h k p i g c l g e a g h v l s k v l a k
560 570 580 590 600
 | ----+------- | ----- +----1-------+---- | ------ +---- | ------+----- |-
FnIII-4 PENLSASFIVQDVNITGHFSWKMAKANLYQPMTGFQVTWAEVTTESRQNSLPNSII
610 620 630 640 650
SQSQILPSDHYVLTVPNLRPSTLYRLEVQVLTPGGEGPATIKTFRTPEL 
660 670 680
His-box PPSSAHRSHLKHRHPHHYKPSPERY
V 5-epitope g k p i p n p l l g l d s t r t g
6-His tag hhhhhh
Figure 6.12 The amino acid sequence and residue numbering of the individual 
domains of recombinant anosmin-1. The sequences of PIWF1 (a) and PIWF4 (b) for 
modelling are shown. The linker peptides are indicated by underlining. The six 
glycosylation sites are marked in red.
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Figure 6.13 Sequence alignments of anosmin-1 CR with epidermal growth factor receptor (EGFR) and insulin-like growth factor 
receptor (IGFR). Cysteine residues are highlighted in red, and underlined if they are not aligned with another cysteine. Brackets 
below the alignment indicate the disulphide bonding pattern of the crystal structure, while those above indicate the disulphide 
bonding pattern for the model. Dotted arrows indicate that a disulphide bond exists between the denoted cysteine and another 
cysteine that is not part of the alignment. DSSP secondary structure is taken from the pdb file where H is an alpha-helix, E is a beta- 
strand, B is a beta-ladder, and T and S are loops. Acc is the solvent accessibility as calculated using the program Naccess and 
hashes represent residues missing from the pdb file.
Figure 6.13, with 25.8% residue identity and 45.8% residue similarity over the 85 
residues of the CR sequence used in the alignment. This segment of EGFR constitutes a 
furin-like domain, a cysteine-rich region of eukaryotic proteins which is involved in 
signal transduction by receptor tyrosine kinases. The alignment also showed nine of the 
ten cysteine residues in the CR to be conserved in EGFR, including three disulphide 
bridges. Though there are several insertions and deletions in the alignment, these were 
all found in loop regions within the structure where these are readily accommodated. 
Consequently, EGFR was used as the initial template for the modelling of the CR 
structure (see below).
Further searches using psi-BLAST identified a second homologue for the CR, 
namely the insulin-like growth factor receptor (IGFR, pdb code: 1IGR), with 22.4% 
sequence identity and 40% sequence similarity over the 85 residues of the CR. This 
sequence alignment now matched nine of the ten cysteines in the CR with the IGFR 
structure and had only two gaps in the alignment, towards the beginning and end of the 
domain and one single amino acid deletion, and one single amino acid insetion in the 
middle of the structure. None of these insertions and deletions occurred inside a 
secondary structural element. Consequently, this model was considered to be the better 
of the two templates for building the CR structure (Figure 6.13).
The modelling process for the CR used the Homology module of the Insightn 
molecular graphics package (Aceelrys, San Diego, USA). The conserved residues 
(marked in bold in Figure 6.13) were used to build the backbone of the CR structure. 
Insertions in the CR were built using the loop search option of Homology, which scans 
a database of known loop structures and returns the ten most favourable loop 
conformations. Manual inspection resulted in the selection of loop regions which did 
not interfere with the conserved structural portions of the CR, and which followed a 
similar spatial path to the EGFR furin-like domain. Residues either side of the 
deletions in the CR structure were manually repositioned and energy minimised by the 
lego-loop option of the molecular visualisation and building package O (Jones et al., 
1991).
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Of the five disulphide bridges present in the IGFR structure, two are conserved in 
the CR (Cys 53-Cys77, Cys90-Cysl01), and another two can be generated by minor 
rearrangement of the loops in the structure (Cys87-Cysl05, Cysll6-Cysl20). A fifth 
disulphide bond (Cys49-Cys83) (marked with a dotted line in Figure 6.13) could be 
generated, but this would require gross conformational changes in the N-terminal part 
of the CR. As a result, these residues were left as free cysteines. Both the CR and 
IGFR structures are highly similar (Figure 6.14). It was concluded that the pattern of 
Cys disulphide bridges in the CR is well understood, using the IGFR structure, 
especially in the lower half of the structure as shown in Figure 6.14.
Oligosaccharide chains were added to the six glycosylation sites on the Fnin N- 
linked glycosylation sites and the CR as required (N71, N209, N300, N470, N553 and N564) 
(Figure 6.12). The oligosaccharide structure was taken from the Fc fragment of 
human IgGl KOL (1FC1) and extended using the BIOPOLYMER package into a bi- 
antenary complex-type structure Asn-GlcNAc-GlcNAc-Man-(Man-GlcNAc-Gal- 
NeuNAc)2, and oriented to point away from the domain surface to which it was 
attached.
6.8 Construction of the full models for PIWF1 and PIWF4
The CR, WAP and FnIII-1 domains are separated from one another by linkers of 
varying lengths (Figure 6.12). These linker peptides were modelled in the 
BIOPOLYMER package of Insightn with extended conformations. The peptides were 
then subjected to a maximum of 300 cycles of steepest descent and Polak-Ribiere 
conjugate gradient minimisation at a temperature of 773K using the DISCOVER 3 
package with default convergence values. This was followed by a 5000 fs molecular 
dynamics simulation, and a further 1.5 x 106 fs simulation saving the linker structure 
every lOOfs. This generated libraries of 1,000 peptide conformations that will in future 
be used to generate several thousand models of intact PIWF1 and PIWF4 by joining the 
peptide linkers with the separate domain homology models for a thorough analysis of
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Cys116--Cys120
C ys90-C ys101
C ys87-C ys105
Figure 6.14 Structural comparison of the CR domain of anosmin-1 and IGFR. 
Ribbon representations show the comparison of the homology model for the 
anosmin-1 CR (a) with that of IGFR cysteine rich region (b). The a-carbon atoms 
of cysteine residues are represented by yellow spheres and the disulphide bridges 
are also indicated. N: N-terminus; C: C-teiminus.
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the structure of these proteins. For the purpose of this thesis, only a preliminary analysis 
of the overall structures of PIWF1 and PIWF4 has been made and these are set out 
below.
6.8.1 Debye scattering curve modelling of PIWF1 and PIWF4
In order to calculate theoretical scattering curves, Debye sphere models were 
constructed from the protein models. For each construct, an extended model was 
generated and placed in the centre of a three dimensional grid of cubes. If the number 
of atoms in a cube exceeded a user-defined cut-off, then the cube was used to calculate 
the volume of the protein. Cube side lengths and cut-off values were optimised to 
produce a volume which was within 1% of that calculated for the construct from its 
amino acid and carbohydrate composition (Perkins, 1986b). Each cube was then 
replaced by a sphere of equivalent volume. X-ray scattering models require the 
addition of a hydration shell. A hydration of 0.3g H20/g glycoprotein and an 
electrostatic volume of 0.0245 nm3 per bound water molecule (Perkins, 2001) was 
modelled using the HYPRO procedure (Ashton et al., 1997) in which excess spheres 
were added to the dry sphere model and sequentially removed until the desired 
hydration volume was reached.
The X-ray scattering curves for PIWF1 and PIWF4 were calculated assuming a 
uniform scattering density for the spheres, using the Debye equation adapted for 
spheres (Perkins and Weiss, 1983). The X-ray scattering curves were calculated from 
the hydrated models assuming no wavelength spread or beam divergence as these are 
considered minimal for synchrotron X-ray radiation. The Rq and Rxs values of the 
models were calculated in the same Q range as the experimental Guinier fits, and the 
assumption of a ± 5-10% deviation from the experimental values Rg and Rxs was 
assumed to constitute an accurate model. Additionally, the models were assessed 
using a goodness-of-fit i^-factor defined by analogy with protein crystallography and 
based on the experimental curves in the Q range extending to 2.0 nm-1 (denoted R{2.o)) 
such that:
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J U - 1 0 0 * 2
l{Q)s ~  In /  (Q)m
f a  In /(G),Q-0
where In I(Q) is the natural logarithm of the intensity, I, at scattering angle, Q, and the 
subscripts E and M refer to the experimental and model data respectively. From this it 
can be seen that the lower the value of Rq.o), the better the model data fits the 
experimental data, /^-factors in the range 1.2 -  8.7 % represent good fits (Perkins et al., 
1998).
6.8.2 PIWF1 and P1WF4 models
The approximate maximal lengths of each domain are as follows: CR, -4.8 nm; 
WAP domain, -4.3 nm, and each Fnin domain -4.2 nm. Because the P(r) curves of 
the PIWF1 and PIWF4 showed maximal molecular lengths of 11 nm and 24 nm 
respectively (Figure 6.9), it can already be deduced from the difference of 13 nm 
between them that the C-terminal three Fnin domains of predicted length 12.6 nm lie 
in an extended conformation. The sum of the lengths of the CR, WAP and the first 
Fnin domain gives -13.3 nm, which is comparable with the experimental length of 11 
nm for PIWF1 if this is extended. Hence it was assumed that the two structures for 
PIWF1 and PIWF4 would be relatively elongated.
To assess the domain structure of PIWF1 and PIWF4, the domains of PIWF1 
were aligned in Insightn to produce a number of linear models from which theoretical 
X-ray scattering curves were generated. Table 6.1 shows the comparison of the Rg 
and Rxs values of the models with the experimentally derived values from X-ray 
solution scattering, and the associated /^-factors. While the Rg values for both the 
extended and compact models of PIWF1 are close to those experimentally derived, the 
Rxs value for the extended form is less than half that required, while the Rxs value for 
the compact form is within 10% of the experimental value. These results suggest that 
the compact model for PIWF1 is a fairer representation of the protein in solution than 
is the elongated form used. In contrast, the values derived for an extended model of
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PIWF4 are better than those generated using a compact N-terminus (Figure 6.15). This 
is unexpected as it would be presumed that both PIWF1 and PIWF4 could possess 
similar domain structures. There is no difference in the calculated Rxs values, and the 
compacted PIWF4 molecule generates an i?-factor that is only slightly worse than that 
of the elongated form. The Rg value of the compacted form of PIWF4 is 66% of that 
derived from experimental measurement, whereas the extended model has an RG value 
which is 80% of the target value. Though there are not enough data at present to 
definitively state that the elongated form is the correct model of PIWF4, it is certainly 
the best model until a more complete analysis of the modelling is carried out. The 
quality of both the PIWF1 and PIWF4 models can be seen in the In 7 (0  v Q curve fits 
below (Figure 6.16). The significance of these models is discussed in Chapter 7.
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Table 6.1 Summary of the results of modelling PIWF1 and PIWF4 in compact and extended conformations
Model Rq Range
Experiment
Rg
Model
Rxs Range Rxs
Experiment
Rxs
Model
itfactor
PIWF1-
extended
0.19-0.38 3.09+/-0.21 3.54+/- 0.01 0.6-1.0 1.49+/-0.13 0.67+/-0.01 13.9
PIWF1
compact
0.19-0.38 3.09+/- 0.21 3.21+/-0.04 0.6-1.0 1.49+/-0.13 1.35+/-0.00 6.0
PIWF4-
extended
0.1-0.2 7.78+/-0.97 6.16+/-0.02 0.3-0.6 1.88+/-0.77 1.33+/-0.01 11.4
PIWF4
compact
0.1-0.2 7.78+/-0.97 5.13+/-0.01 0.3-0.6 1.88+/-0.77 1.33+/-0.00 13.6
PIWFl-extended
CR Fnin-2 FnIH-3Fnin-1
PIWF4-extended
(d) PIWF1-compact
CR
FnIH-3FnIII-1 Fnin-2 FnIH-4
PIWF4-compact
Figure 6.15 Representations of extended and compact forms of the PIWF4 construct, 
(a) Ribbon diagram of the extended conformation of PIWF4 used in modeling. The 
polypeptide backbone is illustrated in green, while the glycosylation are represented in 
red. (b) Cartoon representation of (a) showing where the model has been cleaved to 
generate the comparably extended PIWF1 model, (c) As (a), for the compacted 
model. For the purposes of clarity, the sugar groups have been omitted. The CR and 
FnIII-1 glycosylations run perpendicular to the plane of the page, (d) As (b), but 
illustrating that the CR is folded onto the FnIII-1 domain and the WAP domain is to 
the outside of the structure.
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Q (n m 1)
Figure 6.16 In I(Q) v Q curve fits for the compact model of PIWF1 (top) and PIWF4 
(bottom). Experimental data is represented by circles while the theoretical curve is a 
solid line. Ribbon diagram representations of each of the models used to generate the 
scattering curves are shown in inset.
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C hapter 7
Conclusions and future studies
The molecular pathogenesis of Kallmann’s syndrome is still largely unknown 
although the role of the KAL-1 gene product, anosmin-1, has been investigated mainly 
in neuronal differentiation during the past decade. The studies in this thesis were 
designed to 1) generate desirable quantity and quality of recombinant anosmin-1; 2) to 
characterize and identify anosmin-1’s domain-specific interactants; 3) finally to 
investigate the overall conformation of anosmin-1. The results presented in this thesis 
will help further our knowledge of the biological actions of this modular protein as 
well as extending our understanding of its structural characteristics. The data presented 
will also extend the understanding of the molecular mechanisms of this developmental 
disease.
The method described in this dissertation generated sufficient amounts of 
recombinant anosmin-1 using a Drosophila S2 cell expression system in suspension 
culture, followed by one-step purification using Ni-NTA affinity chromatography 
(Chapter 3). The biochemical interaction between anosmin-1 and HS has been 
systematically studied and these studies demonstrated that 1) the Fnin repeats of 
anosmin-1, particularly the first, make a major contribution to the dose-dependent HS 
binding and 2) their kinetic interaction measured in real-time indicates high affinity 
(K& value = 2 nM) (Chapter 4). uPA is the first identified serine protease interactant 
of anosmin-1. The function repercussions of co-operation between anosmin-1, HS and 
uPA have been investigated on PC-3 cell proliferation (Chapter 5). Finally structural 
studies using X-ray scattering, analytical ultracentifugation and homology molecular 
modelling provide the first experimentally determined evidence that the overall 
conformation of anosmin-1 is an elongated structure (Chapter 6).
7.1 The questions raised from this study
The studies described in this thesis have spawned new and important scientific 
questions that will need to be addressed in future studies. Thus, what is the structural
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specificity of the HS sequence motif involved in anosmin-1 binding and function? As 
described previously, the modified sulphated pattern at the 6-0 site of HS 
monosaccharide residue has been identified as a determining structural requirement for 
anosmin-1 induced neurite outgrowth and axonal branching as demonstrated in 
transgenic C.elegans model (Bulow et al., 2002). However, in these and previous 
studies, there were no data to show whether lack of 6-0 sulphation in HS might affect 
the affinity of HS to anosmin-1. The heparin and HS used in the present study were 
composed of more than 80 fully sulphated saccharide residues, and have not enabled 
us to shed further light on this question. In order to do so, it will be necessary to 
generate specific HS fragments with distinct structural composition, and investigate 
their specific anosmin-1 binding characteristics.
What are the dominant amino acid residues within the FnHI domains that 
participate in the HS interaction? Hitherto, a total of three missense mutations have 
been identified within the Fnin domains: N267K in the 1st Fnlll domain, E514K and 
F517L in 3rd FnlH domain, suggesting that the basic amino acid components around 
these regions are highly likely to represent the main HS binding sites. Of these 
important missense mutations, the N267K seems to be more important since it has 
been established that the 1st FnlH domain is mainly responsible for HS binding. 
During these studies, I attempted to generate full-length mutated anosmin-1 with the 
N267K substitution, but the protein yield was too poor to allow further studies. Thus 
the generation of individual FnlH domains incorporating the individual missense 
mutation might be an alternative approach.
What is the molecular mechanism of anosmin-1 regulation of uPA activity during 
cell processes either via modulation of uPA catalytic activity or through the uPAR 
related signaling pathway? I have generated a hypothesis based on the effect of 
anosmin-l/HS/uPA interplay on PC-3 cell proliferation (Figure 5.8). Anosmin-1, with 
its cell surface association via FnlH domain-HS interactions, may come in contact 
with uPA via its N-terminus including the WAP domain, causing uPA receptor 
(uPAR) activation and/or induction of uPA mediated proteolysis. Studies have shown
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a role of uPA and uPAR during cell proliferation in vitro, and in human malignant 
tumours, uPAR overexpression is often observed (Blasi and Carmeliet, 2002). 
Enhancement of uPA proteolytic activity can lead to activation of a number of growth 
factors such as insulin-like growth factor, FGF2 and transforming growth factor-p 
(Angelloz-Nicoud and Binoux, 1995; Rosini et al., 2002). It is not known, however, 
whether this mitogenic activity is dependent on the uPA mediated proteolysis or uPA 
binding to uPAR. Furthermore, the active domain in anosmin-1 (either WAP or CR 
domain) for uPA interaction still requires further clarification.
What are the structural implications in anosmin-1’s biological function? The 
preliminary homology modelling results showing PIWF1 and PIWF4 possess different 
N-terminal structural conformation may give explanations about the different 
biochemical characteristics between these two recombinant proteins. It is known that 
the FnlH domains are involved in binding HS. The main binding domain is FnIH-1, 
which is present in both PIWF1 and PIWF4. The reduced affinity of PIWF1 for HS 
can be explained by the absence of three FnlH domains. However, this does not 
explain why the C172R mutation in the WAP domain reduces the affinity of PIWF1 
for HS but does not affect the binding affinity of PIWF4. This difference may be 
explained by noting that in PIWF1 the WAP domain is in closer proximity to the 
FnIH-1 domain than it is in PIWF4. Structural changes in the WAP domain, 
introduced by removing a cysteine residue involved in a disulphide bond, may more 
strongly affect the overall conformation of the PIWF1 construct than it does the 
PIWF4 construct. The misfolding of the WAP domain in PIWF1 may cause it to 
elongate. Thus, it is possible that either the CR or WAP domain may facilitate HS 
binding to FnHI-1 in PIWF1. In constrast, because the structure of PIWF4 is already 
extended, disrupting the conformation of the WAP domain has no effect on its binding 
toHS.
uPA amidolytic activity in vitro is not significantly affected by the C172R 
mutation in PIWF4; both wild-type and mutant PIWF4 increased uPA activity by 
three-fold in this assay. However, PIWF1 produces a one-fold increase whereas the
206
mPIWFl172 has the same effect as the full-length PIWF4. If the WAP domain interacts 
with trypsin-like serine proteases, the WAP domain partially unfolded as a result of 
the C172R mutation may cause the serine protease binding site to be fully exposed, 
thus restoring wild-type activity. This suggests that although the WAP domain has to 
some extent unfolded, the parts of its structure required for interaction with serine 
proteases remains intact.
Certainly, further understanding of the coordinate atomic structure of ansomin-1 
and three-dimensional visualization of the complex formed by anosmin-1/ligands will 
require studies using homology modeling, crystallography and NMR.
7.2 Future studies
The availability of a diverse group of structurally modified HS is likely to shed 
important new insights on the interaction between HS and ansomin-1. The libraries of 
size-defined saccharides in mass quantities have been recently generated by partial 
degradation of HS from tissue sources. In addition, the chemical synthesis of defined 
HS and heparin saccharides can serve as the alternative approach to provide such 
molecules. First, biosensor interaction kinetics can be carried out by immobilizing HS 
saccharides containing defined HS size and sulphation patterns onto the sensor chip 
surface, followed by running the purified recombinant anosmin-1. Second, the role of 
specific saccharide sequences in mediating anosmin-l’s biological function can be 
identified through study of signal-transduction kinetics and neuron differentiation 
studies following co-treatment of defined HS and anosmin-1. Finally, homology 
modelling and crystallography can provide structural visualization and atomic 
elucidation of complex formation among anosmin-1, uPA and HS. The direct 
interaction of anosmin-1 with uPA, FGF2 or FGFR1 can be investigated in a domain- 
specific manner using the SPR studies by coupling either anosmin-1 or other 
macromolecules respectively onto the sensor chip surface. FNC-B4 cells have been 
identified as an excellent model system to investigate anosmin-l’s role during GnRHl 
olfactory neuroblast differentiation. Thus, FNC-B4 cells may be used productively in 
enabling further studies on the mechanisms of anosmin-1/uPA interaction. One
207
approach might be to use a method such as Boyden chamber assay or protein coupled 
beads embedded in fibrin gel to investigate die effect of anosmin-1 on GnRH neuron 
migration. Also it can provide a good model for analysis of whether uPA proteolysis is 
involved in neuronal differentiation and migration. In vivo studies such as implanting 
anosmin-1 coupled beads into the olfactory system of chicken embryo may further 
provide insights into the effects of anosmin-1 function on tissue morphogenensis and 
neuronal differentiation.
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